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ABSTRACT
Cancer is one of potentially preventable and treatable diseases. Cancer analysis from
different perspectives is necessary to provide the information for health research and the
initiation of prevention and treatment programs. The purpose of this study was to analyse
five top cancers in the Perth metropolitan area, including lung, melanoma, breast, prostate
and colorectal cancers, using two methodologies: Area-to-Point Poisson (ATP) kriging and
fitting an inhomogeneous Poisson process model using the Berman-Turner algorithm.

ATP Poisson kriging was used to undertake the analysis on the spatial distribution of
cancer rates per 100,000 person-years for Perth Statistical Local Areas during the period
1990-2005. This analysis is based on age-adjusted and age-sex-adjusted rates (non-sex
specific cancers only). For lung, colorectal and melanoma cancer incidence, it is also
evaluated for the period 1990-2005 by sex to investigate how these cancers affect males
and females differently. For mortality data, three contiguous periods: 1990-1995, 19962000 and 2001-2005 are studied to investigate how cancers vary over the time. It is
demonstrated that female cancer incidence varies more continuously than males and male
incidence rates are relatively high. There is difference in estimates and spatial variation
between age-adjusted rates and age-sex-adjusted rates. The cancer risk calculated from agesex-adjusted rates shows less variability than the risk only from age-adjusted rates. Lung
cancer incidence rates are high in Kwinana industrial area and melanoma cancer incidence
rates are relatively high along west coast of Perth. For breast cancer and prostate cancer, the
analysis during three contiguous periods is explored. Breast cancer incidence increased
gradually with time while prostate cancer mortality decreased with time. Prostate cancer
mortality risk from the age is possibly more continuous than the incidence risk from the age.
It is believed that cancer mortality rate varies more continuously than the corresponding
cancer incidence and that spatial correlation is relatively strong for mortality compared with
the incidence.

Spatial point pattern theory focuses on the analysis of the incidence (mortality) rates in the
year 2005. For each individual cancer adequately fitting models were determined and
validated. The model fitting is based on the inhomogeneous Poisson nature of the cancer
data. The spatial trends based on the population distribution in Perth metropolitan area are
iv

important in obtaining an adequate fit. Except for the spatial trends, the fitted intensity
function for the point process is also related to the spatially susceptible population. It is
demonstrated that the distance from Kwinana industrial area (KIA) is an appropriate
covariate for lung cancer incidence and the distance from the coast accounts for melanoma
incidence. Lung cancer incidence increases with proximity to the KIA and similarly
melanoma incidence increases with proximity to the coast. The incidence point pattern in
2005 is quite similar to the point pattern in other individual year (or years) when population
density is included. Compared with incidence, one covariate (susceptible population
intensity) is enough to achieve an adequate fit in most cases for mortality data fitting. The
percentage of selected age groups is a reasonable covariate for prostate cancer and lung
cancer while population density is a good covariate for other cancers since age has more
influence on these two cancer incidences than other cancers. The work shown here presents
spatial maps of incidence and mortality risk for the five major causes in Perth, potentially
aiding planning.
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1 INTRODUCTION
1.1 Background
Cancer is a major public health concern, as one of the world’s leading causes of death with
12% of the 56 million deaths in 2000 being due to cancer (WHO 2003). In some countries
more than 25% of deaths were attributed to cancer. In 2005 the percentage increased to
13%. Cancer killed more than 7 million people worldwide in 2006, which was more than
AIDS, malaria, diabetes, tuberculosis, malnutrition, violence and war combined (WHO
2007). There were 7.6 million cancer deaths in the world in 2008 and the cancer deaths
account for around 13% of all deaths (WHO 2011).

Cancer risk increases with age. With the population aging in some countries, cancer deaths
are predicted to rise to an estimated 9 million in 2015 and to 11.4 million in 2030 (WHO
2007).

Cancer is the leading cause of death in Australia, - more than 36,000 people die from
cancer annually, and the risk of developing some form of cancer is one in four for women
and one in three for men (TCCWA 2007). At least 88,000 new cases of cancer are
diagnosed each year.

In Western Australia (WA), at least 52,000 people are living with cancer. More than 8,000
new diagnoses are reported every year, an average of more than 20 per day (Threlfall and
Thompson 2004). Western Australia covers approximately one-third of the Australian
continent, but has less than one-tenth of the nation’s population, with the majority of the
population living in the Perth metropolitan area. The estimated population in the Perth
metropolitan area is 1,659,000 according to Australian Bureau of Statistics (2009).

According to WHO (2011), more than 30% of cancer deaths can be prevented. This study
aims to analyse cancer incidence and mortality recorded in the Perth metropolitan area
during the period 1990-2005. There are five cancer types considered: lung, melanoma,
breast, prostate and colorectal cancers. The analysis of cancer data will be presented at two
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different spatial scales: Statistical Local Areas (SLA) scale and a point pattern analysis at
finer scale.

1.2 Significance
According to the report by the Western Australian Cancer Registry (WACR 2008), the
most common cancers in males in 2008 were prostate cancer, colorectal cancer, melanoma
and lung cancer. For females, they are breast cancer, colorectal cancer, melanoma and lung
cancer. In 2008 one in seven men could be expected to have a diagnosis of prostate cancer
before the age of 75 and one in eleven women could be expected to develop breast cancer.

Information about the spatial distribution of cancers can be used for etiologic research and
the guidance for control activities in community health. The data used in this study are
cancer count data. The number of cancer cases can be regarded as the realisation of Poisson
random variable. Poisson kriging is applied to cancer data analysis to take into account the
Poisson nature. In addition, the data are recorded at domicile locations and so can be treated
using point pattern analysis. The kriging analysis at Statistical Local Area (SLA) scale
focuses on age-adjusted rates and age-sex-adjusted rates. In addition to age, sex is another
important cancer risk. For example, males have a much higher lung cancer risk than
females (WACR 2008), and this is also shown in Figure 4. As the population distribution
by sex may vary between areas, it is necessary to take into account sex for lung cancer
estimation. To the best of our knowledge this is the first attempt to include the sex
composition of the susceptible population in cancer data analysis aiming at a better
understanding of the correlation between cancer data and population composition. In
addition, this is the first application of Area-to-point (ATP) Poisson kriging to cancer data
in Perth based on the geographical characteristics of Perth.

Geostatistical modelling of cancer data takes place within areas (e.g. SLA) based on
adjusted rates during the entire study period 1990-2005 or three contiguous periods: 19901995, 1996-2000 and 2001-2005. If the aggregate data are too rough (e.g. within areas
greater than SLA), the fine view of geographical patterns of cancer data will be missed. If
the aggregate data are too refined (e.g. suburb), the risk estimation will be unreliable, as
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area might be small or sparsely populated. In fact, the relationship between cancer data and
covariates is not always constant over space. To take into account the heterogeneous nature
of the covariates, spatial point pattern analysis will be applied to investigate the data at a
finer scale for the year 2005. We will explore the application of spatial point pattern
analysis to cancer data by introducing Berman-Turner algorithm for modelling cancer data,
aiming at finer understanding of the influence of covariates on cancer rates and exploring
the intensity of a point pattern.

1.3 Literature Review
Geostatistical techniques have been applied to the modelling of cancer risk since 1998.
Oliver et al. (1998) studied cases of cancer in children under fifteen years of age, Prou et al.
(2003) provided an analysis of leukemia for children aged less than fifteen years, and
Goovaerts and collaborators considered lung cancer (Goovaerts and Jacquez 2004;
Goovaerts 2005a; Goovaerts 2005d), breast cancer (Goovaerts 2005b; Goovaerts 2005c;
Goovaerts 2006b), brain and bladder cancer (Goovaerts et al. 2005), prostate cancer
(Goovaerts 2005a), cervix cancer (Goovaerts 2005c; Goovaerts 2006a), pancreatic cancer
(Goovaerts 2006b) . In addition, Lai (2004) studied sixteen kinds of cancers in some rural
counties in China. Apart from geostatistical modelling, lung cancer mortality rates were
studied using time series analysis (Shibuya et al. 2005), and breast cancer incidence was
analyzed through spatiotemporal random fields (Christakos and Lai 1997).

Geostatistics has its origins in the prediction of ore grades in the analysis of mining data
(Goovaerts 1997). Currently it is applied in various fields including ecology, agriculture,
remote sensing, fisheries research and medical geography. Kriging is a group of
geostatistical techniques for finding an unbiased estimate at unsampled locations using
values obtained from nearby sample locations and it is in essence a spatial linear leastsquares regression.

Simple kriging and ordinary kriging (Goovaerts 1997) are the most commonly used kriging
algorithms. Simple kriging is mathematically the simplest. It assumes that the mean of the
random function is constant throughout the entire study region. However, in most
3

applications that the mean may vary significantly over the study region. Ordinary kriging
assumes that mean is locally constant but unknown throughout the entire study region.

The geostatistical analysis of disease data has received increasing attention with kriging
becoming more popular. Lai (2004) performed ordinary kriging on Chinese cancer
mortality data of 63 rural counties. To produce a set of contour maps, the spatial structure
of the cancer mortality rates was studied but other possible covariates were not
incorporated.

Classical methods of kriging, such as simple kriging and ordinary kriging, are used to
estimate the value of a continuous attribute. In fact, the application of geostatistics in the
medical field is relatively new. As disease count data are discrete, we need to use the
Poisson kriging technique to take account of the discrete nature of the data.

A first attempt to take into account the discrete nature of cancer data was the use of
binomial cokriging which was employed to produce a map of childhood cancer risk in the
West Midlands Health Authority Region (WMHAR) of England (Oliver et al. 1998). The
application of this technique to Long Island (USA) data led to negative variogram estimates.
To avoid this problem, binomial cokriging was extended to the case when the variance of
observed rates is smaller than expected under the binomial model. One geostatistical
filtering approach used is modified binomial cokriging which was applied to estimate breast
cancer incidence in Long Island, New York (Goovaerts 2005b) and lung cancer mortality
recorded in the New England counties and the US State Economic Areas (Goovaerts
2005d). The modified technique was shown to be more flexible and robust concerning the
underlying hypothesis that all counties have the same spatial support, and the simulation
studies have demonstrated its more accurate estimates (Goovaerts 2005d). The technique
was also used in cluster analysis to detect unreliable spatial outliers (Goovaerts 2005b).

Another geostatistical technique, Poisson kriging, was recently developed to filter noise
from the data by accounting for spatially varying population sizes and spatial patterns. The
methodology for estimating a spatial Poisson distribution was first introduced by Kaiser et
al.(1997). They developed the spatial “auto-models” based on the Poisson distribution to be
used to incorporate spatial dependencies among the variables. However, their model is not
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well suited for irregularly sampled data and interpolation. Monestiez et al. (2004; 2006)
introduced Poisson kriging to model spatially heterogeneous observations. The approach
applied by Monestiez et al. (2004; 2006) is similar to binomial cokriging proposed by
Oliver et al. (1998) except that the count data are assumed to follow a Poisson distribution.

Poisson riging was then generalised to estimate prostate cancer mortality risk in the United
States (Goovaerts 2005a), breast and cervix cancer mortality in New England States
(Goovaerts 2005c) and cholera and dysentery incidence risk in Bangladesh (Ali et al. 2006)
by incorporating varying population sizes in the processing of cancer data. When the risk
values were spatially correlated, simulation studies showed that in most cases, Poisson
kriging outperformed other smoothers such as population-weighted estimators and
empirical Bayes smoothers (Goovaerts 2005c). These studies also claimed that when the
risk is spatially random, although it might not be the common situation, global empirical
Bayes smoothers provide more accurate predictions.

It is not practical to represent each geographic unit by its centroid, especially when
geographic units vary greatly in size and shape. The geographical characteristics need to be
incorporated for data analysis together with spatially varying population. The framework
for Area-to-area (ATA) or Area-to-point (ATP) kriging was first introduced by Kyriakidis
(2004) for interpolating point values from available areal data. Goovaerts (2006a) modified
the ATP estimator to a Poisson estimator and applied ATP Poisson kriging to lung and
cervix cancer mortality in counties of the United States. In that study Goovaerts only used
age-adjusted rates to filter noise and created a continuous map of mortality risk by taking
into account the size and shape of study areas, as well as the population density, and so it is
more flexible than Poisson kriging and the cancer risk estimation is more reliable. In
addition, simulation studies showed that the use of ATP Poisson kriging results in more
accurate estimation than point kriging, especially when the geographical units are
heterogeneous. To date, geostatistical techniques have been applied to the data analysis for
geographical units including County, ZIP code and census block group. This study will
apply ATP Poisson kriging to cancer data in Perth at a different scale: SLA. Nearly all
geostatistical analysis is within age-adjusted rates. This study takes into account not only
age but also sex to remove the bias from the population structure in different SLAs.
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An early example of work in spatial epidemiology is the study by Diggle (1990) who
considered point patterns of larynx and lung cancers. The aim in this paper was to
investigate whether there is evidence of raised larynx cancer incidence near the location of
a now-disused industrial incinerator. The lung cancer cases were used as control for the
spatial variation in susceptible population intensity. Since then spatial point pattern analysis
has been applied to data from many different areas including incidence of disease (Gatrell
et al. 1996), prediction of forest fires in Ontario (Podur et al. 2003) and a study of rainforest
spatial point patterns with incomplete covariate data (Waagepetersen 2008).

Before fitting any models the nature of the point process needs to be determined partly to
ensure that the data are not completely spatially random (CSR). CSR process is also known
as homogeneous Poisson process, whose points are independent of each other and have the
same propensity to be found at any location (Baddeley 2008). There are two ways in which
a point pattern can depart from randomness: One is clustering where points tend to be close
together than would be expected if their locations were CSR. The other is regularity where
points tend to avoid each other. The point process modelling approach used by Diggle
(1990) can detect clustering but cannot validate a clustered point process. Baddeley and his
collaborators (2005) developed techniques to validate a point process model. To assess the
departure from CSR Ripley’s K-function can be applied but it is not appropriate when a
spatial trend exists in the data. To take account of the inhomogeneity the inhomogeneous
K-function (Baddeley et al. 2000) needs to be used.

Turner (2009) illustrated the techniques for analysing New Brunswick fire data by cleaning
data, conducting exploratory data analysis, detecting the dependence between points, fitting
models and validating models. However, no actual conclusions on the modelling were
drawn. This study will explore the intensity of the point patterns using the Berman-Turner
technique and interpret the outputs to draw the conclusions based on the modelling.

1.4 Objective
This study aims to analyse the top five cancers in Perth using two methodologies to provide
estimates for cancer incidence and mortality rates at different spatial scales. One method is
Area-to-Point Poisson (ATP) kriging using software SpaceStat which will provide
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estimates at an areal scale. The other method is fitting an inhomogeneous Poisson process
model using the Berman-Turner algorithm via customised R-packages which will provide
rate estimates at point scale.

The innovative application of these two techniques will address questions on spatial
distribution of cancers from different perspectives. Age-sex-adjusted rates are used in this
study to remove bias resulting from population composition. The point process technique is
introduced to cancer data to explore the correlation between the cancer incidence, mortality
data and covariates. The spatial estimation risk maps are used to display incidence and
mortality rates geographically, to potentially inform public health officials about planning
decisions and provide evidencs concerning susceptible population distribution in Perth.

ATP Poisson kriging is a technique to estimate the attribute values at a point using
observed values at SLAs by taking into account the Poisson nature of the disease data. This
technique is within aggregate data. Point pattern analysis is carried out within the locations
of cancer case events and detailed spatial trends for Perth cancers are achieved. The risk
maps obtained using these two techniques provide information from different perspectives
which presents further understanding to researchers and health officials.

For ATP Poisson kriging, the analysis of lung cancer, melanoma cancer and colorectal
cancer is based on age-adjusted rates and age-sex-adjusted rates at SLA level. For the
analysis of sex specific cancers (breast and prostate cancers), the spatial distributions are
compared based on age-adjusted rates. To understand the spatial continuity and variability
of cancer incidence and mortality for five cancers, the variance map and semivariogram
plots are investigated. The study will also identify the difference between males and
females in spatial distribution of cancer incidence. The analysis will be split into two parts:
first, the data over the entire period will be considered, and second analysis for shorter time
periods will be done to see how the distribution develops over time: three contiguous
periods 1990-1995, 1996-2000 and 2001-2005. The following questions will be addressed:

What is the difference between ATP Poisson kriging estimates based on age-adjusted rates
and age-sex-adjusted rates? What is the difference in spatial variability between incidence
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and mortality? What is the difference in spatial variability between different cancers? How
are different cancer mortality rates distributed across the Perth area in different periods?

The second methodology is spatial point pattern analysis. The object of this analysis is to
explore the trend within the point process density and validate the fitted point process
model using the techniques in (Baddeley et al. 2005). Some of the covariates which might
affect cancer incidence and mortality will be examined in this study: age, sex, population
density and susceptible population intensity which is computed based on cancer incidence.
These potential covariates will be evaluated. The following major questions will be
addressed within this analysis:

How to validate the model for Poisson processes and see whether it is appropriate?
What is an appropriate way to treat missing values?
Given a particular type of cancer which covariate is relatively strong?
Is there difference between incidence model fitting and mortality model fitting in terms of
covariates?
What is the spatial intensity of the point pattern for different cancers?

The risk maps at different scales will be used for each cancer to explore and quantify any
differences in the distribution of cancer risk.

1.5 Thesis outline
This thesis will present the ATP Poisson kriging analysis and spatial point pattern analysis
for cancer incidence and mortality data for lung, melanoma, colorectal, breast and prostate
cancers for the time period from 1990 to 2005.

Chapter 2 covers the background theories used in the thesis, including geostatistical theory
and spatial point pattern theory. Geostatistical theory includes a discussion of the random
function model, Poisson model, Poisson kriging and ATP Poisson kriging. In addition, the
proof of theories used for data analysis is provided in detail. Spatial point pattern theory
comprises the test for complete spatial randomness, model validation via the
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inhomogeneous K-function, a generalisation of K-function, model fitting via the BermanTurner algorithm, kernel smoothing, marked point patterns, empty space distances and
Papangelou conditional intensity function.

Chapter 3 describes the methodology used in the thesis. In this chapter we discuss how the
geostatistical analysis is carried out for different cancers by incorporating age or sex. Also
we describe how the coordinates are converted for two types of methodologies. Then we
focus on how the spatial point theory will be applied to five cancers.

Chapter 4 involves the data description. The first section focuses on the general background
of the data used in the thesis and their preparation for analysis. This section includes an
analysis of the survival rates for the different cancers. Raw cancer data are described in the
second section. The fourth section introduces the census data to be used as covariates for
the data modelling. The calculation of age-adjusted rates and age-sex-adjusted rates is
presented in the fifth section. The last section is exploratory data analysis. We provide the
adjusted rates and population at risk for five cancer types on which ATP Poisson kriging
estimation are based. Lastly we introduce the covariates to be used in spatial point pattern
analysis.

Chapter 5 and chapter 6 present geostatistical and spatial point pattern analysis respectively
for lung, melanoma, colorectal, breast and prostate cancers.

Conclusions and recommendations for future work are presented in Chapter 7.
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2 THEORY
This chapter presents geostatistical theory and spatial point pattern theory which provides
the framework for the modelling of disease data.

2.1 The theory of Poisson kriging and its variants
The development of the theory of geostatistics started in the 1950s in the field of mining
deposits evaluation (Sparks et al. 2011). Currently geostatistical techniques are successfully
applied in diverse fields such as soil science, oceanography, geography, forestry and
environmental control. Geostatistics allows the estimation of attribute values at unsampled
locations using available data over a study area. Geostatistical techniques mainly depend on
a statistical model that is based on the random function. A random function is a mapping
from the study region to a family of spatially dependent random variables. The random
function concept is introduced in section 2.1.1. In section 2.1.2, the kriging algorithm is
presented. The Poisson model is introduced in section 2.1.3. In this section, we also derive
the formulae for the first-order moment and second-order moment (variance) of rates
variable. Section 2.1.4 presents the theory of Poisson kriging. In section 2.1.4.1 area-to-area
(ATA) Poisson kriging is brought in. Area-to-point (ATP) Poisson kriging is a particular
case of ATA and is introduced in the last section 2.1.4.2. Unless otherwise stated, the
geostatistical theory given in this chapter is adapted mainly from Goovaerts (1997) and
(2006a).

2.1.1 The Random Function Model
In geostatistical applications, the data are assumed to be a partial realisation of a random
function (RF) because it is impossible to get the observed values at all locations of the
study area. A RF Z is a collection of random variables on the study region A to which the
laws of probability apply

{Z (u ) : u ∈ A ⊂ ℜ }
N

(2.1)
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where ℜ N is N-dimensional Euclidean space, and the spatial index u varies continuously
throughout the study area A . The value of an attribute at location u is denoted by z (u )
which can be regarded as a particular realisation of a random variable Z (u ) at the point u.
When N = 2 , the RF Z is defined on a plane, and the Cartesian coordinates are often
written as u = [x, y ]T . The RF is characterised by its cumulative distribution function and
the corresponding moments:

N-point cdf:
F (u1 , L, u N ; z1 , L, z N ) = Pr ob{Z (u1 ) ≤ z1 , L, Z (u N ) ≤ z N }

(2.2)

The expected value:

m(u ) = E (Z (u ))

(2.3)

The variance:

{

Var[Z (u ) ] = E [Z (u ) − m(u )] 2

}

(2.4)

The (two-point) covariance function:

C (u, u + h ) = E{Z (u ) ⋅ Z (u + h )} − E{Z (u )}⋅ E{Z (u + h )}

(2.5)

The semivariogram function:

2γ (u, u + h ) = Var{Z (u ) - Z(u + h )}

(2.6)

The (two-point) covariance or variogram, is a random variable related to the same attribute
z at two different locations. In general, the values of first-order moment: E (Z (u )) and

second-order moments: Var[Z (u )] , C (u, u + h ) and γ (u, u + h ) are location-dependent. The
separation vector h accounts for distance and direction. The two-point covariance or
semivariogram function is said to be isotropic if it only depends on the absolute distance
between points, and the function is said to be anisotropic when it depends on both
separation distance and direction.
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A RF Z is said to be strictly (or strongly) stationary if the spatial distribution is invariant
under translation of the coordinates, that is:
Prob{Z (u1 ) ≤ z1 , Z (u 2 ) ≤ z 2 , L , Z (u k ) ≤ z k } =
Prob{Z (u1 + h ) ≤ z1 , Z (u 2 + h ) ≤ z 2 , L , Z (u k + h ) ≤ z k }

(2.7)

for all k and h. In practice it is hard to confirm that a RF is strictly stationary from limited
sample data so this assumption is normally relaxed.

A RF Z is said to be second-order (or weakly) stationary if the expected value (mean)

E (Z (u )) exists and is invariant within A ; and the covariance exists and depends only on
the separation vector (lag) h.
Second-order stationarity implies that E (Z (u )) = m and C (h ) = E{Z (u ) ⋅ Z (u + h )} − m 2 for

all u ∈ A . In other words, a RF with such characteristics has constant expected value and
finite covariance which depends only on the separation vector h. If Z (u ) is not secondorder stationary, the increments Z (u + h ) − Z (u ) might be. A RF that has this characteristic
is said to be intrinsic stationary. That is, an intrinsic stationary RF has a constant mean and
a semivariogram function which does not depend on absolute coordinates: E (Z (u )) = m
1
and γ (h ) = Var {Z (u ) - Z(u + h )} , but might not have a finite variance. Strict stationarity
2

implies second-order stationarity but the converse is not true, and second-order stationarity
implies intrinsic stationarity but the converse is not true. The covariance function C (h ) may
not exist when the random function is intrinsic rather than second-order stationary. Many
geostatisticians prefer the semivariogram to covariances when estimating these functions
based on the observed data (Schabenberger and Gotway 2005, §4.2).
In geostatistics, the experimental semivariogram γ (h ) reflects one of the spatial data
attributes: autocorrelation. The experimental semivariogram is computed as:
2

1 N (h )
γ (h ) =
∑ [z(u α ) − z (u α + h )]
2 N (h ) α =1

(2.8)
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where z (u α ) − z (u α + h ) is an h-increment of attribute z and z (u α ) is the known sample
value of the attribute z at location u α . The semivariogram defined in equation (2.8) is also
called the traditional semivariogram.

Kriging estimation is based on a covariance model inferred from the sample data via the
experimental semivariograms. The models used in this study are the the nugget, spherical,
exponential and cubic models. Their definitions are as follows:

Nugget effect model.

This function models a discontinuity at the origin when the

variogram is not differentiable. The nugget effect may indicate measurement error, microscale variation or purely random behaviour.

0 if h = 0
g (h ) = 
b otherwise

where b is positive. This model is bounded and the bound is referred to as the “sill”.

Spherical model. This function models linear behaviour at the origin and is bounded by
the sill b. The model reaches the sill at actual range a.

3
  h
 h  

if h ≤ a
 h  b 1.5 − 0.5 
g (h ) = Sph   =   a
a  


a 
b
otherwise


Exponential model. This function is bounded by the sill b. This model reaches the sill
asymptotically. The practical range a is the distance at which the semivariance is equal to
95% of the sill.


 - 3h 
g (h ) = b 1 − exp
 
 a 
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Cubic model. This function models parabolic behaviour at the origin and is bounded by
the sill b.

   h  2 35  h  3 7  h  5 3  h  7 
b  7  −   +   −    if 0 ≤ h < a
g (h ) =    a 
4 a
2a
4  a  


b
otherwise


2.1.2 Kriging
Kriging is geostatistical techniques to estimate the value of a RF at a unsampled location by
using observed values at contiguous sampled locations. Kriging is a linear regression
estimation algorithm. Simple kriging (SK) and ordinary kriging (OK) are classical types of
kriging. Ordinary kriging considers the mean unknown but constant in the local
neighbourhood. It is used more often than simple kriging which assumes the mean is
known and constant throughout the study area. Ordinary kriging and simple kriging can
estimate the attribute values at unsampled locations. The simple kriging unbiased estimator
is defined as:
n (u )
n (u )
n (u )
*
Z SK
(u ) = ∑ λαSK (u )[Z (u α ) − m] + m = ∑ λαSK (u ) Z (u α ) + 1 − ∑ λαSK (u ) m
α =1
α =1
 α =1


(2.9)

where m is the known stationary mean and λαSK (u ) are the simple kriging weights to be
determined. Let R(u ) = Z (u ) − m (and hence R (u α ) = Z (u α ) − m ), then the error variance
can be expressed as:
*
(u ) − Z (u )}
σ E2 (u ) = Var {Z SK

{[

]

*
(u ) − m − [Z (u ) − m]
= Var Z SK

}

 n (u )

= Var ∑ λαSK (u ) R (u α ) − R (u )
α =1

*
= Var R SK (u ) − R (u )

{

(2.10)

}

n (u ) n (u )

n (u )

α =1 β =1

α =1

SK
= ∑ ∑ λαSK (u )λ SK
β (u )C R (u α − u β ) + C R (0 ) − 2 ∑ λα (u ) C R (u α − u )
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To determine the weights which minimize the error variance, we have to solve:
n (u )
∂σ E2 (u )
=
2
λSK
∑
β (u ) C R (uα − u β ) − 2 C R (uα − u ) = 0,
SK
∂λα (u )
β =1

α = 1, 2, ..., n(u )

(2.11)

and the simple kriging variance (the minimum error variance) is deduced as (by replacing
(2.11) into (2.10)):
n (u )

2
σ SK
(u ) = C (0) − ∑ λαSK (u )C (u α − u )

(2.12)

α =1

The ordinary kriging estimator is defined similarly to the simple kriging estimator except
that the mean is locally constant but unknown across the study area:
n (u )

*
Z OK
(u ) = ∑ λαOK (u ) Z (u α ) with

α =1

n (u )

λα (u ) = 1
∑
α
OK

(2.13)

=1

The minimization of the error variance needs a function of the data weights λαOK (u ) and a
Lagrange parameter 2 µOK (u ) :

 n(u)

L λαOK (u ), α = 1, ..., n(u); 2 µOK (u ) = σ 2E (u ) + 2 µOK (u ) ∑ λαOK (u ) − 1
 α =1


(

)

(2.14)

The optimal weights are obtained by setting each of the partial first derivatives to zero. In a
similar way, the ordinary kriging system is given by:
n (u )
∂σ E2 (u )
=
2
λOK
∑
β (u ) C (uα − u β ) − 2 C (uα − u ) + 2 µOK ( u) = 0,
∂λαOK (u )
β =1
n(u)

λ α (u ) = 1
∑
α
OK

=1

and the ordinary kriging variance is calculated as:
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α = 1, 2, ..., n (u )

n (u )

σ

2
OK

(u ) = C (0) − ∑ λαOK (u )C (uα − u ) − µOK (u )

(2.15)

α =1

where µOK (u ) is the Lagrange multiplier.

2.1.3 Poisson model
2.1.3.1 Model definition
The Poisson distribution plays an important role in the study of discrete (or categorical)
data. Disease data are always available by case count. In the geostatistical study, the given
units (e.g. suburb, counties, states, SLA) have a common geographic reference such as their
centroids u = ( x, y ) . At each unit with centroid u α , the recorded disease count d (u α ) can
be regarded as a particular realisation of a random variable D(uα ) . For a given number of
K locations u α belonging to the study region D, the model for the random variable D(uα )
is defined by

D(u α ) R (u α ) = Poisson (n (u α )R (u α )) α = 1,..., K

(2.16)

where D(u α ) R (u α ) is Poisson distributed with a parameter n (u α ) R (uα ) . The random
variable R (uα ) and n (u α ) represent the local disease risk and the size of the population at
risk at location u α
z(u α ) =

d (u α )

n (u α )

respectively. The observed disease rates are denoted as

. Conditionally on R (u α ) , the rates variables Z(u α ) are assumed to be

independent since the correlation between observed rates is normally dependent on
population composition or local individual risks. The random function R is modelled as a
positive stationary random function with mean m, variance σ R2 and covariance C R . To
simplify notation, R̂ PK (u α ), R (u α ), Z(u α ), z(u α ) and n (u α ) in this study will be
abbreviated in the following as R̂ α , R α , Zα , z α and n α respectively. In any kriging
system, Cij denotes the covariance function C R (u i − u j ) .
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2.1.3.2 Expectation and variances of rates variables Z(u α )
The conditional mean and variance of rates variable Zα are defined in (Goovaerts 2005c):

E[Zα R α ]= R α
Var[Zα R α ]=

(2.17)

Rα

(2.18)

nα

Since Zα and R α are two random variables, and the expectations exist, we have

E(Zα ) = E(E(Zα R α ))

(2.19)

Var [Zα ] = E[Var(Zα R α )] + Var[E(Zα R α )]

(2.20)

and

Proof of (2.19): Let f (z α , rα ) be the joint pdf of Z α and R α . According to the definition,
we have

E [Zα ] = ∫ ∫ z α f (z α , rα ) dz α d rα

[

]

= ∫ ∫ z α f (z α rα )dz α f Rα (rα )d rα
= ∫ E [Zα rα ] f Rα (rα )d rα
= E(E(Zα R α ))

Proof of (2.20): With (2.19), we have

( )

Var [Zα ] = E Zα2 - [E(Zα )] 2

[ ( )]
= E [E (Z R )] − E [E (Z R )]  + E [E (Z



= E[Var (Z R )] + Var [E (Z R )]
= E E Zα2 R α − [E (E (Zα R α ))]

2

2

2

α

α

α

α

α

α

α

α

Rα

)]  − [E(E(Z
2

α

Rα

))]

2

α

According to equations (2.19) and (2.20), the unconditional mean and variance can be
obtained directly from (2.17) and (2.18):
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E[Zα ] = E [R α ] = m

(2.21)

[ (

)]

[(

Var [Zα ] = E Var Zα R α + Var E Zα R α

)]

= E[R α n α ] + Var [R α ] = σ R2 + m

(2.22)
nα

As for the conditional mean value of observed rates at independent locations u α and u β , it
is calculated as:

[

]

[

]

= δ αβ Var [Z α R α ] + R α R β = δ αβ

Rα

+ Rα R β

E Zα Z β R = Cov (Zα , Z β R ) + E[Zα R α ] E Z β R β
nα

(2.23)

where δ αβ is 1 when α = β and 0 otherwise.

2.1.4 Poisson kriging
Although standard kriging methods are fairly common, they are not suitable for data having
a discrete distribution like disease data. Poisson kriging accounts for the Poisson nature of
the count data but ignores the spatial supports of geographic entity. Each entity is assumed
to have point support, and be located at its geographic centroid. The Poisson kriging
estimator is derived from the OK estimator. The Poisson kriging disease risk is estimated as
a linear combination of K neighboring data:

K

R̂ PK (u α ) = ∑ λi (u α ) z (u i )

(2.24)

i =1

where z (u i ) is the observed disease rate. In order to make sure this estimator is unbiased,
we compute its expectation by application of expression (2.17):

[

]

K

K

i =1

i =1

ˆ R =
ER
∑ λi (u α )E(z i R i ) = ∑ λi (u α ) R i ,
α
i
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referring back to (2.19), since

[

[ ]

]

K

K

i =1

i =1

ˆ = EE R
ˆ R =
ER
∑ λi (u α )E(R i ) = m ∑ λi (u α ) ,
α
α
i

the condition for the estimator to be unbiased is:

K

∑ λ (u α ) = 1

(2.25)

i

i =1

Similarly, to minimise the mean square error of prediction under the unbiasedness

(

)

2
condition (2.25), we have to compute E  R̂ α − R α  , since



(

)

(

)

2
Var R̂ α − R α = E  R̂ α − R α 



The following calculation is derived by application of equations (2.23) and (2.25):

E  R̂ α − R α


(

)

2

R


2
 K
 
= E  ∑ λi (u α ) z i − R α  R 
 i =1
 
K

K

(

)

K

= ∑∑ λi (u α )λ j (u α )E z i z j R + R α − 2R α ∑ λi (u α )E (z i R )
2

i =1 j =1
K

i =1

K

[

]

K

= ∑∑ λi (u α )λ j (u α ) δ ij × R i n i + R i R j +R α − 2R α ∑ λi (u α )R i
2

i =1 j =1

i =1

Then, by deconditioning:

(

K

)

K

K

K

2
E  R̂ α − R α  = ∑ ∑ λi (u α )λ j (u α ) δ ij m + ∑∑ λi (u α )λ j (u α ) m 2 + C ij

 i =1 j =1
n i i =1 j =1
K

(

+ σ R2 + m 2 − 2∑ λi (u α ) m 2 + C iα
K

= ∑ ∑ λi (u α )λ j (u α ) δ ij m
i =1 j =1

K

ni

)

)

i −1
K

(

K

+ ∑∑ λi (u α )λ j (u α ) C ij
i =1 j =1

K

+ σ R2 − 2∑ λi (u α ) C iα
i −1
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(2.26)

,

By minimising the expression (2.26) on λi s with the unbiasedness condition (2.25), the
following (K + 1) equations are obtained:

K

∑λ

j

j =1


m
(u α ) C ij + δ ij  + µ (u α ) = C iα
ni 


i = 1,..., K
(2.27)

K

∑λ

j

(u α ) = 1

j =1

where µ (u α ) is a Lagrange multiplier. The term,

m
, accounts for variability resulting from
ni

the population size. The prediction variance associated with the estimate (2.24) is computed
using the traditional formula for the ordinary kriging variance (2.15):

K

2
σ PK
(u α ) = C R (0) − ∑ λi (u α )C R (u i − u α ) − µ (u α )

(2.28)

i =1

The covariance of the unknown risk, C R (h) , or its equivalent semivariogram

γ R (h) = C R (0) − C R (h) , is estimated according to Monestiez et al. (2004; 2006) based on
the traditional semivariogram (2.8):

γˆ R (h) =
1
N(h )
n (u α )n (u α + h)
2∑
α =1 n (u α ) + n (u α + h )

 n (u α )n (u α + h)

[z(u α ) − z(u α + h)]2 − m
α =1 
α ) + n (u α + h )


N(h)

∑  n (u

(2.29)

The calculations of semivariogram in the geostatistical analysis are carried out using this
equation within software SpaceStat.

2.1.4.1 Area-to-Area (ATA) Poisson kriging
When geographic units vary greatly by size and shape, it is important to take into account
their spatial supports. Area-to-Area (ATA) kriging was first introduced by Kyriakidis
20

(2004). Goovaerts (2006a) generalised this technique and introduced ATA Poisson kriging
for the modelling of disease data. This terminology refers to the situation when the
measurement and prediction supports are areas rather than points. Area-to-area spatial
interpolation is used to predict an areal value z (vα ) using K areal data {z (vi ), i = 1,..., K }:

K

z * (vα ) = ∑ λi (vα ) z (vi )

(2.30)

i =1

where the areal supports vi are disjoint. The weights λi (vα ) are computed to ensure the
minimization of prediction mean square error under the condition of the unbiasedness of
z * (vα ) , and they are the solution of the following equations:

K

∑ λ (v
j

α

j=1


m 
)  C ( v i , v j ) + δ ij
 + µ( v α ) = C ( v i , v α ) i = 1,..., K
n
(
v
)

i 

K

∑ λ (v
i

α

(2.31)

) =1

i =1

where C (vi , v j ) is the covariance between areal suppots vi and v j . It is the average of
point covariance values C (s − t ) corresponding to vectors s − t formed by all possible
pairs of points s ∈ vi and t ∈ v j respectively (Kyriakidis 2004). The difference between the
system of linear equations in (2.27) and (2.31) is that the prediction and measurement
supports is a point support in (2.27) while in (2.31) it is an areal support.
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2.1.4.2 Area-to-Point (ATP) Poisson kriging
ATP kriging is the special case of ATA kriging where the prediction support is reduced to a
point u α . ATP Poisson kriging will be applied to cancer data in this study. Area-to-point
spatial interpolation is to predict any point value z(u α ) using K areal data

{z( v i ), i = 1,..., K}:
K

z * (u α ) = ∑ λ i (u α ) z ( v i )

(2.32)

i =1

The weights λ i (u α ) are computed to ensure that the prediction mean square error is
minimised under the condition of the unbiasedness of z * (u α ) , and they are the solution of
the following equations:

K

∑ λ (u
j

α

j=1


m 
)  C ( v i , v j ) + δ ij
 + µ(u α ) = C ( v i , u α ) i = 1,..., K
n(v i ) 


K

∑ λ (u
i

α

(2.33)

) =1

i =1

where the covariance C ( v i , u α ) between areal supports vi and the point u α is the average
of point covariance values C(s − u α ) corresponding to vectors s − u α formed by all
possible pairs of points s ∈ vi and µ(u α ) is the Lagrange multiplier, δ ij = 1 if i = j and 0
otherwise. The size of the population at risk in area vi is denoted by n(vi ) . The term

m
ni

accounts for variability resulting from the population size. That is, the more reliable the
data (i.e. measured over larger populations) are, the more weight they get. The variance is
calculated as:

K

σ 2PK (u α ) = C(0) − ∑ λ i (u α ) C ( v i , u α ) − µ(u α )
i =1
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(2.34)

where C(0) = Var (Z(u α ) ) . Since the population is not uniformly distributed across the
study area and disease rates computed from sparsely populated geographic units tend to be
less reliable. This effect, known as "small number problem" (Waller and Gotway 2004). To
filter the noise caused by small number problem, it is important to assign a weight to an
area’s observed rate based on the size of the population at risk. When the area is sparsely
populated the weight is small, when the area is densely populated the corresponding weight
is large. The calculation of weights λ i (u α ) based on equation (2.33) can be corrected for
small number problem.

To apply ATP Poisson kriging to the data, it is important to know point-support
semivariogram. Derivation of a point-support semivariogram from the regularized
experimental semivariogram computed from areal data is called “deconvolution”
(Goovaerts 2008). Using iterative procedure, it seeks the point support model that
minimizes the difference between the theoretically regularized model and the model fitted
to data. The deconvolution is based on the following relationship between the regularized
−

semivariogram model γv (h ) and γ(v, vh ) which is a function of the unknown point-support
model γ(h ) :

−

−

γ v (h ) = γ(v, v h ) − γ h (v, v )

(2.35)

−

where γ h (v, v ) is the within-area semivariogram as a function of the separation distance h.
−

γ(v, vh ) is the mean value of the point-support semivariogram between an arbitrary point in

the support v and another in the translated support vh and this area-to-area semivariogram
value is estimated as:
−

γ h (v, v h ) =

1 N (h ) −
∑ γ h (vα , vα+h )
N (h ) α =1

(2.36)

where N(h ) is the number of pairs of areas separated by the distance h. The semivariogram
−

value γ h (vα , vα + h ) between any two areas vα and vα + h is calculated as:
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−

γ h (vα , vα + h ) =

1
Pα Pα + h

Pα Pα + h

∑ ∑ γ (u
s =1 s' =1

s

, u s' )

(2.37)

where Pα and Pα + h are the number of points u s and u s' used to discretize the two areas
−

respectively. The within-area semivariogram γ h (v, v ) is calculated using equation (2.37)
with h=0.

2.2 Spatial point pattern theory
Spatial data, also known as geospatial data, are associated with three components: features,
supports and attributes (Waller and Gotway 2004, p.38). In this study, the spatial feature is
the point, that is, the location of cancer incidence and mortality characterised by
latitude/longitude. Points have the smallest support. Unless otherwise stated, the spatial
point pattern theory presented in this chapter is mainly from Baddeley (2008).

2.2.1 The spatial point pattern
The observed point pattern is denoted by x and a random point process is denoted by X.
Every point in a spatial point pattern may carry extra information called a “mark” and this
point pattern is called a marked point pattern. In spatial point pattern analysis, the observed
point pattern x is treated as a realisation of a random point process X in two-dimensional
space. The data comprise a spatial point pattern x observed in a bounded region W of the
plane ℜ 2 . The spatial point pattern is denoted by

x = {u1 , u 2 ,L, u n },
where the number of points, n ≥ 0 , is not fixed and each u i is an observed point in W.

Each point u corresponds to its coordinates in the plane ℜ 2 . Let N(B) be the number of
points in any given sub-region B of W. The (first-order) intensity of a point process,
denoted by λ(u) , is defined (Marcon and Puech 2003) as:
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E [ N ( dB )]
dB →0
dB

λ(u) = lim

where dB is the area of an infinitesimal disk centred at point u and E denotes the
mathematical expectation. The point process is homogeneous when λ(u) = λ for all u ∈ W .
The point process is inhomogeneous when its intensity λ(u) is not constant. To capture the
spatial dependency of event locations, (second-order) density is defined (Schabenberger
and Gotway 2005):

λ2 (u i , u j ) =

lim

dxi → 0, dx j → 0

E [ N ( d u i ) N ( d u j )]
d ui

d uj

When the point pattern is a homogeneous Poisson process, λ2 (u i ,u j ) only depends on
distance, λ2 (u i ,u j ) = λ2* ( u i - u j ) = λ2* ( h ) .

2.2.2 Inhomogeneous K-function
A point process is a uniform Poisson point process in the plane when its intensity is
constant. The uniform Poisson point process is also called Complete Spatial Random (CSR).
In point pattern analysis, the assumption of CSR is normally taken as the ‘null’ hypothesis.
The classical test for CSR is the chi-square approximation test based on quadrat counts
which is described by Diggle (2003). In this approximation test, the domain W is assumed
to be bounded by a rectangle, which is partitioned into equal-sized non-overlapping
subregions (‘quadrats’) with r rows and c columns: B11 , B12 ,L , Brc . The number of
observed points falling in each subregion is denoted by nij = n (x ∩ Bij ) for
1 ≤ i ≤ r , 1 ≤ j ≤ c . Under the null hypothesis of CSR the counts nij are independent and

identically distributed (i.i.d) Poisson random variables with the same expected value in
each quadrat. The Pearson chi-square goodness-of-fit test performs very well when the
expected number of events per quadrat exceeds 1 and rc > 6 (Diggle 1983 p.33).
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Ripley’s K-function (1977) is used to describe spatial structures of a homogeneous point
process. The K-function is defined as:

r

K (r ) = ∫ g (h)2π h dh
0

where g (h) =

λ 2 (h)
. For a homogeneous Poisson process, λ 2 ( h) = λ 2 for all values of h,
2
λ

so K (r ) = π r 2 . A clustered pattern and an inhibited pattern are defined by Schabenberger
and Gotway (2005) as: a point pattern is clustered when the average distance between an
event and its nearest-neighbour event is smaller than the same average distance in a CSR
pattern; a point pattern is called inhibited when the average distance between an event and
its nearest neighbour is larger than expected under a CSR pattern. For a clustered point
pattern, g ( h) > 1 indicates K (r ) > π r 2 . That is, the chance of discovering a point within
distance r is greater than the chance of discovering a point at any other location with the
same area in the domain. For an inhibited point pattern, g ( h) < 1 , and so K (r ) < π r 2 . The
product λ K (r ) is the expected number of points other than point u within the circle of
radius r, centred on u (Baddeley 2008):

λ K (r ) = E [ n( X ∩ b(u, r ) \ {u})| u ∈ X]

However, Ripley’s K-function is used for homogeneous point processes and it does not
consider the weighting of points in the calculation. Consequently, the K-function was
generalised by Baddeley (2000) to the inhomogeneous K-function. If λi is the intensity
function of the point process X at location u i and each point u i is weighted by the inverse
of the intensity function at this point, the inhomogeneous K-function is defined as:

 1

1
K inhom (r ) = E 
1{0 < u − u i ≤ r } u ∈ X 
∑
 λ(u ) ui ∈X λ (u i )
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(2.38)

where 1 (⋅) is the indicator function. If the process is homogeneous, then λ( u i ) = λ and

[

]

K inhom (r ) = K (r ) , since K inhom (r ) = E 1{0 < u − u i ≤ r } u ∈ X = π r 2 . According to

(2.38), we have:



1
1
E ∑ ∑
1{0 < u − u i ≤ r }
area (W )  u∈X ui ∈X λ(u ) λ ( u i )

(2)
ρ (u i ,u )
1
=
d ui d u
∫
∫
area (W ) ) u∈W 0< u −u i ≤ r λ ( u i ) λ(u )

K inhom (r ) =

where g(u, u i ) =

ρ (2) (u i ,u )
, u i , u ∈ W ⊂ ℜ 2 is the pair correlation function of W and
λ (u i ) λ(u )

“ ρ (2) (u i ,u ) d u i d u is the probability that W has a point in each of two infinitesimally small
discs with centers u i , u and volumes d u i , d u respectively” (Baddeley et al. 2000). As for
an inhomogeneous Poisson process function g ≡ 1 (Baddeley et al. 2000), so
K inhom (r ) =

1
area ( W ) W∫

∫du

j

d u= πr2 .

πr2

2.2.3 Berman-Turner algorithm
The inhomogeneous Poisson model with covariates included (Baddeley 2008) has the
parametric form:
λθ (u ) = exp(β 0 + β1 × Z (u))

(2.39)

where θ , a vector of unknown parameters β 0 and β1 is to be estimated. In practice

Z (u ) could be a covariate, spatial coordinates, or any transformation of covariate or spatial
coordinates (Baddeley 2008). They all can work as the statistic for the intensity function.
The log-likelihood of θ for an inhomogeneous Poisson process with parametric intensity
function λθ (u ) is given by (Berman and Turner 1992):
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n

L(θ; u 1 ,L ,u n ; W ) = ∑ log λθ (u j ) − ∫ λθ (u ) d u
W

i =1

(2.40)

where θ denotes the unknown parameters to be estimated. The numerical estimator of the
integral

∫

W

λθ (u ) d u is given by:

∫

M

W

λθ (u ) d u ≈ ∑ w j λθ (y j )

(2.41)

j=1

M

where ∪ y j ≡ y and the quadrature weight w j is the area of the Dirichlet tile based on
j=1

Dirichlet tessellation (Baddeley and Turner 2000). The points y j are chosen so that

x ≡ {u 1 , L ,u n } ⊂ W ⊂ {y 1 , L , y M } . The points in y , x and y -x are called the design
points, the data points and the dummy points respectively.

Substituting equation (2.41) into equation (2.40), it follows that

n

M

i =1

j=1

L(θ; u1 , L ,u n ; W ) = ∑ log λθ (u i ) − ∑ w j λθ (y j )

 s j

= ∑ w j  log λθ (y j ) − λθ (y j )
 w j

j=1
M

1 if
where s j = 
0 if

(2.42)

yj ∈x
yj ∈y −x

Then the expression (2.42) is maximised in which the intensity function λθ (u ) is of the
form
log λθ (u ) = θ ⋅ Z (u )

(2.43)

where the values of Z (u ) are known for all locations u ∈ W , even when u is not a data
point. In a point pattern process, the observed information does not include only the data
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points locations, the absence of other points locations is also important (Baddeley et al.
2005). The form of Z in (2.43) is arbitrary.

2.2.4 Methods to obtain covariate
There are spatial covariates which are important in the analysis and these spatial covariates
are treated as explanatory variables. This thesis will study whether the intensity of the
spatial point patterns depends on the covariates. It is possible to fit a model with an
intensity function which depends on the available covariates. The covariates used in the
inhomogeneous Poisson model (2.39) are pixel images. Pixel images in this study are
calculated using a kernel function, and also inhomogeneous K-function is calculated using
kernel function. A kernel function is a weighting function and it is more commonly used in
non-parametric estimation. In kernel estimation, bandwidth is a scalar parameter and it
determines what range of the nearby data points will be heavily weighted when making an
estimate. Popular kernel functions are the Gaussian kernel, the quadratic kernel and the
minimum variance kernel. The Gaussian kernel is defined as:

k (u) = 1

exp{−u

2π

2

2

}

(2.44)

and ∫ u 2 k (u ) d u = 1 for the Gaussian kernel where σ is the standard deviation.
In practice, choosing kernel functions is less important than choosing the bandwidth
(Schabenberger and Gotway 2005). In R documentation, smooth.ppp is described as
performing spatial smoothing of numeric values observed at irregular locations. If the
observed numeric values are m1 , L , mn at a set of irregular locations u 1 , L ,u n
respectively, then the smoothed value at a location u is

n

∑ k (u − u ) m
i

g (u ) =

i

i

=1
n

∑ k (u − u i )
i
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=1

(2.45)

where edge correction is ignored and {u 1 ,L ,u n } must be a marked point pattern. Points
which are classified into two or more different types may be regarded as marked points,
with a mark which identifies which type they belong to. The mark can be a categorical or a
continuous variable.

Distance methods can be used to explore point dependence, and they are measured by
calculating the distances between points. The empty space distance is one of these and it
reflects how far away each observed point is from the nearest point on a pre-defined regular
grid (thus resulting in a pixel image). The empty space distance is the distance from a fixed
reference location u in the window to the nearest data point in a point pattern x. It is
defined by

d(u , x ) = min{ u − u i : u i ∈ x}

(2.46)

The models are fitted by spatstat command ppm using a formula with regard to
Papangelou conditional intensity λ (u,x) (Papangelou 1974). This intensity function is
dependent on the realisations of the point process at all spatial locations except u itself.
This conditional intensity is briefly introduced (Baddeley et al. 2005) here for the purpose
of data analysis.

Suppose the point process X in W has a probability density f(x) which is hereditary, that is

If f (x) > 0 and

y ⊂ x ⇒ f (y ) > 0 for any x, y ⊂ W

(2.47)

For dummy points in the bounded region W: u ∈ W but u ∉ x , the intensity function is
defined


λ(u, x ) = 


f ( x ∪ {u}) / f ( x ) f ( x ) > 0
f (x) ≤ 0

0

For data points: u ∈ W and u ∈ x , the intensity function is defined
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(2.48)

λ(u, x) = λ(u, x \ {u})

(2.49)

where λ(u, x ) d u can be interpreted as the conditional probability of finding a point at a
specified location provided that the information of the point pattern is known at locations

(x \ {u}) .

2.2.5 Validation of the fitted model
Quantile-quantile plots and diagnostic plots are used to validate the fitted model. The
residuals used in these plots are raw residuals. For any set B ⊆ W , raw residuals (Baddeley
et al. 2005) are defined as the difference between the observed value and the expected value.
That is:
P( B ) = n (x ∩ B ) − ∫ λθ̂ (u, x ) du
B

where θ̂ is the estimator of θ . When the covariates account for point process intensity, it is
important to indicate how strongly the point pattern depends on the covariates. A lurking
variable plot not only shows the appropriateness of the fit but also illustrates how much the
fitted intensity function relies on the covariates. A lurking variable is defined by Box (1966)
as a variable that may have important influence and yet is not incorporated among the
explanatory variables under consideration. The lurking variable plot is a plot of
residuals B( z ) , denoted by C ( z ) = R(B( z )) , against covariate value z where

B(z ) = {u ∈ W : Z (u ) ≤ z}
is the region of space where the covariate value is less than or equal to z (Baddeley,2008).
In the next chapter the approach to the modelling of the data is outlined, including a
discussion of the data preparation.
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3 METHODOLOGY
In this study, two distinct types of cancer data will be considered: incidence and mortality
data at SLA level. These data are given as rates; the other type of data is at individual level
where the occurrence of incidence or mortality is recorded and these data are binary. For
the first type geostatistical techniques can be used, and for the second point process theory
is more appropriate.

3.1 Geostatistical analysis
The incidence and mortality for the five top cancers are considered in this study: lung,
melanoma, colorectal, breast and prostate cancers. For the geostatistical analysis, to avoid
the use of temporal structure in the model setup, the study period is broken down into three
contiguous periods: 1990-1995, 1996-2000 and 2001-2005 to get a relatively refined
mortality data analysis, and to see how cancers vary over time. The changes for each period
are shown in the temporal plots (Figure 2). For breast cancer and prostate cancer incidence,
the analysis during the three contiguous periods is explored. For lung cancer, colorectal
cancer and melanoma cancer incidence, we also provide an analysis for the period 19902005 by sex and investigate how these cancers affect males and females differently. The
analysis of individual contiguous periods for each sex is not carried out within the study
since there are not enough data. Spatial continuity and variability of age-adjusted rates and
age-sex-adjusted rates will be investigated based on omnidirectional semivariogram plots.
For the cancers in this study, omnidirectional semivariograms are well-behaved and show
good structure compared with directional semivariograms. What we will obtain from ATP
Poisson Kriging are estimates and variance based on the adjusted rates.

3.2 Tools for coordinates conversion
For the coordinates of SLAs, Redfearn’s formulae (Redfearn 1948) are used to convert
coordinates individually from geographic (latitude & longitude) to Universal Transverse
Mercator (UTM) grid coordinates using the GRS80 ellipsoid. This projection is used for
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Australia’s new coordinate system. It is compatible with the global coordinate system
(WGS84). The formulae are accurate to 1mm in any zone. All UTM coordinates are
measured in meters.

Geostatistical analysis is carried out for aggregate data within SLA. To get a refined view
of geographical patterns, spatial point pattern analysis is applied. Coordinates in spatial
point pattern analysis are converted from Latitude/Longitude to UTM using command
convUL

within Jon Schnute’s PBSmapping package (CRAN 2009). In this command, UTM

coordinates in kilometres are used when km is true. The window, a map of Perth, was
obtained in the form of GIS “shapefiles”. These files were read into spatstat using
maptools

package from CRAN (2009). See Appendix 9.2 for the commands.

3.3 The treatment of missing coordinates in spatial point pattern
analysis
In the original cancer data set, there is a small percentage of cases where only the Statistical
Local Areas (SLAs) at the time of diagnosis (or death) is recorded, but not the exact
location. Two methods will be used to treat these missing values in Section 6.1 for spatial
point pattern analysis. One method is to remove the case locations without coordinates. The
other method is to assign the mean of 16-year period cancer case locations within SLA to
them. We will verify whether a slightly different point pattern of data has any influence on
the model fitting using lung cancer data as an example, and see which data treatment is
better and why.

3.4 Model fitting based on inhomogeneity for spatial point pattern
analysis
The quadrat counting test is used to verify whether a point pattern is homogeneous within
the Rpackage spatstat. Based on the test, the cancer incidence and mortality point
processes for 2005 are not completely spatially random (see details in chapter 6). In order
to take account of the inhomogeneity, the inhomogeneous K-function (Baddeley et al. 2000)
is applied in Chapter 6 for each individual point process to test whether the point pattern is
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independent. If an inhomogeneous point pattern is independent, then the point pattern is an
inhomogeneous Poisson process.

The inhomogeneous K-function is a generalisation of the K-function to inhomogeneous
point patterns. To calculate the inhomogeneous K-function for a point process a kernel
estimate of the point process intensity is required. We will be using an isotropic Gaussian
kernel with standard deviation σ to calculate the estimate. In addition to the expected value
of the Kinhom 5% confidence limits are calculated via simulation and again, a smoothing
bandwidth is required. As the K-function of an inhomogeneous Poisson process is π r 2 the
smoothing bandwidth sigma needs to be chosen so that the estimated values of the
inhomogeneous K-function are of the same order of magnitude as π r 2 . So, when the r
values are in the range 0 to 15, the maximum values of K-function should be about 700. In
the inhomogeneous K-function plot, the range of ‘r’ values shown is the ‘recommended
range’ according to Ripley’s rule, which is [0,R] where R is one quarter of the smallest side
of the rectangle containing the study region. The estimate of Kinhom may also be available
for large values of r, but is not plotted for these larger values by default.

3.5 The inhomogeneous Poisson model
In the inhomogeneous Poisson model (2.44), the covariate can be a dataframe or a pixel
image. In this study, the covariates available for different cancers are considered for model
fitting. How to find an adequate fit and how to validate the fitted models are studied
individually for five cancers.

The treatment options for missing values will be illustrated using the lung cancer point
patterns and their potential covariates. The validated treatment method is then applied in the
discussion of the other cancers. Prostate cancer is used as an example, to discuss the
process to select an appropriate model.

When the fitted model involves spatial covariates, lurking variable plots are important to
show how much the fitted model captures the dependence of intensity on the covariates.
The plot indicates approximate 5% significance bands for the cumulative residual
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(Baddeley 2008). The selected covariate does not account for the point pattern when the
plot is totally outside of the significance bands and just stays either over or below the
horizontal axis.

What we obtain from point pattern analysis is the spatial trends within the point process
intensity and the validation of the fitted point process model using the techniques in
Baddeley et al.(2005).
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4 DATA DESCRIPTION
4.1 Data preparation
The data used in this study are cancer incidence and mortality data for lung, melanoma,
colorectal, breast and prostate cancers for the period 1990-2005 in the Perth metropolitan
area. Perth is the capital city of Western Australia, located in the southwest of Western
Australia. Western Australia has a total of 2.3 million inhabitants, the majority of whom
(1.7 million) live in the Perth metropolitan area. There are 55519 observations for cancer
incidence with 1314 missing values and 18043 observations for cancer mortality with 192
missing values. The cancer incidence and mortality data obtained from the Department of
Health of WA cover the areas Perth, Bunbury and Geraldton. Since Bunbury and Geraldton
are not close to Perth, the data from these two areas are removed for the analysis in this
study. The records used in this study include the following variables: Coded ID number;
Latitude/longitude of location at incidence and death; age in 5-year brackets at time of
diagnosis and death; sex (1 denotes males, and 2 denotes females); year of diagnosis and
death; type of cancer; survival time; cause of death if applicable (by these cancer types,
other cancer, other cause) and indigenous status.

Acoording to the data, nearly all the cancer patients died of the diagnosed cancer rather
than other cancers or other causes. As for the indigenous status, nearly 99% of the cancer
patients are not indigeneous and 1% are indigeneous or of unknown status. Therefore, these
variables are not informative for this study.

4.2 Raw cancer data
During the period 1990-2005, there is an overall increase in the number of incidence and
mortality cases for top five cancers in the Perth metropolitan area and the total number of
cancer incidence cases is increasing more rapidly than the number of mortality cases in
1990-2005 (Figure 1 and Figure 2). The cancer rates are higher for men than for women in
Perth. This overall increase is apparent in all cancers. However, for prostate cancer
incidence there was rapid growth from 1990 to 1994 followed by a sharp decline until 1997
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and again a phase of rapid growth from 2000 onwards. The number of mortality cases is
much lower than the number of incidence cases for each type of cancer. For melanoma
mortality, the number of cases is relatively low compared with other cancers in each
individual year. There is slight increase with fluctuations in cancer mortality for breast and
prostate cancer during the period 1990-2005.

Figure 1 Counts of cancer incidence (left) and mortality (right) recorded in the Perth metropolitan area (T
denotes total, M denotes males and F denotes females).
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Figure 2 Yearly incidence cases (left) and mortality cases (right) recorded in Perth metropolitan area.

Survival rate is the percentage of people who survive a disease such as cancer for a given
period of time after diagnosis. The plots for survival rates (Figure 3) show that about 40%
of people with lung cancer were alive one year after diagnosis. In comparison, the survival
time of melanoma cancer patients is relatively long: about 50% survived 6 years after
diagnosis. The survival rates for breast and prostate cancers are quite similar. The
percentages of breast and prostate cancer patients who were alive for 6 years are 43% and
38% respectively. The survival rates for lung cancer are relatively low compared with other
cancers. The survival rates are not directly used for the modelling in this study, but they are
the reference for the selection of covariates (susceptible population intensity) in spatial
point pattern analysis.
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Figure 3 Survival rates for lung, colorectal, melanoma, breast and prostate cancers recorded in 1990-2005.

Barplots shown in Figure 4 and Figure 5 are based on incidence and mortality cancer data
respectively recorded in the Perth metropolitan area from 1990 to 2005. They indicate
clearly that males and females have different risk from lung, colorectal and melanoma
cancer especially when people are of age 50 or above. Moreover, different age groups of
people have different cancer risks. Generally speaking, age is a main cancer risk factor. The
incidence risk for lung cancer and colorectal cancer increases greatly with age for both
sexes and reaches the highest at age 70. While the growth rate for lung cancer incidence
with age is higher for males than females, this is not the case for colorectal cancer. For
melanoma cancer, people aged 50-60 are the most affected group. Melanoma incidence risk
increases with the age for males but this is not the case for females. For sex-specific
cancers, breast cancer has the similar pattern with female melanoma cancer: age group 4060 is the most affected. The risk of having prostate cancer increases with age, especially
when males are aged 50 or over. For mortality, the number of cases is much lower than the
corresponding number of incidence cases. And also the influence of sex on mortality is not
so strong compared with the influence of sex on incidence. Based on these observations,
kriging analysis will incorporate age and sex for incidence and mortality data to make the
estimation more reliable.

To obtain further information on incidence and mortality data from different perspectives,
we will look at the kriging analysis for lung, melanoma and colorectal cancer incidence by
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sex and the kriging analysis for the mortality of three cancers will be carried out for three
contiguous periods: 1990-1995, 1996-2000 and 2001-2005.

Figure 4 Counts of cancer incidence by age and sex (M denotes males and F denotes females) recorded in
Perth during the period 1990-2005 (B denotes breast and P denotes prostate). The age is in 10-year brackets
with the lower limit stated and this is not the case for 30-.
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Figure 5 Counts of cancer mortality by age and sex (M denotes males and F denotes females) recorded in
Perth during the period 1990-2005 (B denotes breast and P denotes prostate). The age is in 10-year brackets
with the lower limit stated.

4.3 Coordinates transformations
For geostatistical modelling, data were aggregated within Statistical Local Areas (SLAs)
(see Figure 6 for the SLA map of Perth). For nearly all cancer records the SLA name is
recorded. An SLA is a general purpose spatial unit. The SLAs cover the Australia without
gaps or overlaps. The SLAs vary in terms of area size and population.

To apply ATP Poisson Kriging the centroid of each SLA is required. The centroid for each
SLA is calculated as the mean value of the non-zero coordinates of cancer case locations in
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each SLA during the entire study period. For example, to obtain the centroid for
Bassendean (T), 602 case locations of the total of 611 records for five cancers were used to
compute the mean coordinates of cancer incidences. There are cancer incidence cases
between 1990 and 2005. For nine case locations no coordinates were recorded. The
coordinates were first converted from Lat/Long to UTM and then the mean location was
calculated by simple averaging of the UTM Eastings and Northings. The nine locations in
this area without latitude and longitude were then allocated the coordinates of the centroid.
The coordinates for other Statistical Local Areas at incidence and mortality with more than
one case are calculated in a similar way. In the original data file, there are ten incidence
locations without SLAname. Eight of them are located within the Perth metropolitan area.
In this study, they are allocated to the SLA Perth (inner). The Cartesian coordinates for the
SLAs in Perth obtained in this fashion are shown in Table 1.
Table 1 The Cartesian coordinates of SLA in Perth for cancer incidence. The coordinates were converted
from Lat/Long to UTM using Redfearn’s formulae.
Perth-SLAname
X-coord
Armadale (C)
407322.54
Bassendean (T)
400317.66
Bayswater (C)
396438.27
Belmont (C)
399181.15
Cambridge (T)
386167.12
Canning (C)
396783.75
Claremont (T)
384679.25
Cockburn (C)
387280.63
Cottesloe (T)
382734.38
East Fremantle (T)
383705.84
381680.86
Fremantle (C) - Inner
Fremantle (C) -Remainder 383769.04
Gosnells (C)
403035.30
Joondalup (C) - North
381979.41
Joondalup (C) - South
383964.98
Kalamunda (S)
408917.19
Kwinana (T)
388897.37
Melville (C)
388976.49
383341.10
Mosman Park (T)

Y-coord
6444166.60
6469864.53
6469526.74
6463667.39
6466178.95
6455249.60
6460828.65
6447590.60
6459614.62
6454632.45
6452813.13
6452235.92
6452388.93
6486667.41
6479576.16
6461435.01
6432425.66
6454343.56
6457489.73

Perth-SLAname
X-coord
Mundaring (S)
415780.97
Nedlands (C)
386260.98
383489.96
Peppermint Grove (S)
391980.03
Perth (C) - Inner
391615.85
Perth (C) - Remainder
Rockingham (C)
381723.06
Serpentine-Jarrahdale (S) 404937.22
South Perth (C)
392968.21
Stirling (C) - Central
390694.93
Stirling (C) - Coastal
384360.80
Stirling (C) - South-Eastern 393378.79
Subiaco (C)
388340.94
Swan (C)
403502.47
Victoria Park (T)
396471.29
Vincent (T)
391602.65
Wanneroo (C) - North-East 387298.47
Wanneroo (C) - North-West 375295.14
Wanneroo (C) - South
390817.14
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Y-coord
6470986.32
6461326.06
6459023.52
6464115.81
6463716.63
6424365.49
6429136.66
6459442.73
6471749.66
6471370.77
6467827.54
6463779.82
6475236.37
6460747.02
6466696.34
6486843.25
6499582.94
6477623.66

Figure 6 Statistical local area (SLA) map of Perth.

43

4.4 Census data
The population data were obtained from Australian Bureau of Statistics (ABS) and they are
only available for census years. The population data (year 1995, 2000 and 2006) used for
kriging analysis are recorded by SLA, age in 5-year brackets and sex. There is a gradual
increase in the population with time, so the year 2000 population is appropriate to be used
in equation (4.2) for the calculation of rates. The population data by sex in SLAs of the
Perth metropolitan area in the year 2000 are shown in Table 2. In this table, the population
size of males, females and total in each SLA is denoted by Males, Females and Total
respectively. The population data in year 2006 (Table 3) used for point pattern analysis
have the variables by suburb: ObjectId, Total (population size), Area (suburb size by square
kilometers), XY (coordinate by Lat/Long), Thirtypp (proportion of people aged 30 above)
and Fiftypp (proportion of people aged 50 above). The corresponding Perth map in the
form of “shapefile” by SLA and by suburb was also obtained from ABS. The population
data in 2006 by sex (Table 4) used for point pattern analysis have the variables by suburb:
ObjectId, Mpop (male population size), Fpop (female population size), Area (suburb size
by square kilometers), XY (coordinate by Lat/Long), Mfortypp (proportion of males aged
40 above) and Ffortypp (proportion of females aged 40 above).
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Table 2 The population data by SLA in Perth metropolitan area in year 2000.

SLANAME

Males Females Total

Armadale (C)
26594
6948
Bassendean (T)
Bayswater (C)
28382
Belmont (C)
14685
11643
Cambridge (T)
Canning (C)
38281
4494
Claremont (T)
Cockburn (C)
34642
3706
Cottesloe (T)
East Fremantle (T)
3306
Fremantle (C) - Inner
434
Fremantle (C) - Remainder 12664
Gosnells (C)
42021
23295
Joondalup (C) - North
55795
Joondalup (C) - South
Kalamunda (S)
24514
Kwinana (T)
11186
Melville (C)
46890
3779
Mosman Park (T)

26788
7015
28495
14759
12356
38452
5028
33531
3893
3354
310
12596
41359
23448
54893
24965
10367
50459
4340

53382
13963
56877
29444
23999
76733
9522
68173
7599
6660
744
25260
83380
46743
110688
49479
21553
97349
8119

SLANAME

Males Females Total

Mundaring (S)
Nedlands (C)
Peppermint Grove (S)
Perth (C) - Inner
Perth (C) - Remainder
Rockingham (C)
Serpentine-Jarrahdale (S)
South Perth (C)
Stirling (C) - Central
Stirling (C) - Coastal
Stirling (C) - South-Eastern
Subiaco (C)
Swan (C)
Victoria Park (T)
Vincent (T)
Wanneroo (C) - North-East
Wanneroo (C) - North-West
Wanneroo (C) - South

17431
10454
731
341
3526
35022
5962
18814
48135
30472
8269
7671
41752
13368
12766
9333
12032
17975

17584
11051
1017
238
2680
35730
5520
18870
49887
31282
8744
8092
40619
14131
12570
9145
12011
18235

Table 3 The extract of the population data by Suburb in Perth metropolitan area in year 2006.
ObjectId
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Total
7233
798
11090
3685
680
740
9
781
0
69
10929
5633
11420
4840
3794
2740
2653
2054
1195
2741
11549

Area
2.83614
1.55409
5.83138
3.5533
0.32683
1.34342
6.20102
12.4735
0.57674
5.84969
20.1763
8.37551
13.9844
3.21225
3.09271
1.53811
4.90167
1.56839
1.6777
1.4514
7.53015

X
115.7382
115.9976
115.7543
115.8665
116.0424
116.0725
115.7902
115.8762
115.8147
115.8315
115.8161
115.8663
115.7694
115.9418
115.8088
115.9063
115.7963
115.8866
115.7599
115.8411
115.8672

Y
-31.71801
-31.8775
-32.31566
-31.84142
-31.90809
-31.99616
-32.22808
-32.19426
-32.24972
-31.79418
-31.75743
-31.80763
-32.34137
-32.04081
-31.83965
-31.96756
-32.26056
-32.01573
-31.85283
-31.93191
-32.0759
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Thirtypp
0.299737
0.086466
0.03183
1.56445
1.938235
0.468919
31.55556
2.957746
0
5.811594
0.022143
0.218889
0.08993
0.665496
0.383237
0.708029
1.093856
0.363681
0.119665
0.502736
0.223742

Fiftypp
0.167289
0.357143
0.256447
0.271913
0.282353
0.313514
0
0.28041
0
0.507246
0.338915
0.160128
0.210946
0.270661
0.387454
0.319343
0.166981
0.325219
0.422594
0.245166
0.304615

35015
21505
1748
579
6206
70752
11482
37684
98022
61754
17013
15763
82371
27499
25336
18478
24043
36210

Table 4 The population data by Suburb for males and females in Perth metropolitan area in year 2006.
ObjectId
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Mpop
3555
382
5526
1871
339
369
9
418
0
33
5447
2752
5630
2469
1873
1379
1280
1060
585
1346
5725

Fpop
3678
416
5564
1814
341
371
0
363
0
36
5482
2881
5790
2371
1921
1361
1373
994
610
1395
5824

Area
2.83614
1.55409
5.83138
3.5533
0.32683
1.34342
6.20102
12.4735
0.57674
5.84969
20.1763
8.37551
13.9844
3.21225
3.09271
1.53811
4.90167
1.56839
1.6777
1.4514
7.53015

X
115.7382
115.9976
115.7543
115.8665
116.0424
116.0725
115.7902
115.8762
115.8147
115.8315
115.8161
115.8663
115.7694
115.9418
115.8088
115.9063
115.7963
115.8866
115.7599
115.8411
115.8672

Y
-31.71801
-31.8775
-32.31566
-31.84142
-31.90809
-31.99616
-32.22808
-32.19426
-32.24972
-31.79418
-31.75743
-31.80763
-32.34137
-32.04081
-31.83965
-31.96756
-32.26056
-32.01573
-31.85283
-31.93191
-32.0759

Mfortypp
0.355837
0.489529
0.411328
0.385355
0.410029
0.460705
0
0.449761
0
0.545455
0.452176
0.349564
0.359147
0.378696
0.486385
0.476432
0.325781
0.437736
0.555556
0.360327
0.469345

Ffortypp
0.348287
0.528846
0.423077
0.421169
0.407625
0.490566
0
0.498623
0
0.555556
0.503831
0.319334
0.377547
0.414171
0.550234
0.493755
0.296431
0.512072
0.590164
0.370609
0.497596

4.5 Calculation of cancer rates
The crude cancer rate in each SLA during the period 1990-2005 was calculated as the ratio
of 100,000 × the total number of cancer incidences during the 16-year period applied
to 16 × the total population in year 2000 , in which 16 is the time span between 1990 and
2005. The crude rate in an SLA may be affected by the population structure in the SLA.

The rates can be adjusted for demographic factors such as age or sex to remove the bias
from them. In this study, nine age specific groups are used: 0-9, 10-19, …, 70-79 and one
80+ group. The age-adjusted rates (Goovaerts 2005c) per 100,000 person-years for each
cancer in each SLA during the period 1990-2005 were computed as:
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9

R= 100,000 × ∑ ri × p i

(4.1)

i =1

where p i is the percentage of age group i in WA in the year 2000, and ri is the age-specific
rate for the population of age group i and computed as

ri =

di

16 N i

(4.2)

where d i is the total number of incidence cases over the period 1990-2005 for age group i
and N i is the population of age group i in SLA in the year 2000. An age-adjusted rate will
reflect what the overall rate would be in different Statistical Local Areas if the population
in SLA had the same age distribution as the WA age distribution in 2000. For each cancer,
the population at risk was computed as:

100,000 × d

R

(4.3)

where d is the total number of incidence cases over the period 1990-2005 and R is the age
adjusted rate. The population at risk will be used in the kriging estimation calculation.

The age-sex-adjusted rate is calculated based on the calculation of age-adjusted rates. The
age-sex-adjusted rates per 100,000 person-years for each cancer in SLA during the period
1990-2005 were computed as:

9

100,000 × ∑ (r1i × p1i + r2i × p 2i ) / 2

(4.4)

i =1

where p1i and p 2i are the percentages of male age group i and female age group i
respectively in WA 2000. r1i and r2i are the age-specific rates for the male population of
age group i and female population of age group i respectively.

Since the age distribution may vary greatly by geographic region, age-adjusted rates are
commonly used in cancer data analysis to eliminate the bias resulting from the difference in
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the population structure (Klein and Schoenborn 2001). Compared with crude rates, ageadjusted rates can make the groups in diverse regions more comparable. Much of the recent
research and discussion on geostatistical analysis of the cancer data are associated with ageadjusted rates. In fact, in addition to age, sex is another significant risk factor. For example,
lung cancer rates are higher for males than females in Western Australia and it is more
common for old people than young people (Threlfall and Thompson 2007). The age-sex
adjusted rate will help to eliminate the bias resulting from differences in age and sex. Also,
rates need to be corrected for the small number problem.

4.6 Exploratory data analysis
The ATP Poisson kriging analysis is based on the adjusted rates and population at risk.
While the point pattern analysis incorporates the observed covariates. In the first section,
we will introduce the age-adjusted rates and age-sex-adjusted rates for cancer incidence and
mortality. The population at risk which is based on the adjusted rates is in the second
section. For crude rates for different cancers see Appendix 9.1. In the third section, the
available covariates used for different cancers are provided.

4.6.1 Adjusted rates for geostatistical analysis
In this section, the adjusted rates for the five types of cancer are considered to identify the
difference of cancer distribution in Perth SLAs. First, we look at the maps of the ageadjusted and age-sex-adjusted rates for lung, melanoma and colorectal cancers.

For the overall incidence rates, Figure 7 indicates that lung cancer incidence is relatively
low compared with melanoma and colorectal (CRC) cancer and the difference between ageadjusted and age-sex-adjusted rates is slight. Higher melanoma cancer incidence rates arise
mainly in the western part of the Perth metropolitan area. Higher colorectal cancer
incidence rates occur mainly in the north-west of the Perth metropolitan area and in the
suburbs near Perth.
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Age-adjusted rates

Age-sex-adjusted rates
Lung cancer incidence

66.23
48.52
45.72
44.14
42.25
41.34
38.58
35.64
34.28
31.24

Melanoma incidence

92.55
63.12
56.42
51.40
47.51
44.55
43.09
41.29
39.09
35.82

CRC incidence

92.41
60.48
58.55
56.98
53.75
52.25
50.21
47.81
45.87
42.00

Figure 7 Adjusted rates for cancer incidence.

For the incidence rates by sex, Figure 8 indicates that the difference between males and
females is relatively strong for lung cancer compared with melanoma and colorectal
cancers. Males and females have relatively low lung cancer risk compared with melanoma
and colorectal cancers. Lung cancer adjusted rates of males are much higher than those of
females in most areas. For melanoma, the difference between males and females is slight.
For colorectal cancer, the highest incidence rate is 130 per 100,000 person-years for males
during the period 1990-2005 but only 90 for females.
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Male

Female
Lung cancer incidence
56.89
33.11
30.91
29.59
28.26
26.79
25.76
23.79
22.19
19.97

90.57
67.19
65.15
63.09
58.19
55.58
51.54
46.57
45.28
40.44

Melanoma incidence

131.30
49.91
44.70
42.78
39.97
37.55
35.71
33.82
32.05
29.51

126.56
82.48
75.71
63.97
55.33
52.77
49.00
46.36
43.01
38.95

CRC incidence

90.49
58.86
53.20
51.67
49.53
46.78
43.33
42.59
39.63
36.69

129.61
71.99
68.09
62.93
59.85
58.31
54.27
49.80
48.74
43.83

Figure 8 Cancer incidence rates by sex, 1990-2005.

Although lung cancer incidence rates are lower than other cancer rates, the mortality rates
for lung cancer are relatively high according to Figure 9. Compared with incidence rates,
the two mortality adjusted rates are quite similar. This indicates that age and sex probably
have less influence on cancer mortality than on incidence. For melanoma cancer, the rates
are much lower than for other cancer types. During the 16-year period, the highest mortality
rate is 17 per 100,000 person-years across the Perth metropolitan area. However, the rate is
56 for lung cancer and 38 for colorectal cancer. For colorectal cancer, the mortality rates
around Perth metropolitan are relatively high.
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Age-adjusted rates

Age-sex-adjusted rates
Lung cancer mortality
55.68
42.49
40.22
38.42
36.45
34.18
32.69
29.42
27.71
25.56

Melanoma mortality
16.80
7.29
6.28
5.53
5.13
4.75
4.60
4.23
4.07
3.75

CRC mortality
37.83
25.57
23.86
22.98
21.94
21.48
20.14
19.14
18.48
16.67

Figure 9 Adjusted rates for cancer mortality.

In Figure 10 the development with time of the mortality rates is shown. We see that there is
an overall increase on the lung cancer rates in the Perth metropolitan area. For melanoma, it
seems that there is a slight increase in mortality rates in most areas over three periods. For
colorectal cancer, the change is slight. It seems that higher colorectal cancer rates are
mainly near the inner city suburbs in each period.

51

1990-1995

1996-2000
Lung Cancer mortality

2001-2005

70.35
46.24
41.53
38.54
36.11
32.78
29.03
25.12
23.09
19.75

Melanoma mortality

53.76
8.83
7.08
6.17
5.57
4.74
4.11
3.57
3.02
1.96

CRC mortality
49.40
30.47
27.06
25.11
23.07
21.05
19.35
17.19
15.45
12.21

Figure 10 Age-adjusted rates for cancer mortality during three time periods.

Next we will consider the maps of the age-adjusted rates for sex specific cancers: breast
and prostate cancers. For the incidence, overall prostate cancer incidence rates are relatively
high compared with breast cancer in western part of the Perth metropolitan area (Figure 11).
However, breast cancer rates are higher than prostate cancer rates in most of the eastern
part of the study area. The overall higher rates arise in the inner suburbs of Perth. Based on
Figure 7 and Figure 11, it can be seen clearly that breast cancer incidence is the most
common cancer risk for females while the most common incidence risk for males is
prostate cancer. For the mortality, it seems that breast cancer has higher overall mortality
rates than others in western part of Perth metropolitan area. Generally speaking, the sex
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specific cancer mortality rates are relatively low compared with lung cancer mortality
(Figure 9).
Breast Cancer

Prostate cancer
Incidence 90-05

314.55
153.01
138.24
129.06
120.74
113.98
108.25
101.39
97.42
85.10

Mortality 90-05

48.48
33.57
28.55
26.61
24.69
23.36
20.75
18.81
17.69
15.41

Figure 11 Age-adjusted rates for breast and prostate cancer in 1990-2005.

The cancer rates for the three time periods 1990-1995, 1996-2000 and 2001-2006 are
shown in Figure 12. Breast cancer incidence increases steadily in these three periods in the
Perth SLAs and the incidence is higher in the inner suburbs of metropolitan Perth. For
prostate cancer incidence, it seems that there was a slight decrease in cancer rates around
Perth metropolitan by the second period and a significant increase in cancer rates across
Perth metropolitan area by the third period.

In comparison, higher mortality rates for breast cancer mortality are mainly in areas close
to Perth city centre where the rates kept decreasing with time. However, mortality rates
increased in other areas in three time periods. For prostate cancer, the overall mortality
rates are relatively high in the second period and low in the third period.
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1990-1995

1996-2000
Breast Cancer incidence

2001-2005

508.38
147.29
134.77
128.54
118.56
113.80
108.03
98.43
93.40
79.48

Prostate cancer incidence

244.23
156.50
142.52
130.29
117.20
109.57
97.83
89.01
80.51
63.19

Breast Cancer mortality

206.72
37.86
33.89
29.34
26.57
24.13
21.93
20.06
18.38
15.07

Prostate Cancer mortality
61.11
31.68
27.55
24.84
22.39
20.08
17.51
15.36
12.93
9.41

Figure 12 Age-adjusted rates for breast and prostate cancer in three time periods.
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From the discussions above, it can be seen that males have a much higher lung cancer
incidence risk than females but they have quite similar incidence risk for melanoma and
colorectal cancers. The lung cancer incidence risk is lower than melanoma and colorectal
cancer risks for both males and females. However, lung cancer mortality risk is much
higher than melanoma and colorectal cancer mortality risk. Although people have a very
high melanoma cancer incidence risk, the mortality risk is very low compared with other
cancers.

4.6.2 Population at risk for geostatistical analysis
In this section, the population at risk for the five types of cancer are provided for reference.
The population at risk is based on the adjusted rates which are discussed in details in
section 4.6.1. The population at risk for lung, melanoma and colorectal cancers are
presented in Figure 13-Figure 16. The population at risk for sex specific cancers are given
in Figure 17 and Figure 18. See section 4.5 for the calculation of the population at risk.
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Age-adjusted rates
Age-sex-adjusted rates
Lung Cancer incidence

6.29
6.05
5.96
5.87
5.77
5.70
5.59
5.42
5.26
5.03

Melanoma incidence

6.25
6.05
6.00
5.79
5.70
5.66
5.50
5.39
5.17
5.03

Colorectal incidence

6.29
6.06
5.97
5.88
5.72
5.67
5.47
5.39
5.22
5.04

Figure 13 Population at risk (lognormal scale) for cancer incidence.
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Male

Female
Lung cancer incidence

5.99
5.75
5.64
5.54
5.42
5.36
5.24
5.13
4.91
4.72

Melanoma incidence

5.95
5.77
5.71
5.61
5.44
5.37
5.22
5.11
4.94
4.67

Colorectal incidence
5.99
5.76
5.68
5.58
5.44
5.39
5.29
5.12
4.97
4.70

Figure 14 Population at risk by sex (lognormal scale) for cancer incidence.
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Age-adjusted rates

Age-sex-adjusted rates
Lung cancer mortality

6.29
6.05
5.96
5.87
5.77
5.70
5.59
5.42
5.26
5.03

Melanoma mortality

6.28
6.05
5.98
5.87
5.70
5.66
5.44
5.36
5.20
5.03

Colorectal mortality
6.29
6.06
5.95
5.87
5.73
5.71
5.62
5.42
5.25
5.04

Figure 15 Population at risk (lognormal scale) for cancer mortality.
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1990-1995

1996-2000
Lung cancer mortality

2001-2005

5.91
5.60
5.50
5.40
5.27
5.23
5.15
4.99
4.84
4.53

Melanoma mortality

5.90
5.61
5.52
5.43
5.26
5.22
5.13
4.97
4.79
4.56

Colorectal mortality

5.91
5.59
5.50
5.40
5.29
5.24
5.16
4.97
4.81
4.55

Figure 16 Population at risk (lognormal scale) based on age-adjusted rates for cancer mortality during three
time periods.
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Breast Cancer

Prostate cancer
Incidence 90-05
5.99
5.77
5.70
5.61
5.43
5.38
5.22
5.11
4.97
4.68

Mortality 90-05
6.00
5.77
5.66
5.58
5.47
5.41
5.30
5.10
4.94
4.72

Figure 17 Population at risk (lognormal scale) based on age-adjusted rates for breast and prostate cancers.

60

1990-1995

1996-2000

2001-2005

Breast cancer incidence

5.58
5.31
5.23
5.14
4.99
4.91
4.82
4.67
4.49
4.19

Prostate cancer incidence

5.60
5.31
5.21
5.12
4.98
4.93
4.82
4.65
4.48
4.27

Breast cancer mortality

5.61
5.30
5.20
5.12
4.99
4.95
4.86
4.68
4.52
4.15

Prostate cancer mortality

5.61
5.31
5.19
5.10
5.02
4.97
4.86
4.65
4.48
4.28

Figure 18 Population at risk (lognormal scale) based on age-adjusted rates for breast and prostate cancers.
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4.6.3 Covariates for spatial point pattern analysis
For spatial point pattern analysis of the 2005 incidence and mortality data, it is necessary to
explore possible covariates which might be useful for the model fitting. The covariates to
be used in spatial point pattern analysis for cancers are population density, the proportion of
selected age groups and the spatially varying susceptible population intensity.

The population density in each suburb is computed using the total population in the suburb
in 2006 divided by the area of the suburb in square kilometres. Based on the population
density, the population density image is calculated using the equation (2.45). This pixel
image is denoted by popdens (Figure 19). It will be used as covariate for lung cancer,
melanoma and colorectal cancer model fitting. From Figure 4 it can be seen that people of
age 50 or above (50+) have a much higher chance for lung cancer incidence than other age
groups. The pixel image (see Figure 19) based on the proportion of this age group is
denoted by aged. It will be used as covariate for lung cancer model fitting as well.
According to Figure 4, pixel image aged is used as covariate for colorectal cancer model
fitting as well. Similarly, pixel image aged30+ (the proportion of people aged 30 or over)
shown in Figure 19, will be used as covariate in modelling melanoma cancer. The pixel
images popdens, aged and aged30+ are calculated according to population data shown in
Table 3.

For the sex specific cancers, the pixel image agedf (Figure 20) to be used as covariate for
breast cancer model fitting is based on the proportion of females aged 40 above according
to Figure 4. Another pixel image, popdensf (Figure 20) based on the overall population
density of females, will be used for breast cancer model fitting as well. Similarly, pixel
images agedm (the proportion of males aged 40 or over) and popdensm (male population
density) shown in Figure 21, will be used as covariates for prostate cancer model fitting.
All these images are calculated using the equation (2.45) and are obtained from the year
2006 population data using Gaussian Kernel smoothing. In the further discussion of the
thesis, these covariates will be referred to by their pixel image name. The pixel images
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popdensf, agedf, popdensm

and agedm40+ are calculated according to population data

shown in Table 4.

Figure 19 Kernel smoothing estimate of the population density (left, denoted by popdens), the percentage
of people aged 50+ by suburb in 2006 (middle, denoted by aged) and the percentage of people aged 30 or
above (right, denoted by aged30+).

Figure 20 Kernel smoothing estimate of the population density for females (left, denoted by popdensf)
and the percentage of females aged 40+ of all females by suburb in 2006 (right, denoted by agedf).

Figure 21 Kernel smoothing estimate of the population density for males (left, denoted by popdensm) and
percentage of males aged 40+ of all males (right, denoted by agedm) by suburb in 2006.
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Pixel images (distmap) based on cancer incidence case locations are calculated using
empty space distances. The individual images from 1990-2005 will be used as covariates to
reflect the spatially varying susceptible population density for each corresponding cancer
model fitting. One example of this application can be found in Diggle (1990), in which the
lung cancer point process is used as the spatial variation in risk population intensity for
larynx cancer point process analysis. The distmaps, based on lung, melanoma, colorectal,
breast and prostate cancer incidence cancers during the period 1990-2005, are shown in
Figure 22 to Figure 26. The distmap images are calculated based on the equation (2.46)
and will also be used as covariates for model fitting. At each pixel location the empty space
distance is the distance from this location to the closest data point. And so they look quite
similar when the colour scales with 10 kilometers apart are used to describe the empty
space distance based on cancer incidence point patterns. The incidence case locations in
densely populated areas are generally close to each other and so the value for the empty
space distance is low. Inversely, the incidence case locations in sparsely populated areas are
generally far away from each other and so the value for the empty space distance is high.
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1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

Figure 22 Empty space distances for lung cancer incidence case locations by year, 1990-2005.
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Figure 23 Empty space distances for melanoma cancer incidence case locations by year, 1990-2005.
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Figure 24 Empty space distances for colorectal cancer incidence case locations by year, 1990-2005.
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Figure 25 Empty space distances for breast cancer incidence case locations by year, 1990-2005.
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Figure 26 Empty space distances for prostate cancer incidence case locations by year, 1990-2005.
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5 GEOSTATISTICAL ANALYSIS
Age-adjustment and age-sex-adjustment are statistical processes applied to rates of cancer
in the geostatistical analysis. Age-adjusted rate and age-sex-adjusted rate are a weighted
average of the age-specific and age-sex-specific rate compared with crude rate. Cancers
occur more often among older people (WACR 1997) and this is also shown in Figure 4. A
geographic unit with higher proportion of young people will have a lower cancer incidence
and mortality rate than the one with more old people. This is true even if people from the
two units have the same cancer risk. Similarly, males are more susceptible to some cancers
such as lung cancer than females. The age-adjusted rate and age-sex-adjusted rate are used
to remove confounding caused by age or sex. The calculation of the adjusted rates in this
chapter is based on (4.1) and (4.4). Geostatistical estimations for cancers are based on the
adjusted rates (4.6.1) and population at risk (4.6.2). Semivariograms will be used in the
analysis to measure spatial continuity and variability of cancer data. Semivariogram models
are fitted to enable kriging analysis and are plotted in meters. Unless otherwise stated,
kilometres will be used to describe semivariograms for the sake of convenience.

The size and shape of geographical units in the applications can vary greatly, especially
those large rural and sparsely populated areas, which make deconvolution very challenging
(Goovaerts 2006a). Uniform discretizing grids across the study area used in deconvolution
are not flexible enough because minor changes (coarser grids) in the deconvoluted model
have little influence on the kriging estimates (Goovaerts 2008). The population density by
SLA in Perth (Figure 27) shows that there is a great difference in population density
between small SLAs in the middle of the study area and some large SLAs in the east. And
so the deconvolution (2.35) is not used in this study due to these large and sparsely
populated SLAs, which do not make distinct difference between computations based on
point-support semivariogram model and those based on SLA-based semivariogram model.
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2499
1912
1863
1722
1553
1348
1107
777
601
130
Figure 27 Population density per square kilometers in Perth 2000.

5.1 Lung cancer analysis
In this chapter, lung cancer data will be analysed using ATP Poisson kriging. Lung cancer
incidence data during the period 1990-2005 are analysed in the first section. In addition, the
incidence data divided by sex: male and female lung cancer incidence, are explored
separately. Further discussion will show the differences in lung cancer risk between males
and females. Mortality data are analysed in the second section.

5.1.1 Lung cancer incidence analysis
5.1.1.1 Lung cancer incidence analysis in 1990-2005

We have analysed lung cancer incidence data based on adjusted rates in which directional
semivariograms are applied (Shao et al. 2009). In that paper, we have shown that the lung
cancer incidence data can be analysed by taking into account sex and age. Slight
differences can be found between the two adjusted rates and between the two kriging
estimates, but the variance map of the age-sex adjusted rates show much less variability and
relatively lower value than age-adjusted rates. The variation is spatially dependent and the
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risk from age-sex (with zero nugget effect) is possibly more continuous than the risk only
from age.

In this section, the estimates are based on adjusted rates in which omnidirectional
semivariograms are applied (Figure 28). The nugget effect is zero for age-adjusted rates and
8 for age-sex-adjusted rates. The variogram for age-adjusted rates has greater range and
higher sill. This indicates that the spatial continuity and spatial variability for age-adjusted
rates and age-sex-adjusted rates are quite similar.
Age-adjusted incidence rates

Age-sex-adjusted incidence rates

Number of structures: 1
Nugget: 0
Spherical: Range 8.5, Sill: 53.5

Number of structures: 1
Nugget: 8
Spherical: Range 7.6, Sill: 43

Figure 28 Omnidirectional semivariograms of lung cancer incidence adjusted rates 1990-2005.

The estimates and variance based on the age-adjusted rates are calculated according to the
Equations (2.32) and (2.34) respectively (Figure 29). According to the plots, the estimates
based on the age-adjusted rates are relatively smooth and show less variability and the agesex-adjusted rates map is patchier. However, the variance for the age-adjusted estimates is
higher than the one based on age-sex-adjusted rates. The summary statistics for lung cancer
incidence are shown in Table 5. Crude rates per 100,000 person-years have a higher mean
value and variance value than other rates. ATP estimates are quite close to the adjusted
rates and their variance is very low compared with crude rates and the adjusted rates.
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Age-adjusted rates

Age-sex-adjusted rates
Estimates

53.24
43.06
42.46
41.68
40.98
40.52
40.06
39.62
38.80
37.50

Variances

66.47
62.22
62.21
59.82
59.03
58.43
58.42
55.63
48.68
35.59

48.58
46.24
45.99
45.79
45.67
45.42
45.06
44.52
43.35
38.60

Figure 29 ATP Poisson kriging estimates and variances based on lung cancer incidence adjusted rates.
Table 5 Summary statistics for lung cancer incidence estimates during the period 1990-2005.
Estimator
Lung cancer incidence
Mean
Variance Minimum Maximum
Crude rates
42.37
148.56
19.66
66.23
Age-adjusted rates
39.78
82.89
21.64
60.74
Age-sex-adjusted rates
39.97
83.16
22.94
62.94
ATP (age) estimator
40.43
10.52
21.45
53.24
ATP (age-sex) estimator
40.4
6.11
23.1
51.24

5.1.1.2 Lung cancer incidence analysis by sex

In this part, we will investigate the difference in incidence between males and females.
For experimental semivariograms, Figure 30 shows that the difference in spatial variation
between males and females is strong. For the effective distance of spatial dependence, the
value for females is more than 3 times the value for males. Semivariogram values of males
are nearly 10 times those of females. The semivariogram at zero lag is 40 for males and 0
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for females. As a result, female lung cancer incidence varies more continuously and has a
much stronger spatial correlation than that of males. The risk from age (with zero nugget) is
possibly more continuous for females than for males.
Male age-adjusted incidence rates

Female age-adjusted incidence rates

Number of structures: 1
Nugget: 40
Spherical: Range 8, Sill: 98

Number of structures: 1
Nugget: 0
Spherical: Range 30, Sill: 14

Figure 30 Omnidirectional semivariograms of lung cancer incidence age-adjusted rates 1990-2005.

The difference in estimation and the kriging variance (Figure 31) between males and
females is strong. For both males and females the incidence is high in the south of the Perth
metropolitan area and for males it is also high towards the northeast. The values of ATP
Poisson kriging estimates vary between 23 and 80 per 100,000 person-years for males and
between 21 and 34 for females. The estimation map of females is relatively smooth. For the
kriging variance, the map for females is relatively smooth due to small semivariogram
values. However, the male variance map shows great variability. For the maximum
variance value of Poisson kriging estimates, it is 115 for males and 33 for females.
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ATP PK estimates

ATP PK variances
Males

80.41
58.67
57.38
55.89
54.45
53.18
51.87
50.57
49.02
47.00

115.28
109.39
108.61
108.40
108.07
107.62
106.91
105.89
103.85
92.54

Females

33.80
30.33
28.53
28.07
27.57
26.53
26.14
25.81
25.39
24.61

32.77
20.17
17.09
15.14
13.85
12.81
11.90
10.53
8.98
6.14

Figure 31 ATP Poisson kriging estimates and variances by sex based on lung cancer incidence age-adjusted
rates.

The summary statistics for lung cancer incidence by sex are shown in Table 6. Males have
much higher values than females in mean, variance, minimum and maximum for different
rates in 1990-2005. All in all, male lung cancer incidence rates are relatively high and show
greater variability compared with female lung cancer incidence rates during the period
1990-2005.
Table 6 Summary statistics for lung cancer incidence crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates for males and females during the period 1990-2005.
Lung cancer incidence estimator Mean Variance Min
Max
during 1990-2005
Crude rates
M
56.44 336.61
17.10 90.57
F
27.75 79.28
0
44.04
Age-adj rates
M
53.81 195.96
18.50 83.76
F
26.12 69.86
0
56.89
ATP estimator
M
53.00 27.51
23.33 80.41
F
27.09 5.15
20.66 33.80
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5.1.2 Lung cancer mortality analysis

5.1.2.1 Lung cancer mortality analysis in 1990-2005

In this section, the estimation for lung cancer mortality is based on age-adjusted rates and
age-sex-adjusted rates for the period 1990-2005.

For the semivariograms, Figure 32 indicates that the difference in spatial variation between
age-adjusted rates and age-sex-adjusted rates is slight. For age-adjusted rates, the nugget is
8 and the spatial dependence distance is 12km. While for age-sex-adjusted rates, the nugget
is 18 and the spatial dependence distance is 14km. The semivariogram values for both rates
are quite close.
Age-adjusted incidence rates

Age-sex adjusted incidence rates

Number of structures: 1
Nugget: 8
Spherical: Range 12, Sill: 35

Number of structures: 1
Nugget: 18
Spherical: Range 14, Sill: 29

Figure 32 Omnidirectional semivariograms of lung cancer mortality rates 1990-2005.

The difference in estimation and the kriging variance between adjusted rates is slight
(Figure 33). The estimation maps show similar variability and the variance of age-sexadjusted estimation is slightly higher than the other in the eastern exterior suburbs of Perth.
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Age-adjusted rates

Age-sex-adjusted rates
ATP PK estimates
45.48
36.07
34.85
34.24
33.72
33.27
32.71
31.97
30.81
29.31

ATP PK variances

97.32
81.49
79.13
77.42
76.38
75.53
74.70
73.55
71.35
62.95

Figure 33 ATP Poisson kriging estimates and variance of lung cancer mortality based on age-adjusted (left)
and age-sex-adjusted rates (right).

The details of summary statistics for lung cancer mortality in 1990-2005 are shown in
Table 7. Crude rates have a higher mean value and variance value than other rates. ATP
estimates are quite close to adjusted rates and their variance is relatively low.
Table 7 Summary statistics for lung cancer mortality estimates during the period 1990-2005.
Estimator
Lung cancer mortality
Mean
Variance Minimum Maximum
Crude rates
35.93
125.37
16.85
55.68
Age-adjusted rates
33.5
64.74
13.15
51.16
Age-sex-adjusted rates
33.59
59.05
13.9
48.81
ATP (age) estimator
33.20
8.24
16.86
43.91
ATP (age-sex) estimator
32.76
8.35
16.64
45.48

77

5.1.2.2 Lung cancer mortality analysis for three periods: 1990-1995, 1996-2000 and
2001-2005

In this part, we will look at lung cancer mortality in three time periods.

For semivariograms, Figure 34 indicates that the difference between three periods is strong.
The spatial correlation in the first period is very strong and the spatial dependence distance
extends to 22km. Semivariogram values are the highest in the first period and the lowest in
the second period. In addition, the risk semivariograms are not well structured in the second
period and display a much shorter range of autocorrelation, and so the spatial correlation is
very weak. The nugget effect is zero only in the third period and and 20 in the first period.
This indicates that lung cancer mortality risk in the last period is probably more continuous
and in the first period shows great variability.
Age-adjusted mortality rates 1990-1995

Age-adjusted mortality rates 1996-2000

Age-adjusted mortality rates 2001-2005

Semivariogram model parameters
Number of structures for three models: 1
90-95 Nugget: 20
Cubic: Range 22, Sill: 60
96-00: Nugget: 14
Exponential: Range 10, Sill: 22
01-05: Nugget: 0
Spherical: Range 14, Sill: 48.5

Figure 34 Omnidirectional semivariograms of lung cancer mortality age-adjusted rates in 1990-1995 (top
left), 1996-2000 (top right) and 2001-2005 (bottom).

The difference in estimation and the kriging variance for the three periods (Figure 35) is
strong. For the estimated mortality rates, they had an increase from the first to the second
period. However, the difference between the second period and the third period is not
strong. The mortality rates in SLAs close to the Perth city centre are relatively high in each
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period. The estimation map is relatively smooth in the third period and shows slightly more
variability in other periods. The kriging variance for estimated rates, are relatively low in
the second period and very high in most of Perth SLAs in the first period. The variance map
shows greatest variability in the first period and the highest value is 161. In contrast, the
values are very low in the second period and the highest variance is 82 with slight
variability. The variance map is relatively smooth for the third period.
ATP PK estimates

ATP PK variances
1990-1995

161.21
126.99
121.62
117.48
114.80
112.72
109.66
105.29
97.80
79.28

1996-2000
81.93
71.63
69.32
67.90
66.65
65.31
63.90
62.90
61.46
55.68

2001-2005
78.27
64.94
61.34
59.61
57.68
56.22
54.75
52.35
47.28
35.52

44.25
35.41
34.08
33.37
32.76
32.07
31.25
30.30
29.05
26.50

Figure 35 ATP estimated rates (the scale applies to all estimates) and variances based on lung cancer
mortality age-adjusted rates.
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The details of summary statistics for lung cancer mortality are shown in Table 8. The mean
of rates is relatively high in the second period and the rates show great variability in the
first period. Overall, lung cancer mortality rates increase with time in some SLAs.
Table 8 Summary statistics for lung cancer mortality crude rates, age-adjusted rates and ATP Poisson kriging
estimated rates during 1990-1995, 1996-2000 and 2001-2005.
Lung cancer mortality estimator
Age-adjusted rates Crude rates ATP estimator
during: 1990-1995, 1996-2000 and 2001-2005
1990-1995
30.60
35.14
28.73
Mean
1996-2000
33.08
36.61
32.48
2001-2005
30.82
32.62
33.44
1990-1995
135.99
203.76
26.01
Variance
1996-2000
138.50
202.52
5.71
2001-2005
106.17
137.08
10.63
1990-1995
8.19
10.59
12.9
Minimum
1996-2000
0
0
22.86
2001-2005
0
0
18.27
1990-1995
69.76
68.93
44.25
Maximum
1996-2000
70.35
69.08
42.49
2001-2005
54.69
54.86
40.73

5.2 Melanoma analysis
Melanoma cancer incidence data based on adjusted rates from 1990 to 2005 are analysed in
the first section. In the second section, the differences in melanoma cancer risk by sex are
investigated. The mortality data for 1990-2005 are analysed in the third section. To get a
temporal view, mortality data in three contiguous periods: 1990-1995, 1996-2000 and
2001-2005 are also investigated.

5.2.1 Melanoma incidence analysis
5.2.1.1 Melanoma cancer incidence analysis in 1990-2005

For melanoma cancer incidence risk in the period 1990-2005, Figure 4 in Chapter 4
indicates that the difference between males and females is becoming obvious for people
aged 50 above. The analysis in this section is based on age-adjusted rates and age-sexadjusted rates.
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For semivariograms, Figure 36 displays that there is slight difference between age-adjusted
and age-sex-adjusted rates. The nugget effect is 0 for both rates. The age-adjusted rates
have relatively lower semivariogram values and a slightly shorter range than the age-sexadjusted rates.
Age-adjusted incidence rates

Age-sex-adjusted incidence rates

Number of structures: 1
Nugget: 0
Spherical: Range 11, Sill: 125

Number of structures: 1
Nugget: 0
Spherical: Range 13.5, Sill: 145

Figure 36 Omnidirectional semivariograms of melanoma cancer incidence adjusted rates in 1990-2005.
Age-adjusted rates

Age-sex-adjusted rates
ATP PK estimates

80.14
48.71
45.50
43.38
42.22
41.40
40.68
39.98
39.12
37.95

ATP PK variances

290.11
229.91
221.12
215.67
211.80
207.85
202.73
194.96
180.13
142.74

Figure 37 ATP Poisson kriging estimates and variances based on melanoma incidence adjusted rates.

The estimates and variance based on the age-adjusted rates are shown in Figure 37. For
both ATP Poisson kriging estimates, higher estimates are mainly along west coast of the
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study area. The estimation map for age-sex-adjusted rates shows slightly more variability
than the age-adjusted rates. For the variance, age-adjusted rates have higher values than
age-sex-adjusted rates in sparsely populated areas (eastern outer suburbs of Perth).

The summary statistics for melanoma cancer incidence during the period 1990-2005 are
shown in Table 9. Crude rates show more variability and there is little difference between
adjusted rates and ATP estimates.
Table 9 Summary statistics for melanoma cancer incidence estimates during the period 1990-2005.
Estimator
Melanoma cancer incidence
Mean
Variance Minimum Maximum
Crude rates
51.55
366.02
8.03
92.55
Age-adjusted rates
50.07
168.6
28.46
78.33
Age-sex-adjusted rates
50.48
188.38
28.55
80.08
ATP (age) estimator
42.6
31.92
26.61
76.34
ATP (age-sex) estimator
42.67
36
25.01
80.14

5.2.1.2 Melanoma incidence analysis by sex

In this part, we will analyse male and female melanoma cancer incidence in 1990-2005.

Semivariogram plots for males and females are shown in Figure 38. Semivariogram values
of males are nearly six times the values of females. The maximum distance of spatial
dependence is 13km for males and 20km for females. The semivariogram at zero lag is 20
for males and 27 for females. Thus female melanoma cancer incidence varies less
continuously and spatial correlation is relatively strong compared with males.
Male age-adjusted incidence rates

Female age-adjusted incidence rates

Number of structures: 1
Nugget: 20
Spherical: Range 13, Sill: 330

Number of structures: 1
Nugget: 27
Spherical: Range 20, Sill: 32

Figure 38 Omnidirectional semivariograms of melanoma cancer incidence age-adjusted rates 1990-2005.
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The estimation and the kriging variance for males and females are shown in Figure 39. For
females the incidence is high in the west and south of the study area. For males it is high in
most areas along the coast and also in the middle of the study area. ATP Poisson kriging
estimates for males are relatively high, and also the estimation map shows great variability
compared with females. The highest estimated rate for males is 108 per 100,000 personyears during the 16-year period but only 57 for females. The kriging variance is much
higher for males than for females although the spatial trends are quite similar. The variance
map for females is relatively smooth compared with that for males.
ATP PK estimates

ATP PK variances
Males
689.70
587.12
567.89
561.18
554.69
547.62
537.10
522.70
496.44
417.37

108.20
57.02
53.19
50.25
48.80
47.28
46.17
45.39
44.70
43.63

Females

57.35
39.34
37.49
36.28
35.60
34.65
34.00
33.55
33.28
32.97

100.89
87.71
85.94
83.82
82.32
80.80
79.32
77.70
75.27
65.23

Figure 39 ATP Poisson kriging estimates and variances by sex based on melanoma cancer incidence ageadjusted rates.

The summary statistics for melanoma cancer incidence by sex are shown in Table 10.
According to the table, the mean value of male rates is higher than that of females, and the
difference in variance between males and females is strong. Overall, male rates show more
variability than female rates.
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Table 10 Summary statistics for melanoma cancer incidence crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates for males and females during the period 1990-2005.
Melanoma cancer incidence estimator during 1990-2005 Mean Variance Min
Max
Crude rates
M
63.81 757.07
18.33 126.56
F
43.06 406.19
0
131.3
Age-adj rates
M
60.28 485.45
19.12 107.75
F
40.69 213.58
0
99.89
ATP estimator
M
49.36 69.89
24.68 108.2
F
35.6
9.73
28.73 57.35

5.2.2 Melanoma mortality analysis
5.2.2.1 Melanoma mortality analysis in 1990-2005

In this section, we analyse melanoma cancer mortality for the period 1990-2005 based on
age-adjusted and age-sex-adjusted rates. We then investigate age-adjusted rates for the
periods: 1990-1995, 1996-2000 and 2001-2005.

There is slight difference between age-adjusted rates and age-sex-adjusted rates for
semivariograms indicated by Figure 40. During the period 1990-2005, the semivariogram
values for melanoma cancer mortality are less than 2 and they are very low compared with
other cancers. As a result, the variability for melanoma cancer mortality is not as strong as
for other cancer types. The range and nugget effect are 15km and 0.2 for age-adjusted rate,
and 13km and 0.1 for the age-sex-adjusted rates. The semivariogram values are quite close
for the adjusted rates. This indicates that the risk from age-sex is possibly less variable than
the risk only from age but spatial correlation is relatively strong for age-adjusted rates.
Age-adjusted mortality rates

Age-sex-adjusted mortality rates

Number of structures: 1
Nugget: 0.2
Spherical: Range 15, Sill: 1.7

Number of structures: 1
Nugget: 0.1
Spherical: Range 13, Sill: 1. 9

Figure 40 Omnidirectional semivariograms of melanoma cancer mortality adjusted rates 1990-2005.
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The estimation and the kriging variance for adjusted rates are shown in Figure 41. For the
mortality estimation, the rates along west coast are relatively high. For the kriging variance,
age-sex-adjusted rates have relatively high values and the map shows slightly more
variability than the map based on the age-adjusted rates.
Age-adjusted rates

Age-sex-adjusted rates
ATP PK estimates

8.16
4.89
4.69
4.64
4.62
4.59
4.54
4.43
4.31
4.30

ATP PK variances

2.376
2.195
2.179
2.168
2.159
2.156
2.149
2.138
2.110
1.989

2.858
2.674
2.657
2.641
2.632
2.627
2.615
2.597
2.564
2.390

Figure 41 ATP Poisson kriging estimates and variance based on melanoma cancer mortality adjusted rates.

The summary statistics for melanoma cancer mortality in 1990-2005 are shown in Table 11.
The mean and variance of different rates based on melanoma mortality is very low
compared with other cancers.
Table 11 Summary statistics for melanoma cancer mortality estimates during the period 1990-2005.
Estimator
Melanoma cancer mortality
Mean
Variance Minimum Maximum
Crude rates
6.12
11.4
1.87
16.8
Age-adjusted rates
5.68
7.93
2.38
16.59
Age-sex-adjusted rates
5.52
5.35
2.39
12.57
ATP (age) estimator
4.56
0.1
3.33
7.7
ATP (age-sex) estimator
4.56
0.13
3.2
8.37
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5.2.2.2 Melanoma mortality analysis during three periods: 1990-1995, 1996-2000 and
2001-2005

For experimental semivariograms Figure 42 shows that there is difference between ageadjusted rates in three periods. The variogram in the third period does not show structure.
The semivariogram values in the second period are much higher than other periods. Nugget
effects are 0.5 in the first period while 2 in the second period. This indicates that cancer
mortality shows more variability in the second period.
Age-adjusted mortality rates 1990-1995

Age-adjusted mortality rates 1996-2000

Age-adjusted mortality rates 2001-2005

Semivariogram model parameters for three models
Number of structures for three models: 1
90-95 Nugget: 0.5
Spherical: Range 10, Sill: 1.1
96-00: Nugget: 2
Exponential: Range 10, Sill: 3
01-05: Nugget: 1
Exponential: Range 15, Sill: 1.3

Figure 42 Omnidirectional semivariograms of melanoma cancer mortality age-adjusted rates.

The difference of spatial trends is strong as for estimation and the kriging variance in three
periods (Figure 43). The estimates increase with time in most SLAs of Perth. In each period
the map of estimates shows great variability, and the estimated rates are very low compared
with other cancers. For the kriging variance, the maps show great variability in each period
and the variance values are relatively high in the second period.
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ATP PK estimates

ATP PK variances
1990-1995

4.20
3.71
3.59
3.49
3.42
3.33
3.27
3.20
3.11
2.86

6.39
4.31
4.16
4.05
3.94
3.83
3.74
3.63
3.21
2.55

1996-2000

9.15
5.15
5.01
4.78
4.74
4.58
4.19
4.13
4.09
3.79

8.64
8.12
8.06
8.01
7.98
7.98
7.95
7.90
7.83
7.44

2001-2005

1.83
1.55
1.52
1.48
1.46
1.45
1.44
1.43
1.43
1.39

6.81
5.45
4.93
4.90
4.89
4.88
4.81
4.75
4.71
4.43

Figure 43 ATP estimated rates and variances based on melanoma cancer mortality age-adjusted rates.

The summary statistics for melanoma cancer mortality during three contiguous periods are
shown in Table 12. Mortality rates in the second period are relatively high and so is the
variance.
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Table 12 Summary statistics for melanoma cancer mortality crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during 1990-1995, 1996-2000 and 2001-2005.
Melanoma cancer mortality
estimator during: 1990-1995, 1996-2000 and 2001-2005
1990-1995
Mean
1996-2000
2001-2005
1990-1995
Variance
1996-2000
2001-2005
1990-1995
Minimum
1996-2000
2001-2005
1990-1995
Maximum
1996-2000
2001-2005

Crude rates

Age-adjusted rates

ATP estimator

5.18
6.7
6.04
13.45
76.35
16.9
0
0
0
18.69
53.76
17.9

4.47
6.03
5.89
7.81
69.5
34.18
0
0
0
15.53
52.16
37.46

3.69
4.47
4.89
0.5
0.39
0.1
1.67
2.51
3.99
6.39
9.15
6.81

5.3 Colorectal cancer analysis
Colorectal cancer incidence data during the period 1990-2005 is analysed in the first
section. Also, in this section we will explore the incidence data divided by sex: male and
female. Further discussion will show the difference in colorectal cancer risk between males
and females. Mortality data are analysed in the second section.

5.3.1 Colorectal cancer incidence analysis

5.3.1.1 Colorectal cancer incidence analysis in 1990-2005

First, the data to be analysed in this section are colorectal cancer data based on age-adjusted
rates and age-sex-adjusted rates in 1990-2005.
There is only a slight difference between age-adjusted and age-sex-adjusted rates as for
semivariograms according to Figure 44. The spatial correlation is the same for both rates
and extends to 25km. For age-sex-adjusted rates, the semivariogram values are slightly
higher than age-adjusted rates. The nugget effect is strictly zero for age-sex-adjusted rates
and 1 for the other rate.
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Age-adjusted incidence rates

Age-sex-adjusted incidence rates

Number of structures: 1
Nugget: 1
Spherical: Range 25, Sill: 25

Number of structures: 1
Nugget: 0
Spherical: Range 25, Sill: 30

Figure 44 Omnidirectional semivariograms of colorectal cancer incidence adjusted rates 1990-2005.

For the estimation and the kriging variance, the maps are shown in Figure 45. These two
adjusted rates are quite similar. The estimation map and the krigin variance map for agesex-adjusted rates show a relatively smooth trend compared with the age-adjusted rates.
Age-adjusted rates

Age-sex-adjusted rates
ATP PK estimates

60.04
53.20
51.21
50.29
49.83
49.40
48.37
47.67
46.80
46.01

ATP PK variances

47.01
35.64
32.56
30.48
28.79
27.19
25.64
23.20
19.33
13.19

Figure 45 ATP Poisson kriging estimates and variances for colorectal incidence adjusted rates.

The summary statistics for colorectal cancer incidence during the period 1990-2005 are
shown in Table 13. For mean value, there is little difference between adjusted rates and
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ATP estimates but they are all lower than crude rates. The difference between age-adjusted
rates and age-sex-adjusted rates is not significant.
Table 13 Summary statistics for colorectal cancer incidence estimates during the period 1990-2005.
Estimator
Colorectal cancer incidence
Mean
Variance Minimum Maximum
Crude rates
57.73
350.18
21.59
92.41
Age-adjusted rates
52.48
96.43
21
86.33
Age-sex-adjusted rates
52.36
74.19
23.78
72.27
ATP (age) estimator
49.18
7.24
42.01
59.92
ATP (age-sex) estimator
49.28
8.76
41.1
60.04

5.3.1.2 Colorectal cancer incidence analysis by sex

For semivariograms of colorectal cancer incidence, the difference between males and
females is distinct in terms of nugget, range and sill according to Figure 46. The
semivariogram values for males are nearly five times those of females, and so female
colorectal cancer incidence varies relatively continuously. The distance of spatial
dependence extends to 55km for males and 26km for females, so spatial correlation for
males is relatively strong. The semivariogram at zero lag is zero for females and 15 for
males and so the risk from age is possibly more continuous for females than males.
Male age-adjusted incidence rates

Female age-adjusted incidence rates

Number of structures: 1
Nugget: 15
Exponential: Range 55, Sill: 60

Number of structures: 1
Nugget: 0
Cubic: Range 26, Sill: 16.5

Figure 46 Omnidirectional semivariograms of colorectal cancer incidence age-adjusted rates 1990-2005.

The estimates and the kriging variance for males and females are displayed in Figure 47.
The estimates for both males and females are relatively high in the inner suburbs and
southwest of Perth. The kriging variance is high in eastern exterior suburbs of Perth for
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males and females. Males have much higher estimated rates and variances than females,
and the maps for females are relatively smooth.
ATP PK estimates

ATP PK variances
Males

132.61
114.38
110.64
107.99
105.30
103.24
100.94
96.88
89.59
73.64

74.31
59.74
56.64
54.57
53.92
53.53
52.96
51.80
50.82
49.82

Females

19.77
15.34
14.50
13.93
13.45
12.96
12.44
11.84
10.79
8.47

53.02
47.15
45.71
45.49
45.32
45.16
45.06
44.77
44.37
43.40

Figure 47 ATP Poisson kriging estimates and variances by sex based on colorectal cancer incidence ageadjusted rates.

The summary statistics for colorectal cancer incidence by sex are shown in Table 14. The
mean value of male rates is slightly higher than that of females, but the difference in
variance between males and females is significant. Generally speaking, male rates vary
within a greater range than females and so have a higher variance.
Table 14 Summary statistics for colorectal cancer incidence crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates for males and females during the period 1990-2005.
Colorectal cancer incidence Mean Variance Min
Max
estimator during 1990-2005
Crude rates
M
63.59 516.58
18.33 129.61
Age-adj rates
ATP estimator

F
M
F
M
F

51.6
58.75
45.97
53.96
45.18

329.39
230.1
47.39
14.36
3.5

23.94
19.12
28.44
44.84
39.34
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90.49
114.24
60.38
74.8
53.05

5.3.2 Colorectal cancer mortality analysis

5.3.2.1 Colorectal cancer mortality analysis in 1990-2005

The data to be analysed in this section are colorectal cancer mortality based on age-adjusted
and age-sex-adjusted rates for the period 1990-2005.
For semivariograms, the difference between age-adjusted rates and age-sex-adjusted rates is
slight (Figure 48). The nugget effect is strictly zero for both adjusted rates. In addition, the
effective spatial dependency distance for age-adjusted rates is 31km and 31.6km for the
other. The sill for both rates is the same. Overall the spatial correlation is slightly stronger
for age-sex-adjusted rates.
Age-adjusted mortality rates

Age-sex-adjusted mortality rates

Number of structures: 1
Nugget: 0
Cubic: Range 31, Sill: 5

Number of structures: 1
Nugget: 0
Cubic: Range 31.6, Sill: 5

Figure 48 Omnidirectional semivariograms of colorectal cancer mortality adjusted rates 1990-2005.

The estimates and the kriging variance for colorectal cancer mortality are indicated in
Figure 49. The difference between two adjusted rates is slight. The map of estimates based
on age-sex-adjusted rates is slightly smooth compared with age-adjusted rates. The map for
the kriging variance is smooth for both adjusted rates.
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Age-adjusted rates

Age-sex-adjusted rates
ATP PK estimates
24.12
21.24
20.96
20.68
20.37
20.13
19.90
19.71
19.44
19.19

ATP PK variances

7.56
5.84
5.34
4.92
4.47
4.16
3.78
3.15
2.54
1.43

6.91
5.41
4.96
4.65
4.43
4.12
3.66
3.09
2.41
1.40

Figure 49 ATP Poisson kriging estimates in the same colour scale and variance based on colorectal cancer
mortality adjusted rates.

The summary statistics for colorectal cancer mortality in 1990-2005 are shown in Table 15.
The difference between adjusted rates is not large and so is the difference between ATP
estimates based on both adjusted rates.
Table 15 Summary statistics for colorectal cancer mortality estimates during the period 1990-2005.
Estimator
Colorectal cancer mortality
Mean
Variance Minimum Maximum
Crude rates
23.77
71.24
10.36
37.83
Age-adjusted rates
21.38
12.61
13.3
29.03
Age-sex-adjusted rates
21.44
12.52
13.08
29.74
ATP (age) estimator
20.25
0.96
17.06
23.91
ATP (age-sex) estimator
20.18
1.1
17.1
24.12
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5.3.2.2 Colorectal cancer mortality analysis for three periods: 1990-1995, 1996-2000
and 2001-2005

Here colorectal cancer mortality analysis during the period 1990-2005 is divided into three
periods: 1990-1995, 1996-2000 and 2001-2005.

For semivariograms of colorectal cancer mortality age-adjusted rates, Figure 50 indicates
that the difference between three periods is large. Nugget effects are zero in each period.
Spatial correlation is relatively strong in the first two periods, and extends to 25km. In
comparison, the effective distance for spatial dependence is about 17km in the third period.
As for semivariogram values, they are nearly 13 in the first period but only 1 in the third
period. Overall cancer mortality varies relatively continuously in the third period and shows
more variability in the first period.
Age-adjusted mortality rates 1990-1995

Age-adjusted mortality rates 1996-2000

Age-adjusted mortality rates 2001-2005

Semivariogram model parameters for three models
Number of structures for three models: 1
90-95 Nugget: 0
Spherical: Range 25, Sill: 13
96-00: Nugget: 0
Exponential: Range 25, Sill: 7
01-05: Nugget: 0
Exponential: Range 17.4, Sill: 1

Figure 50 Omnidirectional semivariograms of colorectal cancer mortality age-adjusted rates.

The estimation and the kriging variance in three periods are indicated by Figure 51. For the
estimation, the map is relatively smooth in the third period and shows great variability in
other periods. The estimates are high in the inner suburbs of Perth in three periods. For the
kriging variance, the values of variance are very high in the first period and low in the third
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period, but the maps in three periods do not indicate great variability. In addition, the
spatial trends for the variance maps are quite similar in three periods.
ATP PK estimates

ATP PK variances
1990-1995

35.15
22.59
19.70
17.81
16.42
15.47
14.39
13.14
11.89
9.02

26.12
21.12
20.30
19.92
19.78
19.59
19.38
19.17
18.57
17.08

1996-2000

26.12
21.12
20.30
19.92
19.78
19.59
19.38
19.17
18.57
17.08

9.81
7.66
7.22
6.89
6.64
6.35
6.11
5.82
5.28
3.85

2001-2005

3.74
2.62
2.38
2.20
2.06
1.92
1.76
1.64
1.55
1.45

26.12
21.12
20.30
19.92
19.78
19.59
19.38
19.17
18.57
17.08

Figure 51 ATP estimated and variances based on colorectal cancer mortality age-adjusted rates.

The summary statistics for colorectal cancer mortality during three contiguous periods are
shown in Table 16. The mean values of mortality rates decrease over time. The variance is
lowest in the third period. Overall, colorectal cancer mortality rates do not increase with
time in most areas during the recorded time. The rates in eastern part of the study area vary
greatly with time. The rates have decreased sharply by the second period and then increased
gradually by the third period in most areas except the southwest of the study area.
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Table 16 Summary statistics for colorectal cancer mortality crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during 1990-1995, 1996-2000 and 2001-2005.
Colorectal cancer mortality
Crude rates Age-adjusted rates ATP estimator
estimator during: 1990-1995, 1996-2000 and 2001-2005
1990-1995
24.91
20.62
19.03
Mean
1996-2000
22.52
19.42
19.32
2001-2005
21.85
19.35
19.83
1990-1995
128.09
33.95
7.34
Variance
1996-2000
120.81
46.2
1.93
2001-2005
51.53
17.92
0.4
1990-1995
7.92
9.2
11.87
Minimum
1996-2000
0
0
15.95
2001-2005
8.76
8.03
17.5
1990-1995
49.4
33.46
26.23
Maximum
1996-2000
45.82
37.23
24.92
2001-2005
36.57
27.9
21.9

5.4 Breast cancer analysis
Breast cancer incidence data based on adjusted rates in different periods are analysed in the
first section. In the second section, mortality data are considered. Breast cancer data in
three contiguous periods: 1990-1995, 1996-2000 and 2001-2005 are also investigated in
each section to get a temporal view.

5.4.1 Breast cancer incidence analysis
Breast cancer incidence analysis during three contiguous periods and the entire study period
will be carried out in this section.

A distinct difference exists between semivariograms for the three periods (see Figure 52).
For the effective distance of spatial dependence, it is 35km in the first period and 10km in
other periods. Semivariogram values are the highest in the second period with the value
more than 400 and lowest in the third period with the value 110. The semivariogram at zero
lag is 30 and 100 in the first and second period respectively, and 1 in the third period. As a
result, there is great variability (higher semivariogram values) in breast cancer incidence
during the second period. The best spatial continuity is shown in the variogram for the first
period and spatial correlation is relatively strong.The second period shows almost pure
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nugget. For the entire study period, the semivariogram values are relatively low and spatial
variation ceases to be autocorrelated once case locations are farther apart than 18km. As a
result, the spatial correlation for breast cancer incidence is relatively strong. The
semivariograms at zero lag are 40.
Age-adjusted incidence rates 1990-2005

Age-adjusted incidence rates 1990-1995

Number of structures: 1
Nugget: 40
Spherical: Range 18, Sill: 100

Number of structures: 1
Nugget: 30
Spherical: Range 35, Sill: 250

Age-adjusted incidence rates 1996-2000

Age-adjusted incidence rates 2001-2005

Number of structures: 1
Nugget: 100
Spherical: Range 10, Sill: 328

Number of structures: 1
Nugget: 1
Cubic: Range 10, Sill: 110

Figure 52 Omnidirectional semivariograms of breast cancer incidence age-adjusted rates.

ATP Poisson kriging estimates and the kriging variance for breast cancer incidence are
shown in Figure 53. It can be seen clearly that the incidence estimates in 1990-2005 are
relatively low across Perth SLAs. Higher incidence rates occur mainly in the middle of the
study area. The estimation map of breast cancer incidence shows slight variability. The
kriging variance in 1990-2005 is very low compared with other individual periods. For the
three individual periods, breast cancer incidence goes up with time in the Perth
metropolitan area. Estimation maps are very smooth during the first and third period
compared with the map in the second period (higher variogram values and nugget effects).
This is confirmed by the semivariogram plots in Figure 52. Low incidence rates are in the
north and south, while high rates are in the older suburbs of Perth. When turning to the
kriging variance, it is the greatest in the second period and lowest in the third period. The
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variability in the map for kriging variance in the second period is highest while the maps
for other periods are relatively smooth.
ATP PK estimates

ATP PK variances
1990-2005

134.42
124.41
123.64
122.75
121.94
121.08
120.13
118.52
115.50
99.67

130.40
113.55
110.01
109.37
108.39
107.34
106.67
105.83
104.03
103.33

1990-1995

699.72
304.62
244.74
211.98
189.17
173.35
156.81
138.70
124.28
97.04

108.02
96.28
93.01
88.51
83.79
80.56
78.14
76.03
73.56
58.23

1996-2000
745.55
711.63
708.80
705.02
703.85
702.17
699.08
693.21
681.79
637.64

157.20
116.88
113.26
111.10
109.55
107.98
106.36
104.19
103.03
102.13

2001-2005

144.15
125.29
123.35
121.02
118.56
116.77
114.73
112.62
111.15
109.56

412.24
316.76
297.66
282.10
269.88
260.02
252.09
244.59
233.73
208.47

Figure 53 ATP estimated rates and variances based on breast cancer incidence age-adjusted rates.
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The summary statistics for breast cancer incidence are shown in Table 17. Crude rates have
lower minimum value than other rates in each period. Breast cancer incidence increased
over time and varied greatly in the second period.
Table 17 Summary statistics for breast cancer incidence crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during different periods.
Breast cancer incidence
Crude rates Age-adjusted rates ATP estimator
estimator during: 1990-1995, 1996-2000 and 2001-2005
1990-2005
123.77
120.3
107.9
1990-1995
102.58
91.20
79.90
Mean
1996-2000
131.26
125.17
108.62
2001-2005
130.63
123.03
117.11
1990-2005
1327.68
1343.89
17.98
1990-1995
1026.04
460.52
207.94
Variance
1996-2000
4035.77
4685.03
47.47
2001-2005
1039.47
513.49
38.69
1990-2005
72.66
77.43
96.06
1990-1995
30.41
36.35
38.51
Minimum
1996-2000
66.53
82.59
85.55
2001-2005
56.52
63.78
105.11
1990-2005
262.1
314.55
130.4
1990-1995
164.79
133.47
108.02
Maximum
1996-2000
451.61
508.38
157.20
2001-2005
193.14
174.84
144.15

5.4.2 Breast cancer mortality analysis
Breast cancer mortality analysis during three contiguous periods and the entire study period
will be carried out in this section.

For semivariogram plots of mortality, there is good structure in the experimental
semivariogram for 1990-1995 and 1990-2005, and rather little structure in the other periods.
The semivariogram values are relatively high in the third period (Figure 54). The effective
distance for spatial dependence is 9km. The spatial correlation in the first period and the
entire study period is relatively strong and extends to longer distance: 40km and 50km
respectively. Although breast cancer mortality varies continuously (lower semivariogram
values) in the second period, the range is relatively small and all of the variation ceases to
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be autocorrelated after the distance 10km, and so the data exhibit a pure nugget structure.
The semivariogram at zero lag is 0 in 1990-1995 and 1990-2005, and 100 in 2001-2005. As
a result, the mortality risk from the age is possibly more continuous in the first period and
the entire study period than other periods.
Age-adjusted mortality rates 1990-2005

Age-adjusted mortality rates 1990-1995

Number of structures: 1
Nugget: 0
Cubic: Range 50, Sill: 9

Number of structures: 1
Nugget: 0
Spherical: Range 40, Sill: 60

Age-adjusted mortality rates 1996-2000

Age-adjusted mortality rates 2001-2005

Number of structures: 1
Nugget: 9
Spherical: Range 10, Sill: 7.4

Number of structures: 1
Nugget: 100
Exponential: Range 9, Sill: 105

Figure 54 Omnidirectional semivariograms of breast cancer mortality age-adjusted rates.

Breast cancer mortality ATP Poisson kriging estimates and the kriging variance are shown
in Figure 55. The mortality rate estimates in 1990-2005 are very high except northeast and
southeast of the study area, and the estimation map is relatively smooth. For the kriging
variance, the value is very low in 1990-2005 and the map is relatively smooth. For the three
individual periods, the estimated mortality rates in the first period in areas around the Perth
city centre are quite a contrast to those in other areas where lower rates are found. During
the second period, there was little variation in mortality rates across Perth SLAs. However,
mortality rates vary considerably in the third period. There is marked difference in the
kriging variance between maps of three periods. The kriging variance in the third period is
extremely high and in the second period is extremely low. ATP Poisson kriging variance
based on age-adjusted rates illustrates more variability in the last two periods than in the
first period.
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ATP PK estimates

ATP PK variances
1990-2005
18.29
10.55
8.81
7.45
6.43
5.55
4.78
4.05
3.28
1.96

27.41
22.97
21.96
21.30
20.81
20.52
20.24
19.75
19.43
19.13

1990-1995

103.97
59.22
49.71
43.79
39.65
36.04
32.80
28.49
22.94
15.53

33.11
23.07
20.33
19.53
19.01
18.29
17.46
16.64
15.61
12.58

1996-2000
29.75
26.69
26.46
25.79
25.69
25.50
25.37
25.34
25.20
24.56

29.51
24.36
24.19
22.76
22.59
22.53
22.34
21.63
21.15
21.05

2001-2005

374.13
318.17
308.14
303.00
298.96
296.31
292.74
286.87
276.11
248.45

81.81
25.83
23.92
22.45
21.74
21.13
20.49
19.84
19.20
18.60

Figure 55 ATP estimated rates and variances based on breast cancer mortality age-adjusted rates.

The summary statistics for breast cancer mortality are shown in Table 18. The mean value
of crude rates is higher than other rates in each period. Age-adjusted rates have lower
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variance values than crude rates. In addition, the mean value is the lowest in the second
period and highest in the third period for crude and adjusted rates. Breast cancer mortality
varied over time and increased by the third period when the mortality rates showed the
greatest variability. The variance is very low in 1990-2005 compared with other periods.
Table 18 Summary statistics for breast cancer mortality crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during different periods.
Breast cancer mortality
Crude rates Age-adjusted rates ATP estimator
estimator during: 1990-1995, 1996-2000 and 2001-2005
Mean
1990-2005
27.16
24.62
21.68
1990-1995
30.59
26.64
18.15
1996-2000
23.99
20.71
22.52
2001-2005
32.71
30.85
21.69
Variance
1990-2005
88.98
26.71
4.37
1990-1995
223.26
206.29
18.92
1996-2000
187.17
92.81
2.04
2001-2005
1035.62
1160.18
11.7
1990-2005
11.32
11.83
18.27
Minimum
1990-1995
3.97
4.03
6.78
1996-2000
0
0
19.38
2001-2005
0
0
15.29
1990-2005
48.48
36.76
27.41
Maximum
1990-1995
65.88
93.6
33.11
1996-2000
64.52
50.75
29.51
2001-2005

190.27

206.72

81.81

5.5 Prostate cancer analysis
Prostate cancer incidence data based on adjusted rates in different periods are analysed in
the first section. In the second section, mortality data are considered. Prostate cancer data in
three contiguous periods: 1990-1995, 1996-2000 and 2001-2005 are also investigated in
each section to get a temporal view.

5.5.1 Prostate cancer incidence analysis
Prostate cancer incidence analysis during three contiguous periods and the entire study
period will be carried out in this section. In addition, we will see how the incidence varies
over time.

102

There is quite good continuity except the second period for semivariogram plots of prostate
incidence (Figure 56). In fact, the time series graph shown in Figure 2 in Chapter 4 also
indicates that there are large fluctuations in the number of prostate cancer incidence cases
in the second period. The semivariogram values are very high in the first period but the
spatial correlation is quite strong. The spatial variation is autocorrelated when the distance
between locations is within 23km. In comparison, semivariogram values are very low and
the effective distance for spatial dependence is about 15km in the second period. In the
third period, the semivariogram values are relatively high. Locations farther apart than
20km are not spatially autocorrelated. The semivariogram at zero lag is not 0 in any period:
it is lowest in the first period with value 10 and highest in the second period with value 40.
Thus prostate cancer incidence rates vary more continuously but spatial correlation is weak
in the second period. The short range variability is probably due to the fewer incidence
cases available in the second period. Prostate cancer incidence risk from age is possibly
more continuous in the first period than the risk in other periods.
Age-adjusted incidence rates 1990-2005

Age-adjusted incidence rates 1990-1995

Number of structures: 1
Nugget: 20
Spherical: Range 16, Sill: 370

Number of structures: 1
Nugget: 10
Spherical: Range 23, Sill: 700

Age-adjusted incidence rates 1996-2000

Age-adjusted incidence rates 2001-2005

Number of structures: 1
Nugget: 40
Spherical: Range 14.5, Sill: 200

Number of structures: 1
Nugget: 20
Spherical : Range 20, Sill: 400

Figure 56 Omnidirectional semivariograms of prostate cancer incidence age-adjusted rates.
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The estimates and variance of prostate cancer incidence are indicated in Figure 57. Higher
prostate cancer rates are mainly in northwest of the study area in 1990-2005 and the
estimation map is relatively smooth. For the estimates in three individual periods, incidence
rates vary more continuously in the first and third periods. During the first period, incidence
rates in SLAs near the Perth city centre are much higher than those in other areas. The
incidence rates decreased by the second period but there was little variation in incidence
rates map across Perth. However, incidence rates increased considerably by the third period.
There is a distinct difference in the kriging variance between the maps for the different
periods. The kriging variance in the entire period is relatively low. During the first period,
the kriging variance is very high and shows slight variability. The kriging variance in the
second period is very low and the map indicates more variability.
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ATP PK estimates

ATP PK variances
1990-2005
155.88
117.18
104.20
101.35
99.13
97.92
96.23
93.86
91.62
89.05

635.16
488.78
460.89
441.90
429.61
413.30
394.11
363.87
322.94
193.09

1990-1995

1436.23
935.62
862.41
830.20
793.77
750.46
701.52
637.21
531.86
362.51

144.96
94.31
90.88
87.62
85.70
83.92
82.06
79.81
76.95
67.97

1996-2000

106.49
87.95
84.86
83.87
82.67
82.22
80.64
79.50
79.19
79.06

246.22
229.80
228.66
226.60
225.47
225.10
224.61
223.42
220.88
211.55

2001-2005

639.44
531.99
490.83
473.27
453.40
433.76
416.08
388.11
338.70
184.84

164.39
124.18
116.59
114.58
113.10
111.19
107.41
103.61
99.63
93.13

Figure 57 ATP estimated rates and variances based on prostate cancer incidence age-adjusted rates.
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The summary statistics for prostate cancer incidence are shown in Table 19. The mean
value, maximum value and variance of crude rates are relatively high compared with other
rates in different periods. In addition, the mean value and maximum value are lowest in the
second period and highest in the third period. The variance is the highest in the first period
and relatively low in the second period.
Table 19 Summary statistics for prostate cancer incidence crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during different periods.
Prostate cancer incidence
Crude rates Age-adjusted rates ATP estimator
estimator during: 1990-1995, 1996-2000 and 2001-2005
1990-2005
121.68
113.08
99.68
1990-1995
124.76
102.06
84.5
Mean
1996-2000
92.46
83.66
82.67
2001-2005
137.72
125.41
109.74
1990-2005
1513.68
495.12
125.66
1990-1995
3380.52
1066.66
213.45
Variance
1996-2000
1177.91
647.85
17.14
2001-2005
2200.16
717.54
156
1990-2005
59.13
81.52
77.18
1990-1995
27.82
27.22
47.58
Minimum
1996-2000
0
0
72.43
2001-2005
57.8
60.66
84.88
1990-2005
198.47
163.42
155.88
1990-1995
235.38
158.19
145.12
Maximum
1996-2000
157.29
141.12
106.49
2001-2005
244.23
188.06
164.39

5.5.2 Prostate cancer mortality analysis
This section analyses prostate cancer morality and we also study how the prostate cancer
mortality varies over time.

The experimental semivariogram of prostate cancer mortality show differences among
different periods (Figure 58). The semivariograms in the second period and the third period
are not reaching the sample variance (dashed line). The semivariogram values are very low
compared with those of prostate cancer incidence displayed in Figure 56. The effective
distance for spatial dependence is relatively long in the second period. The semivariogram
values are the lowest and nugget effect is strictly zero in the third period. In comparison,
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semivariogram values are the highest in the first period. Extremely poor structures
exhibited by the semivariograms are partly caused by the fluctuations of low mortality
cases during the study period (Figure 2).
Age-adjusted mortality rates 1990-2005

Age-adjusted mortality rates 1990-1995

Number of structures: 1
Nugget: 7
Spherical: Range 10, Sill: 6

Number of structures: 1
Nugget: 5
Spherical: Range 7.8, Sill: 24

Age-adjusted mortality rates 1996-2000

Age-adjusted mortality rates 2001-2005

Number of structures: 1
Nugget: 2
Spherical: Range 8, Sill: 3.8

Number of structures: 1
Nugget: 0
Cubic: Range 18, Sill: 1

Figure 58 Omnidirectional semivariograms of prostate cancer mortality age-adjusted rates.

ATP Poisson kriging estimates and the kriging variance for prostate cancer mortality are
shown in Figure 59. It can be seen that the rates in 1990-2005 are relatively low in most
areas except the middle part of the study region. The mortality rates show the most
variability in the first period: the rates are very high in south and relatively low in north.
There is slight variability in the estimation map in the second period and the estimates are
low in most areas. The mortality rates vary more continuously and the rates are high in
most areas by the third period. When referring back to the time series plots for prostate
mortality (Figure 2), this feature is visible across Perth: the number of mortality cases is
relatively high during the first six years and goes down greatly in the next five years and
then increases slowly in the last period. It needs to be noted that the spatial trends for the
prostate mortality estimated rates in the third period are slightly different from those of the
crude and age-adjusted rates shown in Figure 104. One reason is that the fluctuations of low
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number of mortality cases during this period (Figure 2). The other reason is that kriging
technique always overestimates low values and underestimates high values.

For the kriging variance, there is great difference between maps in different periods. Spatial
trends in prediction maps have been confirmed by the variogram plots (Figure 58). The
kriging variance is extremely high in the first period, and low in other periods. Prediction
maps indicate more variability in the first two periods and the entire period. The map varies
more continuously in the last period. In contrast, the kriging variance of prostate cancer
mortality rates is much lower than that of incidence rates (see Figure 57) in the
corresponding period.
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ATP PK estimates

ATP PK variances
1990-2005

8.20
7.09
7.03
6.80
6.76
6.70
6.67
6.64
6.58
6.33

27.41
22.97
21.96
21.30
20.81
20.52
20.24
19.75
19.43
19.13

1990-1995

29.43
20.90
20.51
20.36
20.28
20.10
19.81
17.10
17.01
16.55

38.89
36.22
35.74
35.26
35.03
34.95
34.87
34.71
34.42
32.68

1996-2000

21.73
19.79
19.54
19.43
18.88
18.88
18.87
18.86
18.85
18.72

9.26
6.89
6.86
6.01
5.97
5.77
5.73
5.60
5.57
5.53

2001-2005

20.77
18.53
18.75
18.16
17.84
17.57
17.26
17.00
16.69
16.05

9.45
5.35
4.55
3.93
3.39
2.85
2.37
1.97
1.62
1.36

Figure 59 ATP estimated rates and variances based on prostate cancer mortality age-adjusted rates.
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The summary statistics for prostate cancer mortality are shown in Table 20. Crude rates
have relatively large range (low minimum and high maximum) and high variance value.
The mean value of crude rates is higher than other rates in each period. In addition, the
mean value and maximum value decreased with time except adjusted rates. In short,
prostate cancer mortality rates decreased over time and the variance decreased accordingly.
Table 20 Summary statistics for prostate cancer mortality crude rates, age-adjusted rates and ATP Poisson
kriging estimated rates during different periods.
Prostate cancer mortality
Crude rates Age-adjusted rates ATP estimator
estimator during: 1990-1995, 1996-2000 and 2001-2005
1990-2005
21.98
19.61
19.87
1990-1995
23.18
18.22
19.19
Mean
1996-2000
21.37
18.62
19.18
2001-2005
20.35
17.5
17.49
1990-2005
127.51
42.42
0.98
1990-1995
265.72
87.52
7.02
Variance
1996-2000
137.03
71.61
0.52
2001-2005
112.02
45.18
1.02
1990-2005
0
0
17.65
1990-1995
0
0
10.04
Minimum
1996-2000
0
0
17.42
2001-2005
0
0
15.00
1990-2005
45.35
35.63
25.76
1990-1995
61.11
40.17
29.43
Maximum
1996-2000
51.05
40.52
21.73
2001-2005
47.76
27.54
20.77

5.6 Summay
This chapter has provided the geostatistical analysis for cancers recorded in 1990-2005 in
metropolitan Perth.

For lung cancer incidence in 1990-2005, the difference between age-adjusted rates and agesex-adjusted rates is not significant. The incidence risk from age is possibly more
continuous than the risk from age-sex. The estimated incidence rates for males in this
period are much higher than for females in most SLAs of Perth, and the kriging variance is
nearly ten times that of females. Also, female incidence varies more continuously and the
spatial correlation is much stronger than males across Perth SLAs. For melanoma cancer
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incidence in 1990-2005, the rates are relatively high in SLAs near the west coast of Perth.
The spatial correlation is relatively strong for age-sex-adjusted rates compared with ageadjusted rates across Perth SLAs. Males have higher incidence rates than females in Perth
and female incidence rates vary more continuously than males. The highest incidence
estimated rate is 108 per 100,000 person-years for males while it is only 57 for females. For
colorectal incidence in 1990-2005, the cancer risk from age-sex is possibly more
continuous than the risk only from age and so the variance map is relatively smooth. Males
have higher incidence rates than females in Perth, and the incidence shows great variability
compared with females.

For lung cancer mortality rates in 1990-2005, the mortality risk from age is possibly more
continuous than the risk from age-sex. For mortality rates in the three contiguous time
periods, there is an overall increase in most SLAs of Perth over time. However, the
mortality rates are very high in the middle of the study area in the first period. For
melanoma cancer mortality in 1990-2005, the difference between age-adjusted rates and
age-sex-adjusted rates is slight. The kriging variance for melanoma mortality based on
adjusted rates is the lowest compared with other estimates. The mortality risk from age-sex
is possibly more continuous than the risk only from age. Melanoma mortality rates are
relatively low in the first period and the rates vary more continuously than other periods.
The highest melanoma mortality rates occur in the second period and the rates show more
variability in this period. For colorectal cancer mortality, the difference between ageadjusted rates and age-sex-adjusted rates is slight. The mortality rates in eastern part of the
study area vary greatly with time. The rates have decreased sharply by the second period
and then increased gradually by the third period.

As for sex specific cancers, breast cancer incidence rates are relatively low in 1990-1995
and mortality rates are relatively low in 1996-2000. Cancer incidence rates increased
gradually with time in most SLAs of Perth. Breast cancer mortality rates have decreased by
the second period and then have increased a little by the third period. Spatial dependency
for breast cancer is relatively strong in 1990-1995. Breast cancer incidence risk from age is
relatively continuous in the third period, while breast cancer mortality risk from age is
possibly more continuous in the first period.
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For prostate cancer analysis during three periods, prostate cancer incidence rates are
relatively low in 1996-2000 but have increased by the third period. Prostate mortality rates
decrease with time in most Perth SLAs. The population at risk has had a slow increase by
the third period for both incidence and mortality rates. Spatial correlation is relatively
strong in the third period and very weak in the second period for prostate cancer across
Perth SLAs. The mortality risk from the age is possibly more continuous than the incidence
risk from the age.

For the analysis of breast and prostate cancer in the period 1990-2005, breast cancer rates
are slightly higher than prostate cancer rates. The same trends are found for mortality rates
in three contiguous periods: 1990-1995, 1996-2000 and 2001-2005. However, for incidence
rates, breast cancer rates are only higher than prostate cancer rates in the second period.

In brief, the difference in lung cancer incidence risk between males and females is
significant. Estimation and variance maps show more variability for males than for females.
Age-sex-adjusted rates have stronger spatial correlation than age-adjusted rates across Perth
SLAs. For melanoma cancer, males have higher cancer incidence risk than females and the
kriging variance for male estimates is relatively high compared with females. The
difference in colorectal cancer incidence risk between males and females is not significant.
For cancer mortality kriging estimates in three periods, they are generally high in the inner
suburbs of Perth and increase gradually with time in the north of the study area. Lung
cancer mortality rates have increased gradually across Perth SLAs with time. In the west of
the study area which is close to the coast, melanoma cancer mortality rates have decreased
by the second period but increased greatly by the third period. It seems that there are
fluctuations in the east of the study area during three periods and the mortality rates have
decreased by the third period. Colorectal cancer mortality rates have increased with time in
the north of the study area. In comparison, melanoma mortality rates are the lowest and
lung cancer mortality rates are relatively high. The difference between breast and prostate
cancer in 1990-2005 is slight. The spatial correlation for breast cancer is relatively strong
and cancer risk varies continuously compared with prostate cancer across Perth SLAs.

This chapter has provided an analysis of cancer incidence and mortality at the (relatively)
large SLA scale. In the next chapter a finer scale will be used. Spatial point pattern analysis
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will be used to explore the intensity of the point patterns for different cancers. Going back
to the literature review, Turner (2009) illustrated the techniques used for spatial point
pattern analysis but no actual conclusions based on the modelling were drawn. To the best
of our knowledge, our study provides the first detailed application of point process
modeling to cancer data and the results are interpreted to draw conclusions on the spatial
intensity of the point patterns.
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6 SPATIAL POINT PATTERN ANALYSIS
Spatial point pattern theory focuses on the cancer analysis at finer scales. To investigate
model fitting, we explore the point pattern of 2005. There are two reasons for doing this:
firstly, we have more choice for the spatially varying susceptible population density
compared with point patterns in other years. Secondly, the population data by suburb
available in this study are those for the year 2006.

The intensity of the point process for five cancer types will be investigated in this chapter.
Perth Central Business District (CBD) is chosen as the reference point in spatial statistical
modelling. In addition, for lung cancer incidence the Kwinana industrial area is also used as
reference point and for melanoma cancer incidence the coastline is used as reference line as
well. To find an appropriate inhomogeneous Poisson process model, potential covariates
will be incorporated to determine how they account for cancer point process. We will use
lung cancer mortality data to explore whether different point patterns have an influence on
spatial point pattern analysis and to decide what method is appropriate for treating missing
values. We also use prostate mortality data as an example to illustrate the process to select
an appropriate model based on the available covariates and that process illustrated will be
applied to the other cancers.

The quadrat counting test (Table 21) indicates that the incidence and mortality point
processes for the five cancers in 2005 are not completely random. In the further discussion,
we will use this conclusion for model fitting. See Appendix 9.2 for the R codes used in
spatial point pattern analysis.
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Table 21 χ test for testing the hypothesis of CSR for cancers in 2005.
Cancer types
Degree of freedom p-value
χ2
Lung cancer

Incidence
Mortality

1827.78
1279.91

31
31

Less than 2.2e-16
Less than 2.2e-16

Melanoma cancer

Incidence

1737.94

31

Less than 2.2e-16

Mortality

223.85

31

Less than 2.2e-16

Incidence
Mortality
Incidence
Mortality

2902.62
424.99
3007.12
315.27

31
31
31
31

Less than 2.2e-16
Less than 2.2e-16
Less than 2.2e-16
Less than 2.2e-16

Incidence
Mortality

2248.93
593.43

31
31

Less than 2.2e-16
Less than 2.2e-16

Breast cancer
Prostate cancer
Colorectal cancer

6.1 Lung cancer analysis
Lung cancer data will be studied in this section using spatial point pattern analysis. The
available covariates used in lung cancer model fitting are the population density (Popdens),
the percentage of people aged 50 or over (aged) and the susceptible population intensity
(Figure 22).

6.1.1 Exploratory data analysis
In this section, two methods will be used to treat case locations without recorded
coordinates using lung cancer mortality as an example: method 1 is to remove the case
locations without coordinates, and the original point pattern treated using this method will
be called point pattern in the discussion of lung cancer analysis. Method 2 is to assign the
mean location for the 16-year period in the SLA where they occur to them, and the point
pattern treated using this method will be called modified point pattern in the discussion.

The lung cancer incidence point process in 2005 (see Figure 60) is inhomogeneous. The
rejection based on quadrat counting test can be explained partly by the population density
in the Perth metropolitan area (see Figure 19). Under the null hypothesis of inhomogeneous
Poisson process, the seventeen duplicate case locations (about 2.6%) were removed. There
are two reasons for doing this. One is the requirement of the characteristics of the
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homogeneous Poisson process (Senn and Scott 2008 Ch2), in which two points never
coincide. The other is to avoid the “nugget” effect at zero distance when the
inhomogeneous K-function is estimated in the further study (Turner 2009).

In order to take account of the inhomogeneity of the year 2005 data, the inhomogeneous Kfunction is applied to test data independence. The selection of sigma value is generally
based on the data point patterns and the window size of the study region. In Figure 61, the
“smoothing parameter” sigma is set to 7 for incidence. For mortality, the kernel smoothing
bandwidth is set to sigma=4.9. The point process is clustered when the inhomogeneous Kfunction estimate stays above the high bound of the critical envelope and inhibited when
the estimate stays below the low bound of the critical envelope. According to Figure 61,
there is no indication of attraction or inhibition for the year 2005 incidence data point
process (left plot). Although the estimate stays very close to the lower bound of the critical
envelope when the r values are in the range 0 to 5, it can be seen clearly that the point
process is independent. As for the mortality point process, the estimated K values are
slightly lower than the lower bound of the critical envelope when the r values are in the
range 7 to 14. However, it is too early to conclude that there is repulsion between mortality
points within this range at this stage. Although there is evidence against the process being
an inhomogeneous Poisson process, the mortality cases are more dispersed than the
incidence cases from Figure 60. There are almost no mortality cases in the eastern study
region. This could account for the “inhibition” indicated by the K-function.

The point process model to be fitted might include an inhomogeneous spatial trend,
dependence on covariates, and interpoint interactions (Baddeley and Turner 2005). Based
on the characteristics of an inhomogeneous Poisson process, the year 2005 data will be
modelled to see whether the covariates influence the intensity of the point process and how.
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Figure 60 The modified lung cancer incidence (left) and mortality (right) case locations in year 2005 in Perth.
Incidence

Mortality

Bandwith for smoothing intensity : 7
Bandwith for smoothing intensity: 4.9
Bandwith for simulation from data: 7
Bandwith for simulation from data: 4.9
Figure 61 Estimates of the inhomogeneous K-function for the year 2005 lung cancer incidence and mortality
data.
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6.1.2 Analysis of modified lung cancer incidence point patterns
There are 665 lung cancer incidence cases with 17 cases without coordinates in the original
2005 lung cancer data. In this section, the data to be analysed are treated using method 2
and the spatial intensity of the susceptible population is based on Figure 22. The Kwinana
Industrial Area is located in the southwest of the Perth metropolitan area (Figure 6).
According to kriging analysis (Figure 29 and Figure 31), lung cancer incidence risk is
relatively high in Kwinana compared to other SLAs. It has been found that air pollution
increases the risk of lung cancer according to Cancer Research UK (CRUK). Diggle (1990)
developed a methodology for fitting a class of inhomogeneous Poisson point process
models to investigate whether there is evidence of raised cancer incidence near the
industrial incinerator. Similarly, the Kwinana Industrial Area is used as reference point for
modelling incidence data to see whether there is underlying relationship between the
existence of industrial area and lung cancer incidence.

Inspecting the data (see Figure 60), it is apparent that there are more cancer cases in the
inner suburbs of Perth due to higher population density. Since the Perth CBD (391.063, 3536.509) is roughly in the centre of cancer case locations, it is chosen as the reference
point in spatial statistical modelling. The spatial trend model only includes a transformation
of the coordinates of the case locations. A quantile-quantile plot for this model is shown in
left plot of Figure 62. This plot indicates that this model is not suitable for describing the
data. The plot compares empirical quantiles of the smoothed residual field of data with
those of the fitted model (estimated by Monte Carlo sampling).The mean quantile of the
simulated values is not zero, and the range of simulated values is much smaller than the
range of data values. Inclusion of additional covariates, such as popdens or aged, does not
improve the fit. One example shown here is the quantile-quantile plot for the model
including the spatial trend and dependence on covariate popdens (see right plot of Figure
62).
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Figure 62 The quantile-quantile plots for the inhomogeneous Poisson model fitted to the year 2005 incidence
data: trend only model (left) and the model including spatial trend and covariate popdens (right).

According to Figure 60, there is a very high intensity of cases in the middle of the western
part of the study area where the Central Business district is, so it is important to take into
account the spatial variation in vulnerable population density.

The empty space distances of cancer incidence case locations reflect how dense the
susceptible population is in Perth. Among the empty space distances of lung cancer
incidence during the period 1990-2004, the fit is adequate when only those of year 1993 are
used for the model fitting data 2005. This probably due to the similarity of the point
patterns in these two years. The quantile-quantile plot for the model is shown in left plot of
Figure 63. The fit has improved greatly. The lower end of the plot stays close to the
theoretical ideal line. However, the middle of the plot touches the lower edge of the critical
envelope and the upper end of the plot protrudes the upper edge of the critical envelope.
The smoothed residual field for the data has lighter right-hand tail and less variability than
the smoothed residual field for simulation from the fitted model. That is, the pattern is more
inhibited than the model. To improve the fit, popdens (population density) is added as
covariate. Converting back to the form (2.39), the revised fitted model is
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λθ (u ) = (( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.03 × exp(− 0.708 − 0.987 Z 1 (u) + 0.001 Z 2 (u) )

(6.1)

where Z 1 (u) denotes the distmap of 1993 incidence point patterns and Z 2 (u) represents
population density. The quantile plot based on model (6.1) indicates that the fit is adequate
(see middle plot of Figure 63). The middle of this plot just sticks to the theoretical ideal line.
This model is acceptable since the plot stays well within the critical band. This plot
confirms that the process is inhomogeneous and that the model (6.1) has a correct trend and
covariate effects.

When the proportion of people aged 50 or above (aged) is included as an additional
covariate instead of the overall population density, the fit (see right plot of Figure 63) is
worse: the residual field for the data has a lighter right-hand tail and higher variability than
the residual field for simulation from the fitted model. It indicates that this covariate is not a
suitable explanatory variable for lung cancer incidence.
Distmap + spatial trends

Distmap+ spatial trends
+ popdens

Distmap+spatial trends
+ aged

Figure 63 The quantile-quantile plots for the inhomogeneous Poisson model fitted to the year 2005 incidence
process as function of coordinates and the distmap of year 1993 incidence data. The middle plot and the
right plot incorporate popdens and aged respectively.
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Figure 64 Diagnostic plots and the estimated rates map for model (6.1).

The diagnostic plots are developed to detect spatial trend and covariate effects. The
diagnostic plots for model (6.1) are shown in left plot of Figure 64. The top left of the
diagnostic plots is a mark plot, the top right and the bottom left are the lurking variable
plots for the y-coordinate and x-coordinate respectively, and in the bottom right is the
contour plot of the smoothed mark field. These plots can be used to assess goodness-of-fit,
to identify outliers in the data, and to disclose departures from the fitted model (Baddeley et
al. 2005). The dotted lines in the lurking variable plots are the 2σ-limits which have the
usual interpretation of significance under the model (6.1). The mark plot does not show
extreme outliers. For the x coordinate, the lurking variable plot indicates a slight
overestimation between 400 and 410, and there is underestimation at y = − 3530 and
overestimation at y = − 3570 and around y = − 3510 . Despite this, nearly all values of the
coordinates stay within the 2σ-limits, and the plot in the lower right corner does not appear
to have a visible trend, confirming that the model provides a good fit. The estimation map
(right plot of Figure 64) indicates that the highest estimated incidence rate per 100 square
kilometres in 2005 is 120 people.

For the standard deviations and coefficients of parameters in the fitted models (especially
for popdens and aged) shown in Table 22, the difference in the coefficient of variation
between parameters θ 2 is distinct. The coefficient of variation for the parameter aged is
3.2086
0.0002
≈ 2.5 and for the parameter popdens is
≈ 0.4 . This indicates that
1.3184
0.0005
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popdens

is a better covariate than aged in terms of the measurement of dispersion of a

probability distribution.
Table 22 Standard deviation of the parameters of the fitted model when different covariates are used to
account for the intensity of lung cancer incidence point patterns.
Parameters for model (6.1)
Parameters for model with covariate aged
Parameter

θi

Coefficient of θ i

Std. Dev. (θˆi )

Coefficient f θ i

Std. Dev. (θˆi )

intercept
mapc93
popdens

-0.7083
-0.9874
0.0005

0.4726
0.0539
0.0002

0.0273
-1.0058
----

1.0823
0.0535
----

aged
Transformation of
coordinates

---0.0601

---0.0979

1.3184
-0.1198

3.2086
0.0724

Lung cancer incidence rates are high in Kwinana industrial area according to the kriging
analysis (5.1.1). Does the distance from the Kwinana industrial area have an influence on
lung cancer? Finally, Kwinana industrial area (384.161, 3536.393) is used as reference
point for modelling lung cancer incidence data. The quantile-quantile plots shown in Figure
65 involve the spatial trends (distance from Kwinana industrial area) and the susceptible
population intensity. The middle and the right plot incorporate population density and the
percentage of people aged 50 or above (see Figure 19) respectively. The middle plot
indicates that the distance from the Kwinana industrial area accounts for lung cancer
incidence in 2005 when the population density is considered. The fitted model is:
λθ (u ) = (( x − 384.161) 2 + ( y + 3536.393) 2 ) 0.149 × exp(− 1.886 − 0.977 Z 1 (u) + 0.001 Z 2 (u) )

(6.2)

where Z 1 (u) denotes the distmap of 1993 incidence point patterns and Z 2 (u) represents
population density. The diagnostic plots for the model (6.2) shown in left of Figure 66
confirm that the fitted model is adequate. The estimation map (right plot of Figure 66)
demonstrates that the highest estimated incidence rate per 100 square kilometres in 2005 is
120 people.

The intensity of the point process in 2005 is given by model (6.1) and model (6.2) from
different perspectives. The first model is based on the distance from the Perth Business
district and the second is based on the distance from the Kwinana industrial area. They all
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indicate that the point process in 2005 is similar to that in 1993 and the fitted models are
adequate to describe the incidence data in 2005. In fact, the point patterns in other
individual years have been tested and only the point pattern for year 1993 is a good
covariate.
Distmap + spatial trends

distmap+ spatial trends
+ popdens

distmap+spatial trends
+ aged

Figure 65 The quantile-quantile plots for the inhomogeneous Poisson model fitted to the year 2005 incidence
process as function of coordinates in which Kwinana industrial area is used as reference, and the distmap of
year 1993 incidence data. The middle and the right plot incorporate popdens and aged respectively.

Figure 66 Diagnostic plots and the estimated rates (per square kilometres) map for model (6.2).

The parameters in the model (6.1) and (6.2) are shown in Table 23. There is slight
difference between two models except intercept and transformation of coordinates in terms
of coefficients and standard deviations. The coefficient of variation for the intercept is
0.4726
0.6152
≈ 0.67 in model (6.1) and it is
≈ 0.31 for the other model. The
0.7083
1.9799
coefficient of variation for the spatial trends (transformation of coordinates) is
0.0979
0.1243
≈ 1.63 in model (6.1) and it is
≈ 0.38 for the other model. This indicates
0.0601
0.3256
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that Kwinana industrial area is a better reference location for lung cancer incidence
modelling than the Perth CBD.
Table 23 Standard deviation of the parameters of the fitted model when different spatial trends are used to
account for the intensity of lung cancer incidence point patterns.
Parameters for model (6.1)
Parameters for model (6.2)
Parameter

θi

intercept
mapc93
popdens
Transformation of
coordinates

Coefficient of θ i
-0.7083
-0.9874
0.0005
0.0601

Std. Dev. (θˆi )

Coefficient of θ i

0.4726
0.0539
0.0002
0.0979

-1.9799
-0.9834
0.0010
0.3256

Std. Dev. (θˆi )
0.6152
0.0534
0.0002
0.1243

6.1.3 Analysis of lung cancer mortality point patterns
We will analyse the 2005 mortality lung cancer data and will use them to explore whether
slight differences in point patterns have influence on model fitting, and if yes, what kind of
data treatment will produce better model fitting. Turning to lung cancer mortality in 2005,
there are 531 cases with five locations without coordinate records in the original data. In
this section, the data to be analysed and covariates used (based on incidence point patterns)
are treated using two methods respectively.

First, the data treated using the first method are analysed. Survival rates (Figure 3) for lung
cancer are relatively low compared with other cancers. About 40% of lung cancer patients
were alive one year and 28% were alive two years after diagnosis. It has been found that
year 2003 incidence point patterns are more suitable to be used as a covariate in modeling
mortality data based on the survival plots. The fit is very good when the model only
incorporates the spatial trend and the spatially susceptible population (see left plot of Figure
67). The fit is tolerably good when aged is taken into consideration (see right plot of
Figure 67). However, the fitting becomes worse when popdens is added as covariate (see
middle plot of Figure 67). Converting back to the form (2.39), the fitted model for the left
plot of Figure 67 is

λθ (u ) =

exp(0.998 − 1.511 × Z 1 (u) )
(( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.181
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(6.3)

where Z 1 (u) denotes the distmap of 2003 incidence point patterns.

Distmap + spatial trends

distmap+ spatial trends
+ popdens

distmap+spatial trends
+ aged

Figure 67 The quantile-quantile plots for the inhomogeneous Poisson model fitted to the year 2005 mortality
data. The model involves transformations of coordinates and the distmap of year 2003 incidence data. The
middle plot and the right plot incorporate popdens and aged respectively.

Next, the data are treated using the second method. The fitting is adequate when the model
incorporates spatial trend and the spatially susceptible population in 2003. Converting back
to the form (2.39), the fitted model is

λθ (u ) =

exp(1 − 1.543 × Z 1 (u) )
(( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.179

(6.4)

where Z 1 (u) denotes the distmap of 2003 modified incidence point patterns. The quantilequantile plot for this model is shown in the left plot of Figure 68. When the covariate
population density (middle plot) or the proportion of the people aged 50 or over (right plot)
is considered respectively, the fit does not improve.
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Distmap + spatial trends

distmap+ spatial trends
+ popdens

distmap+spatial trends
+ aged

Figure 68 The quantile-quantile plots for the inhomogeneous Poisson model fitted to the year 2005 modified
mortality data plotted in Figure 60. The model involves transformations of coordinates and the distmap of
year 2003 modified incidence data. The middle and the right plot incorporate popdens and aged
respectively.

The diagnostic plots for models (6.3) and (6.4) are shown in Figure 69. In bottom right
panel, the colour scheme represents the value of residuals: negative residuals are in blue,
positive residuals are in red and zero residuals are in green. The plots indicate clearly that y
is a better explanatory variable compared with x. The two plots are nearly the same and
they do not show distinct trend, so the fitted models are accepted.

When the spatial covariates play an indispensable part in the model fitting, the lurking
variable plots can be used to investigate how much the intensity function is dependent on
the covariates. The total residuals for the entire observation window must equal zero. The
plots start and finish at the horizontal axis where the residuals are zero.The lurking variable
plots (see Figure 70) illustrate that the fitted function for mortality data captures the
dependence of intensity on these covariates. The proportion of the population age 50 or
above (aged) accounts for mortality data more than the population density.
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Figure 69 Diagnostic plots (left) for the model (6.3) and the right for the model (6.4).

Figure 70 Lurking variable plots of lung cancer mortality for the spatial covariates: popdens (left), aged
(middle) and the distmap of year 2003 lung cancer incidence data (right).

The coefficients and standard deviations of parameters are compared when the data
analysed and the data used as covariates (distmap) are treated in two ways individually
(see Table 24). According to this table, the coefficient and standard deviations are
comparable for the two methods, with standard deviations for method 2 slightly lower.
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Table 24 Standard deviation of the parameters of the fitted model when 2005 lung cancer mortality data and
covariates (lung cancer incidence case locations) are treated using two methods.
Method 1
Method 2
Covariates
intercept
Mapc2003
Transformation
of coordinates

Coefficient of θ i

Std. Dev. (θˆi )

Coefficient of θ i

Std. Dev. (θˆi )

0.9984
-1.5105

0.1605
0.0867

1.0000
-1.5427

0.1588
0.0867

-0.3614

0.0621

-0.3575

0.0614

Unless otherwise stated, in the further discussions method 2 will be used to accommodate
data with missing coordinates, but known SLA. From now on the data treated with this
method are called point patterns rather than modified point patterns for the remaining
cancers.

6.2 Melanoma analysis
For spatial point pattern analysis of melanoma cancer data, the available covariates used in
the model fitting are population density (Popdens), the percentage of people aged 30 or
over (aged30+) shown in Figure 19 and susceptible population intensity (Figure 23).
Looking back at section 5.2.1, kriging analysis has shown that melanoma cancer incidence
is relatively high along the coast, and so the coastline will be used as reference as well for
incidence modelling to explore whether the coast accounts for melanoma cancer incidence.
The mortality data are analysed in the last section.

6.2.1 Exploratory data analysis
The point pattern in 2005 for melanoma cancer incidence and mortality (Figure 71) is not
completely random and this has been verified in the beginning of Chapter 6. The
inhomogeneous K-function (Baddeley et al. 2000) is applied in the data analysis in order to
take into account the inhomogeneity of data characteristics.

The estimated K-function plot for the year 2005 incidence data is shown in left plot of
Figure 72 and the right plot is for the mortality data. These two plots indicate that there is
128

no obvious attraction or inhibition for the year 2005 cancer data, so the point process is
inhomogeneous Poisson process.

Figure 71 Melanoma cancer incidence (left) and mortality (right) case locations in year 2005 in Perth.
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Incidence

Mortality

Bandwith for smoothing intensity: 7
Bandwith for smoothing intensity : 3.5
Bandwith for simulation from data: 7
Bandwith for simulation from data: 5.5
Figure 72 Estimates of the inhomogeneous K-function for the year 2005 melanoma cancer incidence and
mortality data.

For the relative proportions of intensity of 16-year period, melanoma cancer incidence and
mortality in year 1990, 1993, 1997, 2001 and 2005 are shown in Figure 73. It can be seen
from Figure 73 that spatial trends are totally different in the selected years for incidence. It
can be seen clearly that incidence cases increase in Perth during the period 1990-2005.
However, the difference in the relative proportions for mortality is not significant.
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1993

1997
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Relative proportion of intensity for Incidence

Relative proportion of intensity for Mortality

Figure 73 The relative proportion of intensity of 16-year period for melanoma cancer incidence (top) and
mortality (bottom) in year 1990, 1993, 1997, 2001 and 2005.

6.2.2 Melanoma cancer incidence 2005 model fitting
In this section, Perth CBD is used first as the reference point in modelling. Then coastline
is used as the reference line for incidence modelling to check whether proximity to the
coast accounts for melanoma incidence.

It has been found that the year 2001 point pattern is more related to year 2005 data
compared with point patterns in other years. An adequate model is obtained when
susceptible population based on year 2001 and population density are used as covariates to
model the year 2005 data. The fitted model is shown below:
λθ (u ) = (( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.057 × exp(− 1.923 − 1.009 Z 1 (u) + 0.001 Z 2 (u) )

(6.5)

where Z 1 (u) denotes the distmap of 2001 melanoma cancer incidence point pattern and

Z 2 (u) denotes population density (popdens).
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The corresponding quantile-quantile plot, diagnostic plots and the estimation map for the
model (6.5) are shown in Figure 74. The quantile-quantile plot just stays within the
theoretical ideal line and this indicates that the agreement is good between the fitted model
and the data. For diagnostic plots: mark plot shows no extreme outliers; nearly all the
lurking variable plots for the coordinates stay within the 2σ-limits; contour plot does not
appear to have a visible trend, so the fitted model is a good fit. The estimation map
indicates that the highest estimated incidence rate per 100 square kilometres in 2005 is
about 140 people. The proportion of people above 30 is not a good explanatory variable
according to the quantile plot Figure 75.

Figure 74 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.5) fitted to the year 2005 melanoma cancer incidence data.

Figure 75 The quantile-quantile plot for the inhomogeneous Poisson model fitted to the year 2005 melanoma
cancer incidence data. The models involve spatial trends in which Perth city center is the reference point,
aged30+ and the distmap of year 2001 melanoma cancer incidence data.
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Next, the coastline is used as the reference line for the modelling. The coastline looks like a
parabola which opens west with the horizontal line ( y = − 3531.256 ) as the axis of
symmetry. This horizontal line passes the middle of metropolitan Perth. The point
(381.8623, -3531.256) is used as the origin. Then the other point (373.796, -3499.855) on
the northwestern border of metropolitan Perth is selected as the passing point of parabola.
And so the equation for parabola is:

x = −0.0082 × ( y + 3531.256) 2 + 381.8623
An adequate model is obtained when susceptible population based on year 1997 and
population density are used as covariates to model the year 2005 data. The fitted model is
shown below:

λθ (u ) =

exp(− 1.202 − 0.931 × Z 1 (u) + 0.001 × Z 2 (u) )
x + 0.0082 × ( y + 3531.256) 2 − 381.8623

0.058

(6.6)

where Z 1 (u) denotes the distmap of 1997 melanoma cancer incidence point pattern and

Z 2 (u) denotes population density (popdens). The distance between the point ( x , y ) and the
coastline is denoted by x + 0.0082 × ( y + 3531.256) 2 − 381.8623 . The corresponding
quantile-quantile plot, diagnostic plots and the estimation map for the model (6.6) are
shown in Figure 76. The quantile-quantile plot indicates that the agreement is good between
the fitted model and the data. The diagnostic plots do not show extreme outliers or visible
trend. The estimation map indicates that the highest estimated incidence rate per 100 square
kilometres in 2005 is about 135 people which is slightly lower than the estimation in model
(6.5) although these two estimation maps are quite similar. Overall, the coastline accounts
for melanoma incidence when it is used as the spatial trends. The two fitted intensity
functions produce very similar estimates according to the estimation maps shown in Figure
74 and Figure 76. The intensity of the melanoma incidence point process is given by model
(6.5) or (6.6) when different reference locations are used. However, the point patterns used
as covariates are not the same: one is year 2001 in model (6.5) and the other is year 1997 in
(6.6). These two models describe the point process properly using different spatial trends.
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Figure 76 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.6) fitted to the year 2005 melanoma cancer incidence data.

6.2.3 Melanoma cancer mortality 2005 model fitting
The survival rates (Figure 3) for melanoma cancer are relatively high compared with other
cancers. About 65% of people with melanoma were alive four years and 50% six years after
diagnosis. To model mortality data in 2005, the susceptible population density in year 2001
is best suited for fitting compared with the point patterns in other years.Neither population
density (popdens) nor the proportion of people aged 30+ (aged30+)are needed to obtain an
adequate fit. The fitted model is given by:

λθ (u ) =

exp(− 0.617 − 1.397 × Z1 (u) )
(( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.195

(6.7)

where Z 1 (u) denotes the distmap of the 2001 melanoma cancer incidence point pattern.
The quantile-quantile plot, diagnostic plots and estimation map for the model (6.7) are
shown in Figure 77. The quantile-quantile plot indicates an adequate agreement between
model (6.7) and mortality data. No extreme outliers or distinct spatial trends are detected
from the diagnostic plots. Also, nearly all the lurking variable plots for the coordinates stay
within the 2σ-limits. The estimation map indicates that the highest estimated mortality rate
per 100 square kilometres in 2005 is 25 people. To obtain an adequate fit, modelling
incidence needs covariates such as popdens or aged30+. However, these covariates are not
necessary for modelling melanoma mortality.
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Figure 77 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.7) fitted to the year 2005 melanoma cancer mortality data.

The lurking variable plot (Figure 78) indicates that the fitted model is able to capture the
dependence of intensity on the susceptible population intensity although there are values
outside the envelope.

Figure 78 Lurking variable plot for the empty space distances of 2001 melanoma cancer incidence used in
model (6.7).

6.3 Colorectal cancer analysis
6.3.1 Exploratory data analysis
The estimated K-function plots for the year 2005 colorectal cancer data (Figure 79) are
shown in Figure 80. The left plot is for incidence data and the right plot is for mortality data.
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These two plots indicate that there is no obvious attraction or inhibition for the year 2005
cancer poin patterns, so the point process is inhomogeneous Poisson process.

Figure 79 Colorectal cancer incidence (left) and mortality (right) case locations in year 2005 in Perth.
Incidence

Mortality

Bandwith for smoothing intensity: 2.5
Bandwith for smoothing intensity :4.5
Bandwith for simulation from data: 6
Bandwith for simulation from data: 4.5
Figure 80 Estimates of the inhomogeneous K-function for the year 2005 colorectal cancer incidence and
mortality data.
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For colorectal cancer incidence and mortality, the relative proportions of intensity of 16year period in year 1990, 1993, 1997, 2001 and 2005 are shown in Figure 81. It can be seen
that spatial trends in year 1990, 1993 and 1997 are quite similar but the trends are different
from those in year 2001 and 2005 for both incidence and mortality. The geographical
difference of incidence over the years is distinct compared with mortality.

1990

1993

1997

2001

2005

Relative proportion of intensity for Incidence

Relative proportion of intensity for Mortality

Figure 81 The relative proportion of intensity of 16-year period for colorectal cancer incidence (top) and
mortality (bottom) in year 1990, 1993, 1997, 2001 and 2005.

6.3.2 Colorectal cancer incidence 2005 model fitting
It was ientified that the year 1998 point pattern is more similar to year 2005 colorectal
incidence point pattern compared with point patterns in other years. An appropriate model
is obtained when spatial trends, susceptible population based on year 1998 and population
density (popdens) are used as covariates to model the year 2005 data. The fitted model is
shown below:
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λθ (u ) =

exp(− 1.079 − 0.956 × Z1 (u) + 0.001× Z 2 (u) )
(( x − 391.063) 2 + ( y + 3536.509) 2) 0.011

(6.8)

where Z1 (u) denotes the distmap of 1998 colorectal cancer incidence point pattern and

Z 2 (u) denotes population density (popdens).

The corresponding quantile-quantile plot, diagnostic plots and estimation map for the
model (6.8) are shown in Figure 82. For Q-Q plot, the line of observed value stays close to
the line of theoretical value and this indicates that the agreement is adequate between the
fitted model and the data. For diagnostic plots: no extreme outliers are found in mark plot;
nearly all the lurking variable plots for the coordinates stay within the 2σ-limits; the
contour plot does not appear to have any visible trend, so the fitted model is acceptable.
When we replace the covariate popdens in model (6.8) using aged, the fit becomes worse.
The estimation map indicates that the highest estimated incidence rate per 100 square
kilometres in 2005 is 100 people.

Figure 82 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.8) fitted to the year 2005 colorectal cancer incidence data.

6.3.3 Colorectal cancer mortality 2005 model fitting
The survival rates (Figure 3) for colorectal cancer patients are higher than lung cancer and
lower than melanoma cancer during the sixteen-year period. About 60% of people
diagnosed with colorectal cancer were alive after two years and 50% were alive for three
years after diagnosis. To model mortality data in 2005, susceptible population density in
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year 2003 is more suitable for the fitting compared with the point patterns in other years.
An adequate fit is obtained even when population density (popdens) or the proportion of
people aged 50+ (aged) is not included in the model. The fitted model is:

λθ (u ) =

exp(0.473 − 1.357 × Z1 (u) )
(( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.231

(6.9)

where Z1 (u) denotes the distmap of 2003 colorectal cancer incidence point pattern.
The quantile-quantile plot, diagnostic plots and estimation map for model (6.9) are shown
in Figure 83. The Q-Q plot indicates an adequate agreement between the fitted model and
mortality data. No “extreme” outliers or distinct spatial trends are detected from the four
panel plots. Also, nearly all the lurking variable plots for the coordinates just stay within
the 2σ-limits. The estimation map based on model (6.9) shows the spatial distribution of
cancer rates and it indicates that the highest estimated mortality rate per 100 square
kilometres in 2005 is about 65 people in the Perth metropolitan area. Compared with
modelling colorectal cancer incidence, modelling mortality does not have to include
covariates such as popdens or aged to obtain an appropriate fit.

Figure 83 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.9) fitted to the year 2005 colorectal cancer mortality data.

The lurking variable plot (Figure 84) indicates that the fitted model (6.9) is able to capture
the dependence of intensity on the covariate since the plot is not totally outside of the
significance bands and also stays over and below the horizontal axis.
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Figure 84 Lurking variable plots of colorectal cancer mortality in 2005 model fitting for covariates: empty
space distances of 2003 colorectal cancer incidence based on model (6.9). The fitting involves
transformations of coordinates.

6.4 Breast cancer analysis
For the spatial point pattern analysis of breast cancer data, the available covariates used in
the model fitting are the female population density (Popdensf), the proportion of females
aged 40 or over (agedf) shown in Figure 20, and susceptible population intensity (Figure
25).

6.4.1 Exploratory data analysis
In Australia, screening mammograms are used for the early detection of breast cancer.
Women aged 40 or over are eligible for the testing. The development of screening
mammograms contributes to an early diagnosis of breast cancer. The breast cancer risk
increases with age and there is a marked increase when females are aged 40 or above
(Figure 4) and so the proportion of females aged 40+ is considered as covariate for breast
cancer model fitting.

Plots of an estimate of the inhomogeneous K-function, for the incidence and mortality data,
are shown in
Figure 86. The sigma value for the left plot (
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Figure 86) is 5 to calculate intensity and to simulate from the incidence data point pattern.
The estimated K-function is in the range 0 to 1500. The plot indicates no obvious attraction
or inhibition for the incidence data point process, so the point process is inhomogeneous.
For the mortality point process (right plot), the estimated K values are slightly lower than
the low bound of the critical envelope when the r values are in the range 9 to 12. Although
there is evidence against inhomogeneous Poisson process, the mortality cases are more
dispersed than the incidence cases from Figure 85. Also, the eastern part of the study region
is sparsely populated (see Figure 20). This suggests “inhibition” indicated by the Kfunction plot.

Figure 85 Breast cancer incidence (left) and mortality (right) case locations in year 2005 in Perth.
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Figure 86 Estimates of the inhomogeneous K-function for the year 2005 breast cancer incidence and
mortality data.

For the relative proportions of intensity of 16-year period, breast cancer incidence and
mortality in year 1990, 1993, 1997, 2001 and 2005 are shown in Figure 87. Spatial trends
are totally different in the selective years for incidence and mortality. There is a gradual
increase with the year for incidence in most geographic areas, and this is mainly due to the
fact that the number of incidence cases increased gradually with the year (Figure 2).
Generally speaking, compared with the total number of cases in the period 1990-2005,
cancer mortality cases increase in the north of the study area during the four selected years.
Compared with the total number of cases in the period 1990-2005, the proportion of
mortality cases in Perth centre is relatively high in 1990, 1997 and 2001.
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Figure 87 The relative proportion of intensity of 16-year period for breast cancer incidence (top) and
mortality (bottom) in year 1990, 1993, 1997, 2001 and 2005.

6.4.2 Fitting models to 2005 breast incidence data
It has been found that the year 1992 point pattern is more similar to the year 2005 breast
cancer incidence pattern than point patterns in other years (see Figure 88). Converting back
to the form (2.39), the fitted model is:
λθ (u ) = (( x − 391.063) 2 +( y + 3536.509) 2 ) 0.08 × exp(− 1.618 − 0.942 Z 1 (u) + 0.002 Z 2 (u) )

(6.10)

where Z 1 (u) denotes the distmap of 1992 breast cancer incidence point pattern and Z 2 (u)
represents the pixel image of female population density (see Figure 20).

The quantile-quantile plot, diagnostic plots and estimation map for the model (6.10) are
shown in Figure 88. The quantile-quantile plot indicates that the agreement is tolerably
good between the fitted model and the data. The smoothed residual field for the data has a
lighter right-hand tail and lower variability than the smoothed residual field for simulations
from the fitted model. The diagnostic plots illustrate that the trend is slightly overestimated
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at which the lurking variable plots for the coordinates stay over the 2σ-limits. The
estimation map indicates that the highest estimated incidence rate per 100 square kilometres
in 2005 is about 210 people.

Figure 88 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.10) fitted to the year 2005 breast cancer incidence data.

6.4.3 Fitting models to 2005 breast mortality data
For the breast cancer patients survival rates (Figure 3), 58% of women diagnosed with
breast cancer were alive for five years after diagnosis and about 40% were alive for at least
six years. To model mortality data in 2005, susceptible population density in year 1999 is
suitable for the fitting compared with other years in the period 1990-2005. When popdensf
(see Figure 20 for female population density), agedf (see Figure 20 for the proportion of
females aged 40 or over) and the distmap of point pattern (year 1999) work together as
covariates to model mortality pattern, the fitting is adequate. The lurking variable plots in
Figure 89 show that agedf accounts for data less than the other two covariates. If the agedf
is not taken into consideration for modelling, the fit improves (see Figure 90). Converting
back to the form (2.39), the fitted model with two covariates is:
λθ (u ) = (( x − 391.063) 2 +( y + 3536.509) 2 ) 0.18 × exp(− 4.236 − 1.089 Z 1 (u) + 0.003 Z 2 (u) )

(6.11)

where Z 1 (u) denotes the distmap of breast cancer incidence point pattern (year 1999) and

Z 2 (u) represents popdensf (see Figure 20).
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Figure 89 Lurking variable plots of 2005 breast cancer mortality for covariates: female population density
(left), the proportion of the females aged 40 or over (middle) and the distmap of breast cancer incidence
data (year 1999, right).

The fitted intensity function has a good capture of dependence on breast cancer incidence
point pattern in 1999. Model (6.11) is the best model we have found which accounts for
data adequately with the least number of parameters.

The quantile-quantile plot, diagnostic plots and estimation map for the model (6.11) are
shown in Figure 90. The plots indicate a good agreement between model (6.11) and the
data. No “extreme” outliers or distinct spatial trend is detected from four panel plots. The
estimation map indicates that the highest estimated mortality rate per 100 square kilometres
in 2005 is about 26 women in the centre of the study area.

Figure 90 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.11) fitted to the year 2005 breast cancer mortality data.

6.5 Prostate cancer analysis
Prostate cancer only affects males and there is little risk to males under forty, so the
available covariates are male population density (Popdensm) and the proportion of males
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aged 40 above (agedm) shown in Figure 21, and susceptible population intensity (Figure
26).

6.5.1 Exploratory data analysis
The estimated inhomogeneous K-function plots for prostate cancer incidence and mortality
data (Figure 91) are shown in Figure 92 . These two plots all indicate no obvious attraction
or inhibition for the year 2005 prostate cancer data, so the point process is an
inhomogeneous Poisson process.

Figure 91 Prostate cancer incidence (left) and mortality (right) case locations in year 2005 in Perth.
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Figure 92 Estimates of the inhomogeneous K-function for the year 2005 prostate cancer incidence and
mortality data.

For prostate cancer incidence and mortality, the relative proportions of intensity of 16-year
period in year 1990, 1993, 1997, 2001 and 2005 are shown in Figure 93. There is a distinct
difference between year 2005 and other years except year 1997 for incidence. Compared
with the total number of cases in the period 1990-2005, the proportion of incidence cases is
relatively high in the southern part of the study area. However, the proportion in 2005 is
much higher across the study area than other years. For mortality, the relative proportion of
intensity is relatively high in the edge of the study area than inside except year 1990 based
on the fill color of of the legend.
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Figure 93 The relative proportion of intensity of 16-year period for prostate cancer incidence (top) and
mortality (bottom) in year 1990, 1993, 1997, 2001 and 2005.

6.5.2 Prostate cancer incidence 2005 model fitting
We have shown that prostate cancer incidence point pattern in 2005 is an inhomogeneous
Poisson process in Section 6.5.1. There are no appropriate covariates available to model the
2005 prostate cancer incidence point pattern. This indicates that the incidence point pattern
in 2005 is not similar to the point pattern in other years.

6.5.3 Prostate cancer mortality 2005 model fitting
The survival rates (Figure 3) for prostate cancer patients show that about 65% of people
diagnosed with prostate cancer were alive for three years after diagnosis and 55% were
alive for four years. The susceptible population density based on prostate cancer incidence,
popdensm

and agedm are used as covariates to fit the 2005 mortality data. Yearly quantile-

quantile plots (Figure 94-Figure 97) based on these covariates indicate clearly how much
each fitted function captures the dependence of intensity on different covariates. Also, the
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plots show the process to select an appropriate model. Three models are in three columns
and all models involve spatial trends and susceptible population intensity (distmap) based
on prostate cancer incidence. In addition, popdensm is incorporated in the first model (first
column) and agedm is included in the second model (middle column). Susceptible
population density (based on 2002 prostate cancer incidence) and spatial trends are able to
make an adequate fitting. Converting back to (2.39), the fitted model is shown below:
λθ (u ) = (( x − 391.063) 2 + ( y + 3536.509) 2 ) 0.186 × exp(− 0.035 − 1.906 × Z 1 (u) )

(6.12)

where Z1 (u) denotes the distmap of 2002 prostate cancer incidence point pattern.
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Figure 94 The quantile-quantile plots for the inhomogeneous Poisson models fitted to the year 2005 prostate
cancer mortality data.
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Figure 95 The quantile-quantile plots for the inhomogeneous Poisson models fitted to the year 2005 prostate
cancer mortality data.
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Figure 96 The quantile-quantile plots for the inhomogeneous Poisson models fitted to the year 2005 prostate
cancer mortality data.
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Figure 97 The quantile-quantile plots for the inhomogeneous Poisson models fitted to the year 2005 prostate
cancer mortality data
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The quantile-quantile plots (Figure 94-Figure 97) indicate that the models in the middle
column are good in some years and models in the third column look adequate in years such
as year 2001, 2002 and 2003. Although the fit is good for year 1997 (third column), it will
not be considered for the modelling because only about 25% of people diagnosed with
prostate cancer were alive after diagnosis according to Figure 3. They all indicate that the
fitted intensity function captures the dependence on the covariates. However, the models in
the middle column involve one more covariate agedm compared with the third column. The
aim in statistical modelling is to investigate an adequate model for data, and this model
should also be simple. The lurking variable plot (left plot of Figure 98) indicates that the
fitted intensity function (6.12) perfectly captures dependence on prostate cancer incidence
point pattern. In fact, the lurking variable plots have been tested for the years in which the
model is adequate (third column) and it has been found that only the intensity function
captures more dependence on year 2002 incidence point pattern than other years such as
year 2001 and 2003 (right plot of Figure 98).
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Figure 98 Lurking variable plot of 2005 prostate cancer mortality model fitting. The fitted intensity function
involves transformations of coordinates and spatially susceptible population based on the distmap of 2001
(top left), 2002 (top right) and 2003 (bottom) prostate cancer incidence.

The quantile-quantile plot, diagnostic plots and estimation map for model (6.12) are shown
in Figure 99. The Q-Q plot indicates an adequate agreement between the fitted model and
mortality data. No “extreme” outliers or distinct spatial trend is detected from four panel
plots. Also, nearly all the lurking variable plots for the coordinates stay within the 2σ-limits.
The fitted model only involves covariates susceptible population density and spatial trends.
The estimation map is based on model (6.12) and it shows the spatial distribution of cancer
mortality rates. The estimation map indicates that the highest estimated mortality rate per
100 square kilometres in 2005 is about 41 men in the Perth metropolitan area.
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Figure 99 The quantile-quantile plot (left), diagnostic plots (middle) and estimated rates for inhomogeneous
Poisson model (6.12) fitted to the year 2005 prostate cancer mortality data.

6.6 Summary
This chapter has provided the spatial point pattern analysis for cancers recorded in the Perth
metropolitan region in 2005. We have shown that cancer incidence and mortality data in
2005 for five types of cancer are inhomogeneous Poisson processes using the
inhomogeneous K-function. Based on the Poisson nature of the data, the Berman-Turner
algorithm was used for the model fitting. All the covariates available have been
investigated for modelling. However, no covariates have been found to account for 2005
prostate cancer incidence point pattern appropriately.

Two treatments of missing values have been applied to lung cancer mortality for model
fitting and it has been illustrated that point patterns have influence on the spatial point
pattern analysis. The fitting is slightly better when the data are treated using method 2 than
method 1.

Perth CBD is selected as the key reference point as spatial trends for modelling. For lung
cancer incidence, Kwinana industrial area is also used as reference point for modelling. It
has been found that the distance from Kwinana is a better spatial trend for lung cancer
incidence than the distance from Perth CBD. Kriging analysis has shown that melanoma
cancer incidence is high in the western Perth metropolitan area. As a result, coastline is
used as the reference line as well for modelling and we have found that the coastline
accounts for melanoma incidence. Two models indicate that both of them are adequate to
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account for the lung cancer and melanoma cancer incidence data respectively from different
perspectives.

Quantile-quantile plots have been used to check whether the fitted model is acceptable and
lurking variable plots have been applied to show whether the fitted function captures the
dependence of intensity on the covariates. For lung cancer incidence analysis, it has been
found that the point patterns in 1993 and 2005 are quite similar. A good fit is obtained
when popdens is considered for the modelling. For mortality analysis, only one covariate is
enough to get an adequate fit: the susceptible population density based on year 2003.
Although the fitted intensity function captures the dependence of intensity both on the
percentage of population above age 50 (aged) and the population density overall, it seems
that aged contributes to lung cancer death more than population density.

For year 2005 melanoma incidence modelling, population density (popdens) accounts for
more than the proportion of the people aged 30 or above (aged30+). This is probably due to
the fact that melanoma cancer incidence affects any age group of people except children
under the age of 10. The incidence point pattern in 2005 is quite similar to the point pattern
in 2001 when population density and spatial trends are considered. For melanoma mortality
model fitting, lurking variable plots indicate that the fitted intensity function captures
dependence on susceptible population intensity. This covariate is enough to obtain a good
fit for mortality data when spatial trend is considered.

For colorectal cancer analysis, we have shown that there are less covariates involved in
fitting mortality data than fitting incidence data. For year 2005 colorectal incidence
modelling, population density (popdens) accounts for data more than aged. This is
probably due to the fact that colorectal cancer incidence affects any people aged 10 or over.
Spatially susceptible population density and spatial trends are not enough to obtain a good
fitting for incidence point pattern in 2005. For colorectal cancer mortality model fitting,
susceptible population and spatial trends are enough to get a good fitting. The adequacy of
the fit is confirmed by the least variability in the image of the smoothed residual field.
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For breast cancer incidence analysis, it has been found that the point pattern in 2005 is quite
similar to the point pattern in 1992. A good fit is obtained when popdens is considered for
the modelling. For mortality analysis, female population density (popdensf) and spatially
susceptible population intensity (1999) are able to acount for the point pattern in order to
get an adequate fit. Although the fitted intensity function captures the dependence of
intensity on popdensf and agedf, it seems that popdensf contributes to breast cancer
death more than agedf(proportion of females aged 40 above).

For prostate cancer mortality, it has been indicated that the proportion of people aged 40+
(agedm) is a better covariate than male population density (popdensm) in most cases. These
two covariates only improve the fitting when working with susceptible population intensity.
The spatial trends (transformations of coordinates) and susceptible population intensity are
enough to make an appropriate fitting. The estimated mortality number of prostate cancer is
about 43 per 100 square kilometres in Perth 2005. Nearly all prostate cancer death is linked
to prostate cancer incidence because the fitted model has been verified by the perfect
capture of dependence on susceptible population intensity through lurking variable plots.

In conclusion, incidence modelling is more complex than mortality modelling. For
mortality, it is often sufficient to use the susceptible population intensity in addition to the
spatial trends. In contrast, for incidence modelling, the population density (or the
proportion of selected age groups) is also required. Moreover, the agreement between fitted
model and mortality data is usually better than that between fitted model and incidence data.

This chapter has provided the spatial point pattern analysis for cancer incidence and
mortality data in Perth and the correlation between each type of cancer and covariates has
been investigated. These findings will be informative to health service on the spatial
distribution of cancer risks for each individual cancer incidence and mortality.
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7 CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE
WORK
7.1 Conclusions
In this study, geostatistical model has been applied to cancer incidence and motality data
including lung, melanoma, colorectal, breast and prostate cancers. Spatial point pattern
model has been applied to these data from a different perspective. The innovative
application of these two models to cancer data in this study has presented the geostatistical
analysis at SLA scale and a point pattern analysis at finer scale.

ATP Poisson kriging analysis takes into account the size and shape of administrative units
(SLAs) and population within each SLA. This analysis is based on the adjusted rates to
remove bias from the population structure and the rates also need to be corrected for the
small number problem through the assigned weights which account for variability resulting
from the population size. ATP Poisson kriging analysis is on the spatial distribution of
cancer rates per 100,000 person-years for Perth SLAs based on the adjusted rates during
16-year period. To avoid the use of temporal structure in the model setup, the study period
was divided into three contiguous periods to see how cancer mortality varies over time. To
ensure the accuracy of the estimates, a more refined analysis for each individual year
cannot be conducted in this study since there are not enough data available for the
estimation. For breast and prostate cancer incidence, the spatial distribution in the three
contiguous periods was explored. For non-sex specific cancers (lung, colorectal and
melanoma cancer incidence), we have provided an analysis by sex and investigate how
these cancers affect males and females differently.

Spatial point pattern analysis is based on spatial trends (through the selection of reference
locations) and susceptible population intensity. Population density or the proportion of the
selected age groups is also considered in the analysis. The covariates used in the spatial
point pattern analysis are interpolated at every location in the study region. Spatial point
pattern theory focuses on the analysis of the incidence (mortality) rate as the number of
people per square kilometres in the Perth metropolitan area in year 2005. Environmental
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covariates were also considered for lung and melanoma cancer incidence analysis. Two
models indicate that lung cancer incidence risk is relatively high in Kwinana and melanoma
incidence risk is relatively high along the coast.

For ATP Poisson kriging analysis, the estimates are not very accurate when there are not
enough data available and the number of cases varies greatly with time (prostate cancer
mortality in 2001-2005). For spatial point pattern analysis, the diagnostic plots can indicate
the departure from the trend in the fitted model but it is often hard to interpret.

Conclusions from geostatistical analysis
In this study, ATP Poisson kriging was used to analyse incidence and mortality rates of the
top five cancers in Perth by means of age-sex-adjustment. Geostatistical analysis of non-sex
specific cancers is based on adjusted rates by taking into account age and sex. For sex
specific cancers, the analysis only incorporates age. Spatial continuity and variability of
adjusted rates have been investigated based on omnidirectional semivariogram plots
because they are well-behaved and show good structure compared with directional
semivariograms. Due to the distinct difference in the population density between SLAs in
Perth, all kriging estimates have been conducted at the SLA level rather than a pointsupport semivariogram model within this study.

Breast cancer and prostate cancer are the most common cancers in women and men
respectively. After these two cancers, males are more susceptible to lung cancer than
females. Males also have slightly higher melanoma and colorectal cancer risk than females.

There are differences in the estimates between age-adjusted rates and age-sex-adjusted rates.
Overall the risk from age and sex is possibly more continuous than the risk from age only
but spatial correlation is slightly stronger for age-adjusted rates across Perth SLAs.

Spatial correlation is relatively strong for mortality compared with the corresponding
incidence across Perth SLAs. For cancer incidence, the spatial correlation is relatively
strong for colorectal cancer and weak for lung cancer. For mortality, the spatial correlation
is strong for breast cancer but weak for prostate cancer.
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Cancer mortality varies more continuously than the corresponding cancer incidence. For
cancer incidence, prostate cancer shows the greatest variability and colorectal cancer varies
relatively smoothly compared with other cancers. For mortality, lung cancer displays the
greatest variability but melanoma cancer varies relatively smoothly compared with other
cancers. The nugget effect is relatively low for melanoma and colorectal cancer mortality
and this indicates that the cancer mortality case locations are probably close to each other
compared with other cancers.

The mortality of most cancers has an increasing rate with time except prostate cancer. Ageadjusted rates and age-sex-adjusted rates have shown the difference in spatial variation. The
values for the kriging variance are normally low in densely populated areas and high in
sparsely populated areas. Higher rates arise mainly in SLAs in the vicinity of the Perth
metropolitan area and the estimates have lower variance values compared with other areas.

Conclusions from spatial point pattern analysis
In this study, the Berman-Turner algorithm has been applied for model fitting and the
intensity of the point pattern for cancers has been investigated. The model fitting is based
on the inhomogeneous Poisson nature of the cancer data and this was verified via the
inhomogeneous K-function.

The characteristics of the population distribution in the Perth metropolitan area (see Figure
19) play an important role in model fitting, and these spatial trends (a function of spatial
coordinates using Perth city centre as the reference location) are indispensable to make an
adequate fit. Except for the spatial trends, the fitted intensity function for the point process
is also related to the spatial variability in susceptible population. The spatial intensity of the
point patterns for different cancers is shown by the risk maps of estimated rates. The
intensity is generally high in the centre of the study area which is densely populated. The
fitted Poisson process model was validated by quantile-quantile plots and diagnostic plots.

Lung cancer data have been used as an example to illustrate how to treat missing values
properly to get an improved model fit. The raw data are treated by assigning the mean of
161

16-year period cancer case locations in the SLA to those locations without latitude or
longitude recorded.

Spatial point pattern analysis has shown that there are fewer covariates needed for fitting
mortality data than fitting incidence data. In addition, the agreement between the fitted
model and the mortality data is generally better than that between incidence data and the
fitted model . Covariates available in this study were the population density, the distribution
of the proportion of selected age groups and the susceptible population intensity. The
covariates vary between cancers. Spatially susceptible population (based on cancer
incidence) and spatial trends are not enough to obtain a good fit for incidence point patterns.
When they are combined with population density, a good fit is obtained. This confirms a
fact that cancer incidence in a specific year has little influence on incidence in another year.
The incidence point pattern in 2005 is quite similar to the point pattern in another
individual year when population density is included. A good fit is obtained for lung cancer
incidence data when population density is considered for the modelling. For melanoma
incidence modelling, population density is a better covariate than the proportion of the
people aged 30 or above. For colorectal incidence modelling, population density accounts
for data more than the proportion of the selected age groups, and spatially susceptible
population density and spatial trends are not enough to obtain a good fit. When population
density is considered for breast cancer incidence modelling an adequate fit is obtained.
However, no covariates have been found to account for prostate cancer incidence point
pattern appropriately.

For mortality data fitting, one covariate (susceptible population intensity) is enough to
achieve an adequate fit in most cases. This probably reflects a fact that cancer mortality is
mainly due to the corresponding cancer incidence. In fact, nearly all the cancer patients
died of the corresponding cancer rather than other causes according to mortality data
provided by the Cancer Registry, WA Department of Health. For lung cancer mortality
modelling, it seems that the proportion of the selected age groups contributes to lung cancer
death more than population density. In fact, one covariate (the susceptible population
density) is enough to get an adequate fit. For melanoma and colorectal mortality model
fitting, susceptible population intensity is enough to obtain a good fit when spatial trend is
considered. For breast cancer mortality analysis, female population density and spatially
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susceptible population intensity are able to account for the point pattern to get an adequate
fit. For prostate cancer mortality, the spatial trends and susceptible population intensity are
enough to make an appropriate fitting.

In most cases population density is a more reasonable covariate than the percentage of
selected age groups. However, prostate cancer and lung cancer are an exception. This is
mainly because these cancer incidence risks are influenced greatly by the age compared
with other cancers.

7.2 Recommendations for future work
There are some limitations of this study, and so further research is recommended. A
number of areas are worthy of further investigation such as the link between estimates and
possibly sources of the cancer. For example, smoking patterns by SLAs for males and
females will be recommended for lung cancer analysis in the future work if such data are
available. The smoking patterns at finer scales such as suburb are recommended in spatial
point pattern analysis in the future work.

The data modelled in the present spatial point pattern study are for the year 2005. At this
stage, the population data at suburb scale is only available for year 2006. It is recommended
that modelling cancer data in other years should be studied in future work if the population
data by suburb are available for other census years.

The present spatial point pattern study only focuses on modelling cancer data using
covariates such as population density, the percentage of people at higher risk and the
susceptible population intensity. It is recommended that the correlation between different
cancers should be studied in the future work to see whether people with one cancer are
possibly to develop another cancer as a secondary cancer.

Geostatistical modelling and spatial statistical modelling are restricted to two-dimensional
space in the present study. Therefore further investigation of these methods to incorporate
time as a third dimension in the model should be considered.
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9 APPENDICES
9.1 Appendix A-Crude rates of cancers for geostatistical analysis
In this section, the crude rates for the five types of cancer are provided for the reference.
The crude rates for lung, melanoma and colorectal cancers are presented in Figure 100,
Figure 101 and Figure 102. The crude rates for sex specific cancers are given in Figure 103
and Figure 104. Generally speaking, the maps for crude rates show slight more variability
than those of adjusted rates which are discussed in details in section 4.6.1.
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Incidence

Mortality
Lung Cancer

66.23
48.52
45.72
44.14
42.25
41.34
38.58
35.64
34.28
31.24

55.68
42.49
40.22
38.42
36.45
34.18
32.69
29.42
27.71
25.56

Melanoma
92.55
63.12
56.42
51.40
47.51
44.55
43.09
41.29
39.09
35.82

16.80
7.29
6.28
5.53
5.13
4.75
4.60
4.23
4.07
3.75

Colorectal
92.41
60.48
58.55
56.98
53.75
52.25
50.21
47.81
45.87
42.00

37.83
25.57
23.86
22.98
21.94
21.48
20.14
19.14
18.48
16.67

Figure 100 Crude rates for lung, melanoma and colorectal cancer.
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Males

Females
Lung Cancer
90.57
67.19
65.15
63.09
58.19
55.58
51.54
46.57
45.28
40.44

56.89
33.11
30.91
29.59
28.26
26.79
25.76
23.79
22.19
19.97

Melanoma
131.30
49.91
44.70
42.78
39.97
37.55
35.71
33.82
32.05
29.51

126.56
82.48
75.71
63.97
55.33
52.77
49.00
46.36
43.01
38.95

Colorectal
90.49
58.86
53.20
51.67
49.53
46.78
43.33
42.59
39.63
36.69

129.61
71.99
68.09
62.93
59.85
58.31
54.27
49.80
48.74
43.83

Figure 101 Crude rates by sex for lung, melanoma and colorectal cancer incidence.
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1990-1995

1996-2000
Lung cancer mortality

2001-2005

70.35
46.24
41.53
38.54
36.11
32.78
29.03
25.12
23.09
19.75

Melanoma mortality
53.76
8.83
7.08
6.17
5.57
4.74
4.11
3.57
3.02
1.96

Colorectal mortality
49.40
30.47
27.06
25.11
23.07
21.05
19.35
17.19
15.45
12.21

Figure 102 Crude rates for cancer mortality during three time periods.
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Breast Cancer

Prostate cancer
Incidence

314.55
153.01
138.24
129.06
120.74
113.98
108.25
101.39
97.42
85.10

Mortality

48.48
33.57
28.55
26.61
24.69
23.36
20.75
18.81
17.69
15.41

Figure 103 Crude rates for breast and prostate cancer.
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1990-1995

1996-2000

2001-2005

Breast cancer incidence

508.38
147.29
134.77
128.54
118.56
113.80
108.03
98.43
93.40
79.48

Prostate cancer incidence

244.23
156.50
142.52
130.29
117.20
109.57
97.83
89.01
80.51
63.19

Breast cancer mortality

206.72
37.86
33.89
29.34
26.57
24.13
21.93
20.06
18.38
15.07

Prostate cancer mortality

61.11
31.68
27.55
24.84
22.39
20.08
17.51
15.36
12.93
9.41

Figure 104 Crude rates for breast and prostate cancer during three time periods.
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9.2 Appendix B-Codes
9.2.1 Code to read “shapefiles” into R package
The commands of reading “shapefiles” into spatstat are:
x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

9.2.2 Code to produce empty space distances
Take lung cancer incidence in year 1990 as an example, the code to produce empty space
distances is shown below:

esd = function(file="perth suburb06") {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

c90<-read.table("Lcoord90.txt",header=TRUE)
attr( c90,"projection")<-"LL"
c90<-convUL ( c90, km=TRUE)
c90.ppp = ppp(c90$X,c90$Y,window=owin(xlim,ylim))
c90.im = distmap(c90.ppp)

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
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assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(c90.im, main="1990",zlim=c(0,66))
addPolys(water,col="white",border=FALSE)

browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,
c90=c90,c90.ppp=c90.ppp,c90.im=c90.im,bbox=bbox,land=land,water=water))}
out=esd()

9.2.3 Code to produce population density image
The code shown below is used to produce the pixel image popdens (see Table 3 for the file
2006popsuburb.txt). This image is used as covariate for lung, melanoma and colorectal
cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbs<- read.table("2006popsuburb.txt", header=TRUE)
avepopden <- with(burbs, Total/Area)
burb <- with(burbs, ppp(X, Y, range(X),range(Y), marks=avepopden))

window<-as.owin(z)
burbs$window<-window

popdens <- smooth.ppp(burbs)
plot(popdens,main="popdens")
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The following code is used to produce the pixel image popdensf (see Table 4 for the file
2006popsuburbsex.txt). This image is used for breast cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbsf<- read.table("2006popsuburbsex.txt", header=TRUE)
avepopdenf<- with(burbsf, Fpop/Area)
burbsf <- with(burbsf, ppp(X, Y, range(X),range(Y), marks=avepopdenf))

window<-as.owin(z)
burbsf$window<-window

popdensf <- smooth.ppp(burbsf)
plot(popdensf)

The following code is used to produce the pixel image popdensm (see Table 4 for the file
2006popsuburbsex.txt). This code is usd for prostate cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbsm<- read.table("2006popsuburbsex.txt", header=TRUE)
avepopdenm<- with(burbsm, Mpop/Area)
burbsm <- with(burbsm, ppp(X, Y, range(X),range(Y), marks=avepopdenm))

window<-as.owin(z)
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burbsm$window<-window

popdensm <- smooth.ppp(burbsm)
plot(popdensm)

9.2.4 Code to produce the percentage of selected age group
The following code is used to produce the pixel image aged (see Table 3 for the file
2006popsuburb.txt) for lung and colorectal cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbs<- read.table("2006popsuburb.txt", header=TRUE)
burbs<- with(burbs, ppp(X, Y, range(X),range(Y), marks=Fiftypp))

window<-as.owin(z)
burbs$window<-window

aged<- smooth.ppp(burbs)
plot(aged,main="aged")

The following code is used to produce the pixel image aged30+ (see Table 3 for the file
2006popsuburb.txt) for melanoma cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)
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burbs<- read.table("2006popsuburb.txt", header=TRUE)
burbs<- with(burbs, ppp(X, Y, range(X),range(Y), marks=Thirtypp))

window<-as.owin(z)
burbs$window<-window

aged<- smooth.ppp(burbs)
plot(aged,main="aged(30+)")

The following code is used to produce the pixel image agedf (see Table 4 for the file
2006popsuburbsex.txt) for breast cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbsf<- read.table("2006popsuburbsex.txt", header=TRUE)
burbsf<- with(burbsf, ppp(X, Y, range(X),range(Y), marks= Ffortypp))

window<-as.owin(z)
burbsf$window<-window

agedf<- smooth.ppp(burbsf)
plot(agedf,main="agedf")
The following code is used to produce the pixel image agedm40+ (see Table 4 for the file
2006popsuburbsex.txt) for prostate cancer model fitting.

x<-readShapeSpatial("perth suburb06.shp")
y <- as(x, "SpatialPolygons")
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spatstat.options(checkpolygons = FALSE)
z <- as(y, "owin")
spatstat.options(checkpolygons = TRUE)

burbsm<- read.table("2006popsuburbsex.txt", header=TRUE)
burbsm<- with(burbsm, ppp(X, Y, range(X),range(Y), marks= Mfortypp))

window<-as.owin(z)
burbsm$window<-window

agedm<- smooth.ppp(burbsm)
plot(agedm,main="agedm (40+)")

9.2.5 Code to produce relative proportion of intensity
Take breast cancer incidence as an example, the spatstat commands to obtain the relative
proportions of intensity in year 1990 are shown below:

X<-density(split(BIyr))
attach(X)
a0<-X$"1990"
a1<-X$"1991"
a2<-X$"1992"
a3<-X$"1993"
a4<-X$"1994"
a5<-X$"1995"
a6<-X$"1996"
a7<-X$"1997"
a8<-X$"1998"
a9<-X$"1999"
a10<-X$"2000"
a11<-X$"2001"
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a12<-X$"2002"
a13<-X$"2003"
a14<-X$"2004"
a15<-X$"2005"
Relative90<eval.im(a0/(a0+a1+a2+a3+a4+a5+a6+a7+a8+a9+a10+a11+a12+a13+a14+a15))
plot(Relative90,main="Relative proportion of intensity 1990")
detach(X)

where BIyr is a file containing all breast cancer incidence cases during the period 19902005.

9.2.6 Code to produce estimated inhomogeneous K-plot
9.2.6.1 Lung cancer
The spatstat commands to get the estimated inhomogeneous K-plot for lung cancer
incidence (Lcoord05.txt) and mortality (Mor2005L.txt) point patterns in 2005 are:
LI05<-read.table("Lcoord05.txt",header=TRUE)
attr(LI05,"projection")<-"LL"
LI05<-convUL (LI05, km=TRUE)
as.EventData(LI05, projection = NULL, zone = NULL)
LI05<-ppp(LI05$X,LI05$Y,window=owin(range(LI05$X),range(LI05$Y)))

smo<-density.ppp(LI05,sigma=7)
Ken<- envelope(LI05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=7, correction="border")
plot(Ken)

mb<-read.table("Mor2005L.txt",header=TRUE)
attr(mb,"projection")<-"LL"
mb<-convUL (mb, km=TRUE)
as.EventData(mb, projection = NULL, zone = NULL)
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mb<-ppp(mb$X,mb$Y,window=owin(range(mb$X),range(mb$Y)))
smo<-density.ppp(mb,sigma=4.9)
Ken<- envelope(mb, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=4.9, correction="trans")
plot(Ken)

9.2.6.2 Melanoma cancer
The spatstat commands to get the estimated inhomogeneous K-plot for melanoma cancer
incidence (Mcoord05.txt) and mortality (Mor2005M.txt) point patterns in 2005 are:

MI05<-read.table("Mcoord05.txt",header=TRUE)
attr(MI05,"projection")<-"LL"
MI05<-convUL (MI05, km=TRUE)
as.EventData(MI05, projection = NULL, zone = NULL)
MI05<-ppp(MI05$X,MI05$Y,window=owin(range(MI05$X),range(MI05$Y)))
smo<-density.ppp(MI05,sigma=3.5)

Ken<-envelope(MI05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=5.5, correction="trans")
plot(Ken)

mel05<-read.table("Mor2005M.txt",header=TRUE)
attr(mel05,"projection")<-"LL"
mel05<-convUL (mel05, km=TRUE)
as.EventData(mel05, projection = NULL, zone = NULL)
mel05<-ppp(mel05$X,mel05$Y,window=owin(range(mel05$X),range(mel05$Y)))
smo<-density.ppp(mel05,sigma=7)

Ken<- envelope(mel05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=7, correction="trans")
plot(Ken)
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9.2.6.3 Breast cancer
The spatstat commands to get the estimated inhomogeneous K-plot for breast cancer
incidence (Bcoord05.txt) and mortality (Mor2005B.txt) point patterns in 2005 are:

b05<-read.table("Bcoord05.txt",header=TRUE)
attr(b05,"projection")<-"LL"
b05<-convUL (b05, km=TRUE)
as.EventData(b05, projection = NULL, zone = NULL)
b05<-ppp(b05$X,b05$Y,window=owin(range(b05$X),range(b05$Y)))
smo<-density.ppp(b05,sigma=5)

Ken<- envelope(b05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=5, correction="border")
plot(Ken)

mb05<-read.table("Mor2005B.txt",header=TRUE)
attr(mb05,"projection")<-"LL"
mb05<-convUL (mb05, km=TRUE)
as.EventData(mb05, projection = NULL, zone = NULL)
smo<-density.ppp(mb05,sigma=6)

Ken<- envelope(mb05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=6, correction="trans")
plot(Ken)

9.2.6.4 Prostate cancer
The spatstat commands to get the estimated inhomogeneous K-plot for prostate cancer
incidence (Pcoord05.txt) and mortality (Mor2005P.txt) point patterns in 2005 are:
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p05<-read.table("Pcoord05.txt",header=TRUE)
attr(p05,"projection")<-"LL"
p05<-convUL (p05, km=TRUE)
as.EventData(p05, projection = NULL, zone = NULL)
p05<-ppp(p05$X,p05$Y,window=owin(range(p05$X),range(p05$Y)))

smo<-density.ppp(p05,sigma=5)
Ken<- envelope(p05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=5, correction="border")
plot(Ken)

mp05<-read.table("Mor2005P.txt",header=TRUE)
attr(mp05,"projection")<-"LL"
mp05<-convUL (mp05, km=TRUE)
mp05<-ppp(mp05$X,mp05$Y,window=owin(range(mp05$X),range(mp05$Y)))
as.EventData(mp05, projection = NULL, zone = NULL)

smo<-density.ppp(mp05,sigma=3.5)
Ken<- envelope(mp05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=7, correction="trans")
plot(Ken)

9.2.6.5 Colorectal cancer
The spatstat commands to get the estimated inhomogeneous K-plot for colorectal cancer
incidence (Rcoord05.txt) and mortality (Mor2005R.txt) point patterns in 2005 are:

r05<-read.table("Rcoord05.txt",header=TRUE)
attr(r05,"projection")<-"LL"
r05<-convUL (r05, km=TRUE)
as.EventData(r05, projection = NULL, zone = NULL)
r05<-ppp(r05$X,r05$Y,window=owin(range(r05$X),range(r05$Y)))
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smo<-density.ppp(r05,sigma=4.5)
Ken<- envelope(r05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=4.5, correction="border")
plot(Ken)

mr05<-read.table("Mor2005R.txt",header=TRUE)
attr(mr05,"projection")<-"LL"
mr05<-convUL (mr05, km=TRUE)
as.EventData(mr05, projection = NULL, zone = NULL)
mr05<-ppp(mr05$X,mr05$Y,window=owin(range(mr05$X),range(mr05$Y)))

smo<-density.ppp(mr05,sigma=2.5)
Ken<- envelope(mr05, Kinhom,
nsim=99,simulate=expression(rpoispp(smo)),sigma=6, correction="trans")
plot(Ken)

9.2.7 Code to produce estimation map
9.2.7.1 Melanoma cancer
The code to produce the estimation map for melanoma cancer incidence based on model
(6.5) is:
estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
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xlim=rutm[,"X"]; ylim=rutm[,"Y"]

m01<-read.table("Mcoord01.txt",header=TRUE)
attr( m01,"projection")<-"LL"
m01<-convUL ( m01, km=TRUE)
m01.ppp<-ppp( m01$X, m01$Y,window=owin(xlim,ylim))
m01.im<-distmap(m01.ppp)

burbs<- read.table("2006popsuburb.txt", header=TRUE)
attr(burbs,"projection")<-"LL"
burbs<-convUL (burbs, km=TRUE)
avepopden <- with(burbs, Total/Area)
burb <- with(burbs, ppp(X, Y, range(X),range(Y), marks=avepopden))
popdens <- smooth.ppp(burb)

mel05<-read.table("Mcoord05.txt",header=TRUE)
attr(mel05,"projection")<-"LL"
mel05<-convUL (mel05, km=TRUE)
mel05.ppp<-ppp(mel05$X,mel05$Y,window=owin(xlim,ylim))
mel05.ppm<- ppm(mel05.ppp, ~m01.im+popdens+
log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(m01.im=m01.im))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(mel05.ppm), main="Estimated rates")

addPolys(water,col="white",border=FALSE)
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#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,

m01=m01,m01.ppp=m01.ppp,m01.im=m01.im,popdens=popdens,mel05=mel05,me
l05.ppp=mel05.ppp,mel05.ppm=mel05.ppm,bbox=bbox,land=land,water=water))}

out=estmap()

The susceptible population density based on melanoma cancer incidence in 2001
(Mcoord01.txt) is applied as covariate to model melanoma cancer mortality in 2005
(Mor2005M.txt). The code to produce the estimation map of melanoma mortality in 2005
based on model (6.7) is shown below:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),max=2
55)) {#col.im=terrain.colors(300)) {require(grDevices); require(maptools); require(spatstat);
require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

m01<-read.table("Mcoord01.txt",header=TRUE)
attr( m01,"projection")<-"LL"
m01<-convUL ( m01, km=TRUE)
m01.ppp<-ppp( m01$X, m01$Y,window=owin(xlim,ylim))
m01.im<-distmap(m01.ppp)
mel05<-read.table("Mor2005M.txt",header=TRUE)
attr(mel05,"projection")<-"LL"
mel05<-convUL (mel05, km=TRUE)
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mel05.ppp<-ppp(mel05$X,mel05$Y,window=owin(xlim,ylim))
mel05.ppm<- ppm(mel05.ppp, ~m01.im+log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(m01.im=m01.im))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")
plot(predict(mel05.ppm), main="Estimated rates")
addPolys(water,col="white",border=FALSE)
#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,
m01=m01,m01.ppp=m01.ppp,m01.im=m01.im,mel05=mel05,mel05.ppp=mel05.pp
p,mel05.ppm=mel05.ppm,bbox=bbox,land=land,water=water)) }

out=estmap()

9.2.7.2 Breast cancer
The code to produce the estimation map for breast cancer incidence based on model (6.10)
is:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
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xlim=rutm[,"X"]; ylim=rutm[,"Y"]

b92<-read.table("Bcoord92.txt",header=TRUE)
attr( b92,"projection")<-"LL"
b92<-convUL ( b92, km=TRUE)
b92.ppp<-ppp( b92$X, b92$Y,window=owin(xlim,ylim))
b92.im<-distmap(b92.ppp)

burbsf<- read.table("2006popsuburbsex.txt", header=TRUE)
attr(burbsf,"projection")<-"LL"
burbsf<-convUL (burbsf, km=TRUE)
avepopdenf <- with(burbsf, Total/Area)
burbf<- with(burbsf, ppp(X, Y, range(X),range(Y), marks=avepopdenf))
popdensf <- smooth.ppp(burbsf)

b05<-read.table("Bcoord05.txt ",header=TRUE)
attr(b05,"projection")<-"LL"
b05<-convUL (b05, km=TRUE)
b05.ppp<-ppp(b05$X,b05$Y,window=owin(xlim,ylim))
b05.ppm<- ppm(b05.ppp, ~b92.im+popdensf+log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(b92.im=b92.im))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(b05.ppm), main="Estimated rates")

addPolys(water,col="white",border=FALSE)

#browser();return()
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invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,
b92=b92,b92.ppp=b92.ppp,b92.im=b92.im,popdensf=popdensf,b05=b05,b05.ppp=b05.ppp,
b05.ppm=b05.ppm,bbox=bbox,land=land,water=water))}

out=estmap()

The susceptible population density based on breast cancer incidence in 1999 (Bcoord99.txt)
is applied as covariate to model breast cancer mortality in 2005 (Mor2005B.txt). The code
to produce the estimation map of breast mortality in 2005 based on model (6.11) is shown
below:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

b99<-read.table("Bcoord99.txt",header=TRUE)
attr( b99,"projection")<-"LL"
b99<-convUL ( b99, km=TRUE)
b99.ppp<-ppp( b99$X, b99$Y,window=owin(xlim,ylim))
b99.im<-distmap(b99.ppp)

burbsf<- read.table("2006popsuburbsex.txt", header=TRUE)
attr(burbsf,"projection")<-"LL"
burbsf<-convUL (burbsf, km=TRUE)
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avepopdenf <- with(burbsf, Fpop/Area)
burbsf <- with(burbsf, ppp(X, Y, range(X),range(Y), marks=avepopdenf))
popdensf <- smooth.ppp(burbsf)

mb05<-read.table("Mor2005B.txt",header=TRUE)
attr(mb05,"projection")<-"LL"
mb05<-convUL (mb05, km=TRUE)
mb05.ppp<-ppp(mb05$X,mb05$Y,window=owin(xlim,ylim))
mb05.ppm<- ppm(mb05.ppp, ~b99.im+popdensf+log(sqrt((x391.0632)^2+(y+3536.509)^2)), covariates=list(b99.im=b99.im,popdensf=popdensf))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(mb05.ppm), main="Estimated rates")

addPolys(water,col="white",border=FALSE)

#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,

b99=b99,b99.ppp=b99.ppp,b99.im=b99.im,popdensf=popdensf,mb05=mb05,mb05.
ppp=mb05.ppp,mb05.ppm=mb05.ppm,bbox=bbox,land=land,water=water))}

out=estmap()
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9.2.7.3 Prostate cancer
The susceptible population density based on prostate cancer incidence in 2002
(Pcoord02.txt) is applied as covariate to model prostate cancer mortality in 2005
(Mor2005P.txt). The code to produce the estimation map of prostate mortality in 2005
based on model (6.12) is shown below:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

p02<-read.table("Pcoord02.txt",header=TRUE)
attr( p02,"projection")<-"LL"
p02<-convUL ( p02, km=TRUE)
p02.ppp<-ppp( p02$X, p02$Y,window=owin(xlim,ylim))
p02.im<-distmap(p02.ppp)

mp05<-read.table("Mor2005P.txt",header=TRUE)
attr(mp05,"projection")<-"LL"
mp05<-convUL (mp05, km=TRUE)
mp05.ppp<-ppp(mp05$X,mp05$Y,window=owin(xlim,ylim))
mp05.ppm<- ppm(mp05.ppp, ~p02.im+log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(p02.im=p02.im))
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bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(mp05.ppm), main="Estimated rates")

addPolys(water,col="white",border=FALSE)

#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,

p02=p02,p02.ppp=p02.ppp,p02.im=p02.im,mp05=mp05,mp05.ppp=mp05.ppp,mp0
5.ppm=mp05.ppm,bbox=bbox,land=land,water=water))}

out=estmap()

9.2.7.4 Colorectal cancer
The code to produce the estimation map for colorectal cancer incidence based on model
(6.8) is:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {
require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
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rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

r98<-read.table("Rcoord98.txt",header=TRUE)
attr( r98,"projection")<-"LL"
r98<-convUL ( r98, km=TRUE)
r98.ppp<-ppp( r98$X, r98$Y,window=owin(xlim,ylim))
r98.im<-distmap(r98.ppp)

burbs<- read.table("2006popsuburb.txt", header=TRUE)
attr(burbs,"projection")<-"LL"
burbs<-convUL (burbs, km=TRUE)
avepopden <- with(burbs, Total/Area)
burb <- with(burbs, ppp(X, Y, range(X),range(Y), marks=avepopden))
popdens <- smooth.ppp(burbs)

mr05<-read.table("Mor2005R.txt",header=TRUE)
attr(mr05,"projection")<-"LL"
mr05<-convUL (mr05, km=TRUE)
mr05.ppp<-ppp(mr05$X,mr05$Y,window=owin(xlim,ylim))
mr05.ppm<- ppm(mr05.ppp, ~r98.im+popdens+log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(r98.im=r98.im))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(mr05.ppm), main="Estimated rates")

addPolys(water,col="white",border=FALSE)
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#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,
r98=r98,r98.ppp=r98.ppp,r98.im=r98.im,popdens=popdens,
mr05=mr05,mr05.ppp=mr05.ppp,mr05.ppm=mr05.ppm,bbox=bbox,land=land,water=water
))}

out=estmap()

The susceptible population density based on colorectal cancer incidence in 2003
(Rcoord03.txt) is applied as covariate to model colorectal cancer mortality in 2005
(Mor2005R.txt). The code to produce the estimation map of colorectal mortality in 2005
based on model (6.9) is shown below:

estmap = function(file="perth suburb06",
col.im=rgb(colorRamp(c("royalblue","green","yellow","white"))(seq(0,1,len=300)),
max=255)) {
#col.im=terrain.colors(300)) {

require(grDevices); require(maptools); require(spatstat); require(PBSmapping)
sll = importShapefile ("perth suburb06.shp")
attr(sll,"projection")<-"LL"
sutm = convUL (sll, km=TRUE)
plotMap(sutm, projection = TRUE, tckLab = TRUE)
rutm = sapply(sutm,range)
xlim=rutm[,"X"]; ylim=rutm[,"Y"]

r03<-read.table("Rcoord03.txt",header=TRUE)
attr( r03,"projection")<-"LL"
r03<-convUL ( r03, km=TRUE)
r03.ppp<-ppp( r03$X, r03$Y,window=owin(xlim,ylim))
r03.im<-distmap(r03.ppp)
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mr05<-read.table("Mor2005R.txt",header=TRUE)
attr(mr05,"projection")<-"LL"
mr05<-convUL (mr05, km=TRUE)
mr05.ppp<-ppp(mr05$X,mr05$Y,window=owin(xlim,ylim))
mr05.ppm<- ppm(mr05.ppp, ~r03.im+log(sqrt((x-391.0632)^2+(y+3536.509)^2)),
covariates=list(r03.im=r03.im))

bbox=makeGrid(xlim,ylim,addSID=FALSE,projection="UTM")
if (!exists("land",envir=.GlobalEnv)) {
land = joinPolys(sutm,operation="UNION")
assign("land",land,pos=1) }
water = joinPolys(bbox,land,"DIFF")

plot(predict(mr05.ppm), main="Estimated rates")
#plot(mr05.ppm, main="Estimated rates")

addPolys(water,col="white",border=FALSE)
#browser();return()
invisible(list(sll=sll,sutm=sutm,xlim=xlim,ylim=ylim,

r03=r03,r03.ppp=r03.ppp,r03.im=r03.im,mr05=mr05,mr05.ppp=mr05.ppp,mr05.pp
m=mr05.ppm,bbox=bbox,land=land,water=water))}

out=estmap()
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